data_1hx7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hx7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 54' ' ' LYS . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD2' ' CE1' ' A' ' 6' ' ' TYR . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 80' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 33' ' ' ILE . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.125 0.488 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD22 ' CZ ' ' A' ' 83' ' ' PHE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 83' ' ' PHE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 91' ' ' ARG . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.4 ' CB ' ' CD2' ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.429 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 34' ' ' PHE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 83' ' ' PHE . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 11.2 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 79' ' ' LEU . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 2' ' ' ARG . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 83' ' ' PHE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 HG13 ' CE1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 83' ' ' PHE . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 61' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.444 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 90' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 32' ' ' ARG . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.409 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.279 0.562 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 HD13 ' CD2' ' A' ' 34' ' ' PHE . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 79' ' ' LEU . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 33' ' ' ILE . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG11 ' CE1' ' A' ' 83' ' ' PHE . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 ' N ' HD23 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 33' ' ' ILE . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG11 ' CE1' ' A' ' 83' ' ' PHE . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 55' ' ' VAL . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.414 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HE2' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' CD1' ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.442 HD23 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.442 ' CE2' HD23 ' A' ' 79' ' ' LEU . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 33' ' ' ILE . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CD2' HD11 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 83' ' ' PHE . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 83' ' ' PHE . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 55' ' ' VAL . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.482 HG23 HD11 ' A' ' 93' ' ' ILE . 12.7 tt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 23.1 p-10 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 83' ' ' PHE . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.439 HD12 ' CD2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 34' ' ' PHE . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 83' ' ' PHE . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 55' ' ' VAL . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 51' ' ' LEU . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 34' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 92' ' ' PHE . 8.9 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE1' HG13 ' A' ' 63' ' ' VAL . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 54' ' ' LYS . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG2' ' NZ ' ' A' ' 81' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' NZ ' ' CG2' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.296 0.569 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.454 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 83' ' ' PHE . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.445 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.444 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.445 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 18' ' ' ILE . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 33' ' ' ILE . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.447 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG12 ' CE1' ' A' ' 83' ' ' PHE . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.762 0.315 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -133.02 170.27 15.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 54' ' ' LYS . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD2' ' CE1' ' A' ' 6' ' ' TYR . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.04 3.48 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.05 70.44 7.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -158.73 7.75 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -60.82 -30.39 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.424 -1.045 . . . . 0.0 109.265 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -153.45 -173.93 4.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.26 151.17 37.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.38 92.35 3.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.688 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' CE1' ' A' ' 83' ' ' PHE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.33 102.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -100.52 59.27 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 125.15 22.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.418 -0.801 . . . . 0.0 109.702 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.99 44.47 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.595 -0.691 . . . . 0.0 109.647 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.02 -60.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.779 . . . . 0.0 109.929 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 179.95 131.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mt -81.56 -31.34 32.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.153 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.92 131.81 2.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.23 109.48 6.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.6 -73.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 m -113.78 -54.65 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -177.8 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -59.6 -38.29 80.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -97.56 4.78 50.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 110.194 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.05 -23.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 110.147 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 80' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -27.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -49.86 -38.48 35.55 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.828 . . . . 0.0 111.111 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.17 28.47 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -50.74 3.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.8 pt -130.82 175.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.619 -0.93 . . . . 0.0 109.589 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 -69.98 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.378 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.3 t -132.11 51.55 2.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.246 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -61.31 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.747 . . . . 0.0 109.598 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.06 96.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -111.0 29.86 7.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.937 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -63.33 1.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.614 -0.679 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.37 65.02 0.1 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.454 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.0 168.91 17.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 33' ' ' ILE . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 66.3 4.17 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.7 m -45.68 -27.41 0.79 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.691 -0.631 . . . . 0.0 111.528 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.27 -97.04 0.21 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -57.71 -51.81 68.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.641 -0.917 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -95.6 82.81 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.571 -0.706 . . . . 0.0 109.296 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -59.72 149.07 31.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.66 62.16 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.561 -0.712 . . . . 0.0 109.889 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD22 ' CZ ' ' A' ' 83' ' ' PHE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 83' ' ' PHE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 91' ' ' ARG . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t -109.29 136.08 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 169.78 10.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.701 -0.625 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -134.33 99.5 4.4 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.8 tp -114.92 -27.09 7.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.717 . . . . 0.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.42 -50.91 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 110.094 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.24 133.56 0.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.279 -0.888 . . . . 0.0 109.66 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.51 -63.4 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.232 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.06 -162.27 30.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -129.56 -44.2 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.666 -0.902 . . . . 0.0 109.7 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.7 39.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.84 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.9 t -166.32 -157.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.21 47.79 1.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.576 -0.702 . . . . 0.0 109.794 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.04 -43.87 28.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.87 -32.16 71.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.67 -18.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.656 . . . . 0.0 109.939 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CD1' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' CB ' ' CD2' ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt -63.86 -26.51 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -58.5 -27.99 64.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 0.0 110.105 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.81 -52.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.95 46.13 0.21 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.05 159.15 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.669 -0.901 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -66.05 -71.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.631 -0.668 . . . . 0.0 109.634 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t -177.4 68.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -58.82 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.72 -34.04 0.19 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -76.75 -29.69 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.466 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -161.93 -173.12 3.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.66 -98.77 0.13 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.2 pttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.474 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 -146.17 160.2 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.429 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.9 -22.04 23.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -72.93 68.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.876 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 -166.64 11.67 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -58.88 -31.37 68.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.423 -1.046 . . . . 0.0 109.228 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -142.1 163.29 33.26 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.5 t -60.85 174.31 0.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -156.26 43.86 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 34' ' ' PHE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 83' ' ' PHE . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 11.2 p -105.58 161.39 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -138.67 161.79 36.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -126.29 89.76 3.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -49.35 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 109.318 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.06 -43.66 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.645 -0.66 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 130.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.63 -0.669 . . . . 0.0 109.314 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.6 100.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.703 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.07 21.79 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.07 -170.38 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.621 -0.929 . . . . 0.0 109.508 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.21 -27.76 55.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -60.88 167.55 2.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.485 -0.759 . . . . 0.0 109.171 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.45 77.25 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.459 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.17 -25.5 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.665 -0.647 . . . . 0.0 109.48 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.47 4.04 38.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.427 -0.795 . . . . 0.0 109.859 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.03 -23.07 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.071 . . . . 0.0 110.211 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 79' ' ' LEU . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tp -59.15 -24.51 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -28.81 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -120.31 -68.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 109.644 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.1 -29.02 0.64 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.43 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.565 -0.962 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 p -61.35 157.11 17.34 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 t -71.6 71.41 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.61 -0.681 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.16 75.39 1.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.491 -0.756 . . . . 0.0 109.388 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.4 72.88 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.5 -173.26 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.525 -0.985 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.3 mtt -99.59 85.6 3.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.57 -28.37 69.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.537 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 -124.2 153.91 40.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 2' ' ' ARG . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -49.4 -26.47 3.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 m -72.21 66.4 0.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.535 -0.728 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.52 -81.82 0.09 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -114.76 -73.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.946 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -127.55 -46.91 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.571 -0.706 . . . . 0.0 109.449 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 p -171.18 136.26 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.55 50.55 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.402 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 83' ' ' PHE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 HG13 ' CE1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 83' ' ' PHE . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.17 138.62 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -103.42 152.54 21.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.633 -0.667 . . . . 0.0 109.578 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -99.93 59.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.73 -43.85 78.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -72.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.411 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -177.12 138.02 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.707 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 2.2 mm? -56.3 -45.61 80.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 110.111 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.18 -122.48 2.39 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.01 -44.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.999 . . . . 0.0 109.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -155.79 -46.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.462 -0.774 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -61.16 169.56 2.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.501 -0.749 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.03 64.15 0.51 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.0 109.41 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.47 -44.67 20.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.958 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttt -62.56 -38.67 90.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.58 -30.23 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.636 -0.665 . . . . 0.0 109.682 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 61' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.62 -29.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -54.43 -30.08 51.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.358 -0.839 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -139.81 -44.09 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.04 -37.45 2.99 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.478 HG23 HD13 ' A' ' 97' ' ' ILE . 47.3 mt -77.23 162.97 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.71 -0.876 . . . . 0.0 109.19 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -73.52 -162.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -72.64 66.6 0.73 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 108.975 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.92 87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.571 -0.706 . . . . 0.0 109.76 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.26 108.33 0.51 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -101.87 -31.8 10.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.629 -0.924 . . . . 0.0 109.364 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.6 mtp -147.41 119.77 8.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.698 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.42 -63.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mttt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.395 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 -132.48 157.17 45.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.591 -0.693 . . . . 0.0 109.18 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.02 60.28 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 29.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -0.808 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.77 -52.54 1.19 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.41 -48.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.947 . . . . 0.0 109.353 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.0 p -133.51 -54.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.597 -0.689 . . . . 0.0 109.314 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.89 153.54 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 109.357 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.64 54.88 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.744 . . . . 0.0 109.308 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.444 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -124.86 136.8 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -91.04 -171.52 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -147.54 61.68 1.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.484 -0.76 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.97 -31.6 72.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -151.6 -64.02 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.321 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -178.81 142.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.684 . . . . 0.0 109.49 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.8 mm? -54.14 -72.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.39 -139.44 10.51 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -136.63 -65.54 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.381 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.65 -45.93 0.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 m -64.5 162.28 15.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.423 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.32 70.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.493 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.09 -39.39 10.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 108.933 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -74.59 -49.27 22.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.51 -17.38 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 90' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -65.6 -28.27 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -97.81 29.7 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.836 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -174.31 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 109.489 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.9 6.16 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 pt -155.92 -176.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.421 -1.046 . . . . 0.0 109.313 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -63.01 161.79 12.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.307 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 t -71.16 71.02 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.556 -0.715 . . . . 0.0 109.355 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -71.19 70.53 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 109.324 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.71 40.93 0.04 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -121.92 144.46 48.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.969 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.9 mtt -69.52 -69.05 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.412 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.63 49.21 3.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.454 -1.027 . . . . 0.0 109.73 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ttp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 -138.63 147.81 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 109.412 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 32' ' ' ARG . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.409 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.03 20.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -72.11 66.67 0.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.513 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.83 -155.64 6.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -63.57 -31.23 72.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.952 . . . . 0.0 109.433 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.4 m -156.89 -174.82 5.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.395 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p -62.1 129.82 42.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -101.34 66.97 1.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.568 -0.707 . . . . 0.0 109.608 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 HD13 ' CD2' ' A' ' 34' ' ' PHE . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.9 105.9 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -102.02 66.1 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -58.49 146.27 35.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.551 -0.718 . . . . 0.0 110.295 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.89 -33.22 40.13 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.47 -45.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.605 -0.684 . . . . 0.0 109.437 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -174.76 139.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.677 -0.639 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.96 33.54 3.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.34 139.37 2.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -150.37 -65.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.613 -0.933 . . . . 0.0 109.678 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -63.42 -66.39 0.55 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.7 m -92.67 155.34 17.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.581 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.68 68.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.593 -0.692 . . . . 0.0 109.276 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.39 -47.52 15.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.09 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 37.3 ttp -62.82 -40.61 97.94 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.5 -14.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.624 -0.672 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 79' ' ' LEU . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -55.18 -24.28 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.79 -47.23 59.83 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -158.23 23.51 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 110.386 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -17.22 53.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 pt -153.09 -175.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -1.192 . . . . 0.0 109.565 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -148.11 -77.25 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.711 . . . . 0.0 109.317 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 t -90.38 52.29 2.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.725 . . . . 0.0 109.128 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.91 86.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.645 -0.659 . . . . 0.0 109.396 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.61 -52.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -61.87 -26.59 68.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.927 . . . . 0.0 109.75 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.14 64.7 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.53 -0.731 . . . . 0.0 109.382 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.36 54.14 0.5 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.704 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.27 44.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.547 -0.721 . . . . 0.0 109.345 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 33' ' ' ILE . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.86 59.09 2.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 29.8 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.376 -0.828 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.39 -123.96 4.5 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -83.51 -30.46 27.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.989 . . . . 0.0 109.466 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -149.82 -49.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -176.87 155.49 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 109.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -119.96 84.22 2.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.589 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG11 ' CE1' ' A' ' 83' ' ' PHE . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t -139.41 162.25 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 172.92 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -129.31 75.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.666 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.58 -39.14 74.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.569 -0.707 . . . . 0.0 109.317 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.02 -51.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.303 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -178.01 122.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.614 -0.679 . . . . 0.0 109.445 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.99 -52.01 64.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 109.514 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.56 52.11 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -147.09 -53.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -113.68 -75.71 0.59 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 109.636 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -111.0 -158.78 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.477 -0.764 . . . . 0.0 109.411 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.47 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 109.565 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.26 -30.41 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.711 . . . . 0.0 109.615 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -37.67 9.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.541 -0.725 . . . . 0.0 109.518 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp -64.95 -26.36 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 ' N ' HD23 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 tp -61.14 -23.41 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.79 -26.31 61.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.333 -0.854 . . . . 0.0 110.17 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -157.1 -47.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.475 -0.766 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.76 27.11 9.22 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 97' ' ' ILE . 23.0 mt -97.76 164.9 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.963 . . . . 0.0 109.322 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.8 m -63.2 -166.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -67.88 82.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.678 . . . . 0.0 109.363 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.85 36.34 2.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.642 . . . . 0.0 109.544 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.09 33.18 3.11 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -114.83 148.36 38.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.902 . . . . 0.0 109.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -99.68 -56.88 2.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.92 41.93 53.94 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.8 mttt . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.693 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.7 177.37 7.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.597 -0.689 . . . . 0.0 109.163 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 33' ' ' ILE . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.42 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.92 58.26 2.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.27 84.04 2.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.422 -0.799 . . . . 0.0 109.422 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.99 -149.53 7.29 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -78.06 -37.68 46.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.596 -0.943 . . . . 0.0 109.454 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 t -125.09 -175.43 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 p -85.31 127.19 34.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.86 66.9 5.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG11 ' CE1' ' A' ' 83' ' ' PHE . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.31 161.69 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 173.08 11.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.545 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -117.12 94.73 4.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.539 -0.726 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.49 -72.94 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -110.7 -38.71 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -176.26 113.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.705 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.16 -46.51 82.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.592 -0.693 . . . . 0.0 110.0 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.08 -158.36 7.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -122.53 -160.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.677 -0.896 . . . . 0.0 109.373 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.08 -32.78 73.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.392 -0.817 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.1 m -66.1 162.47 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.97 67.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.04 -27.65 30.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.77 15.1 23.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.675 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.42 -30.83 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.279 -0.888 . . . . 0.0 109.058 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 55' ' ' VAL . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.0 tt -67.15 -27.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -56.23 -23.01 33.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.78 . . . . 0.0 110.541 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -171.83 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.39 -0.818 . . . . 0.0 109.708 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.39 -7.39 5.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.26 176.1 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -1.21 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.2 t -155.96 -79.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.653 -0.654 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -99.74 44.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -51.08 -25.82 5.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.14 68.99 0.05 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.02 154.8 18.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 109.832 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.1 mtm -142.14 -52.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.18 56.83 13.64 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 -118.26 156.84 28.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.61 -0.681 . . . . 0.0 109.234 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.32 69.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 t -89.23 68.48 8.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.5 4.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.562 -0.964 . . . . 0.0 109.3 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 t -161.65 -174.25 4.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.664 -0.647 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 130.98 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.87 83.8 2.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t -114.15 155.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.06 153.53 37.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 109.296 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -98.59 77.64 2.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.1 tp -84.1 -43.18 15.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.712 . . . . 0.0 109.28 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.05 -65.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.678 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -178.02 125.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.63 -63.19 1.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.97 108.69 0.49 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.35 -30.25 8.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -1.011 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.46 -71.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -132.23 -157.73 0.84 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 65.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.716 -0.615 . . . . 0.0 109.786 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -94.16 -41.95 9.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 108.873 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.3 tmm? -64.43 -30.63 71.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.42 -21.16 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.548 -0.72 . . . . 0.0 109.898 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.414 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 tp -68.13 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.03 -37.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.17 -22.85 8.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 110.156 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.25 -41.18 2.19 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -155.18 -172.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.844 . . . . 0.0 109.236 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.413 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . 0.5 OUTLIER -150.41 -79.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.496 -0.752 . . . . 0.0 109.246 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.0 t -119.03 52.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.56 -24.25 13.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.548 -0.72 . . . . 0.0 110.172 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.19 91.57 0.09 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.38 56.7 4.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.96 . . . . 0.0 109.495 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 mtp -84.8 -50.31 7.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.66 38.87 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.763 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.47 171.55 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HE2' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.62 67.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 m -93.35 44.71 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.48 -90.79 2.19 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 p -100.26 -28.48 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 109.202 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 m -171.1 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.236 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.0 -178.71 0.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.128 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -171.91 112.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.409 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' CD1' ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.86 152.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.65 -173.5 2.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.454 -0.779 . . . . 0.0 110.601 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.28 100.54 6.74 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 tp -167.67 -43.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 109.162 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -150.04 118.59 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -52.3 167.01 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 110.007 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.0 -30.55 19.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.608 -0.683 . . . . 0.0 109.221 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.37 24.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -148.06 -58.29 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.929 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.62 -45.53 9.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.552 -0.718 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.1 m -98.37 154.87 17.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.654 -0.654 . . . . 0.0 109.331 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.76 65.13 0.69 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.731 . . . . 0.0 109.268 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -79.03 -51.37 9.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.398 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -60.07 -31.32 69.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.63 -23.6 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.513 -0.742 . . . . 0.0 109.854 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.442 HD23 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.442 ' CE2' HD23 ' A' ' 79' ' ' LEU . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.8 tp -58.35 -27.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.68 -35.87 62.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.728 . . . . 0.0 109.61 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.1 -70.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.526 -0.734 . . . . 0.0 109.539 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.78 -34.86 2.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.8 mm -88.32 -65.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.772 -0.84 . . . . 0.0 109.765 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.75 -163.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.773 . . . . 0.0 109.19 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.8 t -74.09 65.55 1.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.505 -0.747 . . . . 0.0 109.281 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.52 80.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 0.0 109.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.34 70.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -155.42 29.57 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.966 . . . . 0.0 109.56 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.32 -65.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.76 2.65 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.38 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -155.87 167.21 31.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.552 -0.718 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 33' ' ' ILE . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.61 -27.44 64.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -72.24 66.17 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 0.0 109.515 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.02 -127.01 2.58 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.7 p -71.18 -30.43 66.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.93 . . . . 0.0 109.245 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 t -175.89 -59.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.547 -0.721 . . . . 0.0 109.337 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -136.68 169.1 18.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.03 55.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -133.11 128.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -78.45 149.99 33.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.612 -0.68 . . . . 0.0 109.232 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 58.51 5.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.469 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mt -62.71 -163.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 109.055 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.15 -45.03 61.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.341 -0.85 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -176.46 147.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 109.939 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -57.49 12.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.573 -0.704 . . . . 0.0 110.05 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.98 -139.82 4.05 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -106.41 -163.82 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.15 76.58 0.35 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.61 -171.16 2.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.482 -0.761 . . . . 0.0 109.142 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.61 46.97 1.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.225 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.81 -47.3 16.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -61.44 -40.56 94.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.49 -21.57 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.588 -0.695 . . . . 0.0 109.978 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CD2' HD11 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -63.27 -29.9 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -51.21 -25.63 5.81 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.397 -0.814 . . . . 0.0 110.68 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -164.65 -63.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.71 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.32 -25.98 1.86 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.7 mt -65.72 162.81 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.99 . . . . 0.0 109.296 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -162.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 t -71.55 68.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.322 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.38 80.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.77 45.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 83.25 2.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.645 -0.915 . . . . 0.0 109.629 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtp -152.84 145.41 24.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.42 60.53 0.37 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.411 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 -132.4 164.87 25.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.638 -0.664 . . . . 0.0 109.346 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.53 -21.24 36.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 t -71.71 67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.46 -156.72 7.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.2 m -63.09 -44.49 95.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -1.04 . . . . 0.0 109.32 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.2 m -140.81 -176.53 4.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -62.87 122.57 16.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.17 70.93 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.342 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 83' ' ' PHE . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 83' ' ' PHE . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.45 112.91 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 179.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 109.879 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -121.59 117.88 27.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.65 -0.656 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tp -177.88 -41.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -120.73 114.66 21.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.97 148.89 3.88 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.439 -0.788 . . . . 0.0 110.41 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 4.0 mm? -57.87 -26.74 62.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 110.198 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.0 150.85 5.52 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -112.22 61.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.94 . . . . 0.0 109.01 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -150.05 -157.89 0.86 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.79 . . . . 0.0 108.975 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 75' ' ' ASP . 9.5 m -48.73 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.93 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.55 -0.719 . . . . 0.0 111.147 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' THR . 63.2 m-20 -103.65 -44.4 5.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.6 ttt -64.09 -39.91 95.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp -72.63 -24.18 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 55' ' ' VAL . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.482 HG23 HD11 ' A' ' 93' ' ' ILE . 12.7 tt -62.37 -24.23 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -58.52 -19.99 42.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.316 -0.865 . . . . 0.0 110.605 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.84 -43.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.37 30.5 1.41 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 pt -155.77 -174.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -1.002 . . . . 0.0 109.267 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.02 -178.74 5.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.31 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.5 t -74.67 67.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.72 85.26 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.24 106.55 0.23 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -110.46 144.96 38.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.956 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -34.28 76.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.747 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.31 -33.59 0.65 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.392 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -135.84 170.05 16.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 109.26 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -25.98 64.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 m -59.08 -19.63 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.443 -0.786 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.46 -168.98 0.19 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -61.38 -74.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.546 -0.973 . . . . 0.0 109.702 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -83.18 -172.19 4.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.53 -0.731 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 23.1 p-10 -145.76 101.96 3.61 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 83' ' ' PHE . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.86 138.5 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.53 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.876 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -23.63 30.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.84 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.47 -54.06 38.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.1 63.58 7.73 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -47.38 159.66 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.592 -0.693 . . . . 0.0 110.994 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.8 mm? -61.31 -77.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.712 -0.617 . . . . 0.0 110.26 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.35 -138.32 2.41 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.417 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.684 -0.892 . . . . 0.0 110.142 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.91 -8.05 35.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.641 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 t -62.55 -157.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.014 . . . . 0.0 109.156 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.8 44.22 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.21 -39.06 21.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.6 ttp -63.12 -17.19 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.36 -25.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.439 HD12 ' CD2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.85 -30.72 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -43.95 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 179.98 -39.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.93 52.83 0.88 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.01 10.96 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.712 -0.875 . . . . 0.0 110.354 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.44 -72.95 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.107 -0.996 . . . . 0.0 109.21 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 t -105.58 52.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.05 80.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.89 73.69 0.45 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.33 175.26 0.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.0 109.635 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.6 ttt -138.35 142.97 39.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 71.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -139.34 168.16 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.662 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.32 -21.08 21.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.53 -22.07 19.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.65 -172.51 0.27 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -60.54 -37.0 79.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.411 -1.053 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 m -131.48 175.5 9.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.126 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -65.65 120.71 13.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 109.399 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.8 69.87 3.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.669 . . . . 0.0 109.235 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 34' ' ' PHE . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 83' ' ' PHE . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.96 115.49 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -122.38 66.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -60.31 155.52 17.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.46 -0.775 . . . . 0.0 110.041 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -36.88 13.49 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -130.59 -53.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.517 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -163.1 153.99 16.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.505 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.0 mm? -55.93 -58.56 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.137 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.35 -104.91 1.72 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -162.54 -46.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.926 . . . . 0.0 109.43 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.78 -45.14 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.7 m -64.71 164.28 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.429 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 91.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 109.701 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -110.05 -24.36 10.81 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.417 ' HE3' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.8 2.21 27.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.75 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.47 -34.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.064 -1.023 . . . . 0.0 110.061 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 55' ' ' VAL . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CD1' ' HA2' ' A' ' 96' ' ' GLY . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt -43.4 -32.69 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.38 -13.21 9.8 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.449 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -78.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' A' ' 92' ' ' PHE . . . 136.13 74.83 0.07 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 97' ' ' ILE . 52.9 mt -76.22 -19.59 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.746 -0.855 . . . . 0.0 110.258 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -53.63 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -98.5 53.21 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.742 . . . . 0.0 109.064 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.79 80.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.602 -0.686 . . . . 0.0 109.413 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.16 68.02 1.82 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -117.56 -173.5 2.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.1 mtp -152.64 -62.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.658 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.94 30.56 9.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.532 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -104.93 159.26 15.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 16' ' ' LEU . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 51' ' ' LEU . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.5 60.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -134.96 82.73 1.98 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.99 -136.0 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -76.81 -34.44 57.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.954 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -143.63 -67.52 0.35 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 p -160.09 159.37 31.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.6 63.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.499 -0.751 . . . . 0.0 109.447 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 34' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 92' ' ' PHE . 8.9 p -104.28 133.96 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -152.6 119.01 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.34 173.96 10.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 109.707 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.2 mm? -64.68 -32.5 74.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.633 -0.667 . . . . 0.0 109.227 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -139.51 -45.97 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -177.41 -173.88 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.0 109.575 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.49 43.19 3.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.509 -0.744 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.03 -172.84 19.17 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -164.04 -64.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.655 -0.909 . . . . 0.0 109.345 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -135.55 -60.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.37 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -71.34 169.29 15.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.686 . . . . 0.0 109.289 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.59 65.23 0.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.475 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.44 -47.62 22.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.51 -0.744 . . . . 0.0 109.023 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.0 tmm? -63.13 -37.03 85.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.22 -20.78 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 110.121 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CG ' ' HB3' ' A' ' 98' ' ' SER . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.43 78.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.8 t70 -179.12 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.02 28.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.682 -0.636 . . . . 0.0 110.252 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.83 28.17 30.68 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.6 pt -148.46 158.12 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -1.025 . . . . 0.0 109.856 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' HB3' ' CG ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -160.48 -68.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.8 t -95.36 34.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.29 -25.88 2.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.654 . . . . 0.0 110.269 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.17 71.8 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.35 166.8 23.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.918 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.2 mtp -161.16 113.9 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.24 -86.0 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -110.14 145.84 36.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' CG1' ' HA ' ' A' ' 30' ' ' ALA . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.58 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -98.15 36.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.51 -0.744 . . . . 0.0 109.604 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.7 -44.77 5.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 p -160.24 -48.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.625 -0.927 . . . . 0.0 109.384 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -138.48 -56.78 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.743 . . . . 0.0 109.552 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -169.13 165.56 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.55 109.33 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.41 109.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -66.59 -168.85 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.701 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -115.77 119.61 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tp -179.79 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.21 112.5 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.4 121.67 8.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.472 -0.767 . . . . 0.0 110.013 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mt -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.565 -0.71 . . . . 0.0 109.7 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.98 150.51 20.57 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 -58.78 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.577 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -131.34 -67.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -99.28 -158.39 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.22 79.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.664 -0.648 . . . . 0.0 109.65 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -96.27 -37.08 10.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 108.914 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -86.65 -1.57 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 110.314 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.66 -27.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 109.525 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tp -58.85 -43.68 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.79 39.48 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.722 . . . . 0.0 109.538 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.2 80.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.26 44.83 3.33 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -108.62 171.01 2.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.457 -1.025 . . . . 0.0 108.969 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 m -62.62 -175.75 0.09 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 108.92 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.1 m -67.38 81.7 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -105.91 121.15 43.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.88 -37.9 1.54 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.03 -28.1 69.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.942 . . . . 0.0 109.646 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.5 ttt -141.72 151.56 43.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.517 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.37 -92.85 0.12 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.8 mttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.438 179.909 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -129.65 155.94 45.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.345 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 54' ' ' LYS . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.35 59.88 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -116.68 -33.18 4.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.44 -157.94 0.11 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.9 m -61.5 -68.99 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.509 -0.995 . . . . 0.0 109.6 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -95.11 170.59 9.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.6 -0.687 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.27 156.62 25.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.85 78.98 2.0 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.704 . . . . 0.0 109.114 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.36 136.51 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -93.29 -176.08 4.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.469 -0.769 . . . . 0.0 110.165 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -129.77 125.76 36.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.615 -0.678 . . . . 0.0 109.549 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.81 -55.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -100.8 121.8 42.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -43.18 123.29 2.83 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.446 0.641 . . . . 0.0 111.341 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mt -54.94 -42.82 72.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.651 -0.656 . . . . 0.0 110.326 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.67 -174.25 44.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -168.51 49.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.637 -0.919 . . . . 0.0 109.336 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.31 -158.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.2 t -53.36 -43.15 67.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.44 68.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.201 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.88 -31.74 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.39 -0.819 . . . . 0.0 109.046 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.406 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -101.43 -39.38 7.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.311 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG2' ' NZ ' ' A' ' 81' ' ' LYS . 3.4 mp -56.36 -22.13 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.89 -1.131 . . . . 0.0 109.374 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 76' ' ' MET . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' NZ ' ' CG2' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.6 tt -48.76 -46.16 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.13 42.27 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.872 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -165.42 -47.48 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 0.0 110.41 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.57 -35.16 4.79 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.26 -175.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.56 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.453 -0.779 . . . . 0.0 109.739 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.1 t -87.21 56.63 4.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.59 68.69 0.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.82 52.45 37.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.9 114.78 3.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.91 . . . . 0.0 109.804 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.9 mtt -164.23 30.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.427 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.85 -55.4 0.02 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -120.45 152.55 37.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.645 -0.66 . . . . 0.0 109.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.1 6.45 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 m -73.16 66.52 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.09 -121.34 2.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 m -94.25 -74.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.915 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -105.73 -47.4 3.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 p -174.48 163.79 3.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.641 -0.662 . . . . 0.0 109.595 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 44.17 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.454 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 83' ' ' PHE . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.445 ' CD1' ' CG ' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.41 88.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -61.44 179.31 0.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.066 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.31 120.59 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.61 -0.681 . . . . 0.0 109.874 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 tp -178.56 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -134.64 110.77 9.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -60.74 144.28 52.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 109.747 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -61.76 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.554 -0.716 . . . . 0.0 109.222 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.88 140.23 46.88 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.11 29.54 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.536 -0.979 . . . . 0.0 109.745 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -102.78 -66.15 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.498 -0.751 . . . . 0.0 109.318 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 t -120.99 -157.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -95.14 -49.97 5.27 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 1.7 tmt? -59.28 -21.83 60.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.757 -0.59 . . . . 0.0 109.759 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 mp -97.84 -20.09 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.426 -0.797 . . . . 0.0 109.909 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 ' CG2' ' CG2' ' A' ' 99' ' ' THR . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.445 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.89 -28.99 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.08 -33.7 76.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.752 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.19 -60.64 0.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 109.825 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.64 2.94 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.6 mm -85.98 167.47 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.735 -0.861 . . . . 0.0 109.603 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -55.66 -68.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.403 ' CG2' ' CG2' ' A' ' 80' ' ' ILE . 2.0 t 179.93 66.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.39 79.29 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.656 -0.652 . . . . 0.0 109.489 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.95 82.09 0.08 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 117.66 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.962 . . . . 0.0 109.284 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.7 ptm -168.91 -42.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.682 . . . . 0.0 109.483 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.25 -69.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.492 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 164.76 25.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.687 . . . . 0.0 109.332 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' ' CD1' ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 18' ' ' ILE . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 33' ' ' ILE . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.95 -16.68 60.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 t -98.53 76.6 2.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.876 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.57 -147.86 4.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -60.89 -29.03 69.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -1.004 . . . . 0.0 109.239 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.49 173.9 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.58 152.24 35.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.39 83.2 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.447 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG12 ' CE1' ' A' ' 83' ' ' PHE . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.38 108.29 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -73.56 -176.2 2.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.668 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.42 76.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.608 -0.682 . . . . 0.0 109.285 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.9 tp -90.21 -66.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -113.02 -67.94 0.96 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.343 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -178.6 151.93 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.61 -0.681 . . . . 0.0 109.207 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.6 mm? -56.74 -65.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 110.367 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.45 -138.01 2.8 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.93 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.581 -0.952 . . . . 0.0 109.811 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.67 -24.35 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 110.48 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.1 t -61.05 -160.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.329 -0.857 . . . . 0.0 109.723 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.54 67.47 0.76 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.19 -57.05 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.823 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.465 ' CE ' ' CE2' ' A' ' 92' ' ' PHE . 3.6 tpp -62.43 -41.16 98.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.5 -20.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.461 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' CE2' ' CE ' ' A' ' 76' ' ' MET . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.28 -28.86 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.02 -23.54 38.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.518 -0.739 . . . . 0.0 110.241 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.18 -67.7 0.94 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.84 . . . . 0.0 109.762 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.9 -30.26 1.66 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.462 HG22 HD13 ' A' ' 97' ' ' ILE . 36.2 pt -127.64 -170.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 109.336 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.82 150.0 38.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.762 . . . . 0.0 109.582 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.419 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 2.5 t -68.89 77.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.0 72.19 3.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.654 . . . . 0.0 109.442 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.1 55.67 4.71 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -122.35 84.91 2.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.529 -0.983 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -63.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.476 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.08 -71.72 0.19 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.578 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.547 HD12 ' HD2' ' A' ' 29' ' ' LYS . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 51' ' ' LEU . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 19' ' ' GLN . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 16' ' ' LEU . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.73 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 15' ' ' SER . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.742 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 33' ' ' ILE . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HD2' HD12 ' A' ' 3' ' ' LEU . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 ' CD1' ' A' ' 16' ' ' LEU . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 4' ' ' PHE . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 61' ' ' ILE . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.704 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 28' ' ' VAL . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.409 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 79' ' ' LEU . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 HD13 ' A' ' 90' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 90' ' ' ILE . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 61' ' ' ILE . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.882 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 27' ' ' GLY . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.715 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.727 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 HG21 ' A' ' 35' ' ' THR . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 33' ' ' ILE . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 7' ' ' ALA . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 5' ' ' GLY . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.791 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.747 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 8' ' ' ARG . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.125 0.488 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 48' ' ' LEU . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD21 HG23 ' A' ' 61' ' ' ILE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 61' ' ' ILE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.698 HD13 ' CD2' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 HG23 ' A' ' 28' ' ' VAL . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.685 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.574 ' N ' HD22 ' A' ' 79' ' ' LEU . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 86' ' ' GLN . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.422 ' CB ' HD23 ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 51' ' ' LEU . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.66 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' HD12 ' A' ' 18' ' ' ILE . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 HD11 HG21 ' A' ' 35' ' ' THR . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.655 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.833 HG22 HG21 ' A' ' 33' ' ' ILE . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 7' ' ' ALA . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.874 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.874 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.749 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 48' ' ' LEU . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 61' ' ' ILE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG13 ' HG ' ' A' ' 51' ' ' LEU . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD1' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 88' ' ' VAL . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 11.2 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.745 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.745 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' ILE . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 61' ' ' ILE . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' CZ ' HG11 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 51' ' ' LEU . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.819 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' ILE . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.815 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 3.5 mm-40 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.047 HG22 HG21 ' A' ' 33' ' ' ILE . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.047 HG21 HG22 ' A' ' 20' ' ' VAL . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 50' ' ' LEU . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.84 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 61' ' ' ILE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HD1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 51' ' ' LEU . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 26' ' ' ALA . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' HD11 ' A' ' 90' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 56' ' ' GLU . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.864 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.825 ' HA3' HG21 ' A' ' 28' ' ' VAL . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.793 HG22 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.509 ' O ' HD12 ' A' ' 18' ' ' ILE . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.793 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.811 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 14' ' ' GLN . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 7' ' ' ALA . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 ' HA3' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 61' ' ' ILE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.512 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.74 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.9 mp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 ' CD1' ' A' ' 90' ' ' ILE . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.74 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 90' ' ' ILE . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 ' CG ' ' A' ' 59' ' ' ASP . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CD1' HD13 ' A' ' 80' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 51' ' ' LEU . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 38' ' ' ALA . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.691 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' THR . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.753 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 33' ' ' ILE . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.893 HD11 ' HB2' ' A' ' 7' ' ' ALA . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.916 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 5' ' ' GLY . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 24' ' ' LYS . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.761 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.279 0.562 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.675 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 51' ' ' LEU . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.6 ' O ' HG22 ' A' ' 88' ' ' VAL . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 48' ' ' LEU . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 61' ' ' ILE . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 56' ' ' GLU . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 61' ' ' ILE . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.862 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 27' ' ' GLY . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.718 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 15' ' ' SER . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 18' ' ' ILE . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.736 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.718 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.859 HG22 HG21 ' A' ' 33' ' ' ILE . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 5' ' ' GLY . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.859 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 16' ' ' LEU . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.692 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 51' ' ' LEU . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.586 ' OD1' HG22 ' A' ' 88' ' ' VAL . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' ARG . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 88' ' ' VAL . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 mp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.805 ' N ' HD22 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 77' ' ' ILE . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.586 HG22 ' OD1' ' A' ' 59' ' ' ASP . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 27' ' ' GLY . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.674 ' CA ' HG21 ' A' ' 28' ' ' VAL . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.002 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 16' ' ' LEU . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.755 HG22 ' OG ' ' A' ' 15' ' ' SER . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HG3' HD11 ' A' ' 18' ' ' ILE . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.871 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.813 HD11 HG21 ' A' ' 35' ' ' THR . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 15' ' ' SER . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.713 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.869 HG22 HG21 ' A' ' 33' ' ' ILE . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.002 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.75 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 20' ' ' VAL . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.813 HG21 HD11 ' A' ' 16' ' ' LEU . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HD3' HD22 ' A' ' 16' ' ' LEU . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 79' ' ' LEU . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 55' ' ' VAL . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 83' ' ' PHE . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.633 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 61' ' ' ILE . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.413 HG13 ' CG ' ' A' ' 59' ' ' ASP . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 83' ' ' PHE . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 27' ' ' GLY . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.721 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 15' ' ' SER . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.763 ' HB2' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 33' ' ' ILE . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.721 HG11 ' HA3' ' A' ' 5' ' ' GLY . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.959 HG21 HG22 ' A' ' 20' ' ' VAL . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.54 ' HB2' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD13 ' A' ' 16' ' ' LEU . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' A' ' 83' ' ' PHE . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.511 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 90' ' ' ILE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CB ' ' A' ' 26' ' ' ALA . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.688 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.489 ' N ' HD22 ' A' ' 79' ' ' LEU . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.531 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CG ' ' A' ' 59' ' ' ASP . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 93' ' ' ILE . 7.4 tp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 36' ' ' ASP . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 15' ' ' SER . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.544 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.888 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.796 HD13 ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 19' ' ' GLN . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.919 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.653 HG11 ' HA3' ' A' ' 5' ' ' GLY . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.919 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 HD11 ' A' ' 16' ' ' LEU . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HD3' HD13 ' A' ' 16' ' ' LEU . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 48' ' ' LEU . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 51' ' ' LEU . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.713 HD13 ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD22 ' HB1' ' A' ' 26' ' ' ALA . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.713 ' CD2' HD13 ' A' ' 61' ' ' ILE . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 59' ' ' ASP . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 27' ' ' GLY . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' C ' HD21 ' A' ' 23' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 16' ' ' LEU . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 15' ' ' SER . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HG3' HD11 ' A' ' 18' ' ' ILE . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 15' ' ' SER . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.667 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.749 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HA3' ' A' ' 5' ' ' GLY . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' HE1' HD13 ' A' ' 50' ' ' LEU . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.828 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' NE ' HD22 ' A' ' 48' ' ' LEU . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 50' ' ' LEU . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.56 HD22 ' NE ' ' A' ' 45' ' ' ARG . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 ' HE1' ' A' ' 34' ' ' PHE . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 55' ' ' VAL . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 88' ' ' VAL . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.749 HD13 ' CB ' ' A' ' 26' ' ' ALA . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 55' ' ' VAL . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 61' ' ' ILE . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' HG ' ' A' ' 62' ' ' LEU . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.859 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 51' ' ' LEU . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 18' ' ' ILE . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.648 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.787 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 15' ' ' SER . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 33' ' ' ILE . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 7' ' ' ALA . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.804 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD2' HD13 ' A' ' 3' ' ' LEU . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 20' ' ' VAL . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 61' ' ' ILE . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 51' ' ' LEU . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' A' ' 88' ' ' VAL . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 51' ' ' LEU . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.634 HD13 ' CB ' ' A' ' 26' ' ' ALA . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.672 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' CD2' HD13 ' A' ' 61' ' ' ILE . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' OD1' ' A' ' 59' ' ' ASP . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.477 HG12 HD12 ' A' ' 61' ' ' ILE . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 62' ' ' LEU . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 27' ' ' GLY . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.629 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.925 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' CB ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' HG3' HD11 ' A' ' 18' ' ' ILE . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 15' ' ' SER . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.549 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 46.4 mm-40 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 16' ' ' LEU . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.925 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.683 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.787 HG21 HG22 ' A' ' 20' ' ' VAL . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 8' ' ' ARG . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 16' ' ' LEU . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 23.1 p-10 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 50' ' ' LEU . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.499 ' H ' HD12 ' A' ' 48' ' ' LEU . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 46' ' ' LYS . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 61' ' ' ILE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.616 HG23 HD21 ' A' ' 51' ' ' LEU . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD22 ' HB1' ' A' ' 26' ' ' ALA . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' CG ' ' A' ' 81' ' ' LYS . 4.8 mp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 90' ' ' ILE . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' CG ' HG22 ' A' ' 77' ' ' ILE . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' HB2' HD11 ' A' ' 90' ' ' ILE . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 61' ' ' ILE . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.772 HG12 ' N ' ' A' ' 16' ' ' LEU . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.58 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.609 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 62.6 mm-40 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 HG21 ' A' ' 33' ' ' ILE . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.633 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG11 ' HA3' ' A' ' 5' ' ' GLY . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.918 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 16' ' ' LEU . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.552 HD11 ' HG2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 55' ' ' VAL . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.658 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 90' ' ' ILE . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 56' ' ' GLU . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 27' ' ' GLY . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 37' ' ' LYS . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.765 HG22 ' OG ' ' A' ' 15' ' ' SER . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.765 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 33' ' ' ILE . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.942 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 16' ' ' LEU . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 48' ' ' LEU . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG11 ' CE1' ' A' ' 83' ' ' PHE . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' A' ' 88' ' ' VAL . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 88' ' ' VAL . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 26' ' ' ALA . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 92' ' ' PHE . 8.9 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG22 ' CE ' ' A' ' 81' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.653 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 83' ' ' PHE . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 63' ' ' VAL . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . 11.5 mmt180 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.622 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 19' ' ' GLN . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 11' ' ' THR . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.664 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.831 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 14' ' ' GLN . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.783 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 19.5 mm-40 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.01 HG22 HG21 ' A' ' 33' ' ' ILE . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.743 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 62' ' ' LEU . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' CG ' HD12 ' A' ' 3' ' ' LEU . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 20' ' ' VAL . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 51' ' ' LEU . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 61' ' ' ILE . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 61' ' ' ILE . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 3' ' ' LEU . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.617 HD11 HG11 ' A' ' 55' ' ' VAL . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 80' ' ' ILE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.744 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 59' ' ' ASP . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 61' ' ' ILE . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' HG23 ' A' ' 60' ' ' VAL . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 35' ' ' THR . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 38' ' ' ALA . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 15' ' ' SER . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' HG23 ' A' ' 11' ' ' THR . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.566 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.657 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.93 HG22 HG21 ' A' ' 33' ' ' ILE . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD12 HG23 ' A' ' 33' ' ' ILE . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 5' ' ' GLY . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 HG22 ' A' ' 20' ' ' VAL . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.731 ' CB ' ' HB3' ' A' ' 7' ' ' ALA . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.676 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD11 ' HG ' ' A' ' 79' ' ' LEU . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 61' ' ' ILE . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 90' ' ' ILE . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.702 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 90' ' ' ILE . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.704 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HE2' HD23 ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 59' ' ' ASP . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 80' ' ' ILE . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 60' ' ' VAL . 1.4 mpt_? . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.46 HD12 ' HD2' ' A' ' 29' ' ' LYS . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.591 ' HB3' HD11 ' A' ' 51' ' ' LEU . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.011 ' HB3' HG23 ' A' ' 35' ' ' THR . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 16' ' ' LEU . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.73 HG22 ' OG ' ' A' ' 15' ' ' SER . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HG3' HD11 ' A' ' 18' ' ' ILE . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.765 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.698 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 15' ' ' SER . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.675 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 33' ' ' ILE . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 5' ' ' GLY . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD2' HD12 ' A' ' 3' ' ' LEU . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 20' ' ' VAL . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CD2' HD12 ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.011 HG23 ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CD ' HD13 ' A' ' 16' ' ' LEU . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.296 0.569 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.986 HD12 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.78 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 2' ' ' ARG . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 HD12 ' A' ' 48' ' ' LEU . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.571 ' HD1' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 89' ' ' SER . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 83' ' ' PHE . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 51' ' ' LEU . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.446 ' C ' HD21 ' A' ' 23' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 16' ' ' LEU . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 35' ' ' THR . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.882 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 33' ' ' ILE . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD2' ' HB2' ' A' ' 7' ' ' ALA . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.7 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD2' HD13 ' A' ' 3' ' ' LEU . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.805 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.909 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 16' ' ' LEU . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 55' ' ' VAL . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.7 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.762 0.315 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.633 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.961 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.74 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 59' ' ' ASP . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.961 HD12 HD13 ' A' ' 80' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.598 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -133.02 170.27 15.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.547 HD12 ' HD2' ' A' ' 29' ' ' LYS . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 51' ' ' LEU . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 19' ' ' GLN . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 16' ' ' LEU . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.73 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 15' ' ' SER . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.742 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.607 ' HB1' ' HD3' ' A' ' 64' ' ' LYS . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 33' ' ' ILE . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HD2' HD12 ' A' ' 3' ' ' LEU . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 ' CD1' ' A' ' 16' ' ' LEU . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -51.03 -24.04 3.48 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.05 70.44 7.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -158.73 7.75 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -60.82 -30.39 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.424 -1.045 . . . . 0.0 109.265 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -153.45 -173.93 4.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.26 151.17 37.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.38 92.35 3.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.688 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 4' ' ' PHE . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 61' ' ' ILE . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.704 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 28' ' ' VAL . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.33 102.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.607 ' HD3' ' HB1' ' A' ' 22' ' ' ALA . 58.4 tttt -100.52 59.27 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 125.15 22.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.418 -0.801 . . . . 0.0 109.702 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.588 HD21 HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -112.99 44.47 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.595 -0.691 . . . . 0.0 109.647 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.02 -60.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.779 . . . . 0.0 109.929 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 179.95 131.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.567 HD13 ' HG3' ' A' ' 76' ' ' MET . 3.7 mt -81.56 -31.34 32.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.153 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.92 131.81 2.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.23 109.48 6.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.6 -73.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 m -113.78 -54.65 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -177.8 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -59.6 -38.29 80.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.567 ' HG3' HD13 ' A' ' 69' ' ' LEU . 6.8 tmm? -97.56 4.78 50.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 110.194 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.409 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -119.05 -23.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 110.147 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 79' ' ' LEU . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 HD13 ' A' ' 90' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 90' ' ' ILE . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 61' ' ' ILE . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.882 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -59.83 -27.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -49.86 -38.48 35.55 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.828 . . . . 0.0 111.111 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.17 28.47 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -50.74 3.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.8 pt -130.82 175.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.619 -0.93 . . . . 0.0 109.589 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 -69.98 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.378 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 99' ' ' THR . 8.3 t -132.11 51.55 2.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.246 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -61.31 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.747 . . . . 0.0 109.598 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.06 96.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -111.0 29.86 7.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.937 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -63.33 1.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.614 -0.679 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.37 65.02 0.1 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.454 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -132.0 168.91 17.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 27' ' ' GLY . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.715 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.727 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 HG21 ' A' ' 35' ' ' THR . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 33' ' ' ILE . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 7' ' ' ALA . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 5' ' ' GLY . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.791 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.747 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 8' ' ' ARG . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 66.3 4.17 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.7 m -45.68 -27.41 0.79 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.691 -0.631 . . . . 0.0 111.528 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.27 -97.04 0.21 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -57.71 -51.81 68.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.641 -0.917 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -95.6 82.81 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.571 -0.706 . . . . 0.0 109.296 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -59.72 149.07 31.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.66 62.16 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.561 -0.712 . . . . 0.0 109.889 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 48' ' ' LEU . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD21 HG23 ' A' ' 61' ' ' ILE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 61' ' ' ILE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.698 HD13 ' CD2' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 HG23 ' A' ' 28' ' ' VAL . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 69' ' ' LEU . 26.3 t -109.29 136.08 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 169.78 10.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.701 -0.625 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -134.33 99.5 4.4 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.8 tp -114.92 -27.09 7.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.717 . . . . 0.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.42 -50.91 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 110.094 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.24 133.56 0.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.279 -0.888 . . . . 0.0 109.66 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG11 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -68.51 -63.4 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.232 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.06 -162.27 30.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -129.56 -44.2 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.666 -0.902 . . . . 0.0 109.7 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.7 39.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.84 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 74' ' ' ALA . 4.9 t -166.32 -157.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 73' ' ' THR . . . -90.21 47.79 1.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.576 -0.702 . . . . 0.0 109.794 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 73' ' ' THR . 78.1 m-20 -78.04 -43.87 28.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.783 ' HG2' HD13 ' A' ' 69' ' ' LEU . 1.2 tmt? -60.87 -32.16 71.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.0 mp -92.67 -18.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.656 . . . . 0.0 109.939 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.685 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.574 ' N ' HD22 ' A' ' 79' ' ' LEU . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 86' ' ' GLN . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' CB ' HD23 ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt -63.86 -26.51 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -58.5 -27.99 64.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 0.0 110.105 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.81 -52.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.95 46.13 0.21 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.05 159.15 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.669 -0.901 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HG ' ' H ' ' A' ' 90' ' ' ILE . 3.2 m -66.05 -71.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.631 -0.668 . . . . 0.0 109.634 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 80' ' ' ILE . 2.2 t -177.4 68.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -58.82 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.72 -34.04 0.19 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 77' ' ' ILE . 52.0 mt-10 -76.75 -29.69 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -161.93 -173.12 3.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.66 -98.77 0.13 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.2 pttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.474 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 -146.17 160.2 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 51' ' ' LEU . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.66 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' HD12 ' A' ' 18' ' ' ILE . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 HD11 HG21 ' A' ' 35' ' ' THR . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.655 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.833 HG22 HG21 ' A' ' 33' ' ' ILE . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 7' ' ' ALA . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.874 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.874 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.749 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . . . -55.9 -22.04 23.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -72.93 68.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.876 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 -166.64 11.67 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -58.88 -31.37 68.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.423 -1.046 . . . . 0.0 109.228 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -142.1 163.29 33.26 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.5 t -60.85 174.31 0.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -156.26 43.86 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 48' ' ' LEU . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 61' ' ' ILE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG13 ' HG ' ' A' ' 51' ' ' LEU . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD1' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 88' ' ' VAL . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 64' ' ' LYS . 11.2 p -105.58 161.39 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 93' ' ' ILE . 20.0 tttt -138.67 161.79 36.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -126.29 89.76 3.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -49.35 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 109.318 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.06 -43.66 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.645 -0.66 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 130.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.63 -0.669 . . . . 0.0 109.314 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.6 100.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.703 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.07 21.79 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.07 -170.38 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.621 -0.929 . . . . 0.0 109.508 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.21 -27.76 55.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 74' ' ' ALA . 14.2 m -60.88 167.55 2.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.485 -0.759 . . . . 0.0 109.171 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 73' ' ' THR . . . -67.45 77.25 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' HD21 ' A' ' 79' ' ' LEU . 3.2 m-20 -95.17 -25.5 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.665 -0.647 . . . . 0.0 109.48 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.689 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -102.47 4.04 38.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.427 -0.795 . . . . 0.0 109.859 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.745 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -119.03 -23.07 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.071 . . . . 0.0 110.211 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.745 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' ILE . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 61' ' ' ILE . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' CZ ' HG11 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 64' ' ' LYS . 6.1 tp -59.15 -24.51 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -28.81 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -120.31 -68.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 109.644 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.1 -29.02 0.64 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.43 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.565 -0.962 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 p -61.35 157.11 17.34 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 99' ' ' THR . 3.6 t -71.6 71.41 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.61 -0.681 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.16 75.39 1.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.491 -0.756 . . . . 0.0 109.388 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.4 72.88 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.5 -173.26 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.525 -0.985 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.3 mtt -99.59 85.6 3.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.57 -28.37 69.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.537 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 -124.2 153.91 40.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 51' ' ' LEU . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.819 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' ILE . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.815 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 3.5 mm-40 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.047 HG22 HG21 ' A' ' 33' ' ' ILE . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 64' ' ' LYS . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.047 HG21 HG22 ' A' ' 20' ' ' VAL . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . -49.4 -26.47 3.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 m -72.21 66.4 0.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.535 -0.728 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.52 -81.82 0.09 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -114.76 -73.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.946 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -127.55 -46.91 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.571 -0.706 . . . . 0.0 109.449 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 p -171.18 136.26 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.55 50.55 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.402 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 50' ' ' LEU . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.84 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 61' ' ' ILE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HD1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 51' ' ' LEU . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 26' ' ' ALA . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.17 138.62 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HD2' ' HB1' ' A' ' 22' ' ' ALA . 2.0 ttpp -103.42 152.54 21.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.633 -0.667 . . . . 0.0 109.578 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -99.93 59.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.73 -43.85 78.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -72.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.411 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -177.12 138.02 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.707 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 2.2 mm? -56.3 -45.61 80.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 110.111 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.18 -122.48 2.39 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.01 -44.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.999 . . . . 0.0 109.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -155.79 -46.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.462 -0.774 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 74' ' ' ALA . 4.4 m -61.16 169.56 2.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.501 -0.749 . . . . 0.0 109.488 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 73' ' ' THR . . . -72.03 64.15 0.51 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.0 109.41 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.47 -44.67 20.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.958 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 80' ' ' ILE . 4.6 ttt -62.56 -38.67 90.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.2 mp -77.58 -30.23 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.636 -0.665 . . . . 0.0 109.682 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 76' ' ' MET . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' HD11 ' A' ' 90' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 56' ' ' GLU . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.864 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.62 -29.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -54.43 -30.08 51.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.358 -0.839 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -139.81 -44.09 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.04 -37.45 2.99 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 98' ' ' SER . 47.3 mt -77.23 162.97 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.71 -0.876 . . . . 0.0 109.19 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.7 m -73.52 -162.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 99' ' ' THR . 3.4 t -72.64 66.6 0.73 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 108.975 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.92 87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.571 -0.706 . . . . 0.0 109.76 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.26 108.33 0.51 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -101.87 -31.8 10.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.629 -0.924 . . . . 0.0 109.364 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.6 mtp -147.41 119.77 8.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.698 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.42 -63.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mttt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.395 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 -132.48 157.17 45.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.591 -0.693 . . . . 0.0 109.18 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.825 ' HA3' HG21 ' A' ' 28' ' ' VAL . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.793 HG22 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.509 ' O ' HD12 ' A' ' 18' ' ' ILE . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.793 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.811 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 14' ' ' GLN . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 7' ' ' ALA . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 ' HA3' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . -74.02 60.28 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 29.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -0.808 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.77 -52.54 1.19 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.41 -48.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.947 . . . . 0.0 109.353 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.0 p -133.51 -54.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.597 -0.689 . . . . 0.0 109.314 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.89 153.54 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 109.357 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.64 54.88 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.744 . . . . 0.0 109.308 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 61' ' ' ILE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -124.86 136.8 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -91.04 -171.52 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -147.54 61.68 1.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.484 -0.76 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.97 -31.6 72.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -151.6 -64.02 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.321 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -178.81 142.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.684 . . . . 0.0 109.49 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.8 mm? -54.14 -72.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.39 -139.44 10.51 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -136.63 -65.54 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.381 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.65 -45.93 0.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 74' ' ' ALA . 40.3 m -64.5 162.28 15.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.423 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 73' ' ' THR . . . -71.32 70.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.493 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -94.09 -39.39 10.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 108.933 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.41 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 5.9 tmm? -74.59 -49.27 22.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.74 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.9 mp -64.51 -17.38 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 ' CD1' ' A' ' 90' ' ' ILE . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.74 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 90' ' ' ILE . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 ' CG ' ' A' ' 59' ' ' ASP . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CD1' HD13 ' A' ' 80' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -65.6 -28.27 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -97.81 29.7 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.836 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -174.31 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 109.489 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 110.62 22.9 6.16 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 96' ' ' GLY . 13.6 pt -155.92 -176.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.421 -1.046 . . . . 0.0 109.313 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -63.01 161.79 12.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.307 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' THR . 5.2 t -71.16 71.02 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.556 -0.715 . . . . 0.0 109.355 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -71.19 70.53 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 109.324 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.71 40.93 0.04 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 77' ' ' ILE . 9.2 pt-20 -121.92 144.46 48.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.969 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.9 mtt -69.52 -69.05 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.412 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.63 49.21 3.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.454 -1.027 . . . . 0.0 109.73 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ttp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 -138.63 147.81 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 109.412 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 51' ' ' LEU . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 38' ' ' ALA . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.691 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' THR . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.753 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 33' ' ' ILE . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.927 ' HB1' ' CD ' ' A' ' 64' ' ' LYS . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.893 HD11 ' HB2' ' A' ' 7' ' ' ALA . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.916 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 5' ' ' GLY . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 24' ' ' LYS . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.761 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -54.73 -24.03 20.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -72.11 66.67 0.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.513 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.83 -155.64 6.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -63.57 -31.23 72.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.952 . . . . 0.0 109.433 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.4 m -156.89 -174.82 5.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.395 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p -62.1 129.82 42.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -101.34 66.97 1.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.568 -0.707 . . . . 0.0 109.608 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.675 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 51' ' ' LEU . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.6 ' O ' HG22 ' A' ' 88' ' ' VAL . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.9 105.9 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.927 ' CD ' ' HB1' ' A' ' 22' ' ' ALA . 4.3 tttm -102.02 66.1 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.531 ' HD3' HD23 ' A' ' 69' ' ' LEU . 12.1 pttt -58.49 146.27 35.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.551 -0.718 . . . . 0.0 110.295 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD11 HE21 ' A' ' 19' ' ' GLN . 0.7 OUTLIER -79.89 -33.22 40.13 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.47 -45.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.605 -0.684 . . . . 0.0 109.437 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -174.76 139.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.677 -0.639 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.571 HD11 ' HG3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -103.96 33.54 3.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.34 139.37 2.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -150.37 -65.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.613 -0.933 . . . . 0.0 109.678 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -63.42 -66.39 0.55 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.7 m -92.67 155.34 17.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.581 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 77' ' ' ILE . . . -71.68 68.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.593 -0.692 . . . . 0.0 109.276 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.39 -47.52 15.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.09 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.571 ' HG3' HD11 ' A' ' 69' ' ' LEU . 37.3 ttp -62.82 -40.61 97.94 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' HB1' ' A' ' 74' ' ' ALA . 3.6 mp -75.5 -14.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.624 -0.672 . . . . 0.0 110.445 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 48' ' ' LEU . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 76' ' ' MET . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 61' ' ' ILE . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 56' ' ' GLU . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 61' ' ' ILE . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.862 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -55.18 -24.28 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.79 -47.23 59.83 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -158.23 23.51 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 110.386 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -17.22 53.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 100' ' ' ASP . 27.4 pt -153.09 -175.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -1.192 . . . . 0.0 109.565 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -148.11 -77.25 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.711 . . . . 0.0 109.317 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 99' ' ' THR . 8.8 t -90.38 52.29 2.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.725 . . . . 0.0 109.128 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 97' ' ' ILE . 15.4 t70 -62.91 86.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.645 -0.659 . . . . 0.0 109.396 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.61 -52.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -61.87 -26.59 68.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.927 . . . . 0.0 109.75 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.14 64.7 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.53 -0.731 . . . . 0.0 109.382 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.36 54.14 0.5 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.704 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' CE ' HG11 ' A' ' 60' ' ' VAL . 22.5 ttp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -134.5 158.27 44.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.547 -0.721 . . . . 0.0 109.345 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 27' ' ' GLY . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.718 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 15' ' ' SER . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 18' ' ' ILE . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.736 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.718 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.859 HG22 HG21 ' A' ' 33' ' ' ILE . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 5' ' ' GLY . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.859 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 16' ' ' LEU . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -77.86 59.09 2.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 29.8 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.376 -0.828 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.39 -123.96 4.5 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -83.51 -30.46 27.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.989 . . . . 0.0 109.466 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -149.82 -49.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -176.87 155.49 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 109.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -119.96 84.22 2.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.589 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.692 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 51' ' ' LEU . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.586 ' OD1' HG22 ' A' ' 88' ' ' VAL . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG11 ' CE ' ' A' ' 1' ' ' MET . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 88' ' ' VAL . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' CG1' HD21 ' A' ' 69' ' ' LEU . 26.2 t -139.41 162.25 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -131.66 172.92 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -129.31 75.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.666 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 66' ' ' LEU . 41.4 tp -70.58 -39.14 74.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.569 -0.707 . . . . 0.0 109.317 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.02 -51.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.303 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -178.01 122.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.614 -0.679 . . . . 0.0 109.445 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' HG3' ' A' ' 76' ' ' MET . 9.5 mt -62.99 -52.01 64.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.56 52.11 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -147.09 -53.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -113.68 -75.71 0.59 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 109.636 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -111.0 -158.78 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.477 -0.764 . . . . 0.0 109.411 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.47 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 109.565 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.26 -30.41 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.711 . . . . 0.0 109.615 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.731 ' HG3' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -99.22 -37.67 9.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.541 -0.725 . . . . 0.0 109.518 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.1 mp -64.95 -26.36 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.805 ' N ' HD22 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 77' ' ' ILE . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.586 HG22 ' OD1' ' A' ' 59' ' ' ASP . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 64' ' ' LYS . 7.5 tp -61.14 -23.41 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.79 -26.31 61.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.333 -0.854 . . . . 0.0 110.17 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -157.1 -47.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.475 -0.766 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.76 27.11 9.22 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 98' ' ' SER . 23.0 mt -97.76 164.9 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.963 . . . . 0.0 109.322 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 97' ' ' ILE . 16.8 m -63.2 -166.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.354 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -67.88 82.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.678 . . . . 0.0 109.363 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.85 36.34 2.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.642 . . . . 0.0 109.544 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.09 33.18 3.11 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -114.83 148.36 38.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.902 . . . . 0.0 109.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -99.68 -56.88 2.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.92 41.93 53.94 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.8 mttt . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.693 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.7 177.37 7.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.597 -0.689 . . . . 0.0 109.163 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 27' ' ' GLY . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.674 ' CA ' HG21 ' A' ' 28' ' ' VAL . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.002 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 16' ' ' LEU . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.755 HG22 ' OG ' ' A' ' 15' ' ' SER . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HG3' HD11 ' A' ' 18' ' ' ILE . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.871 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.813 HD11 HG21 ' A' ' 35' ' ' THR . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 15' ' ' SER . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.713 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.869 HG22 HG21 ' A' ' 33' ' ' ILE . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.002 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.75 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 20' ' ' VAL . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.813 HG21 HD11 ' A' ' 16' ' ' LEU . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HD3' HD22 ' A' ' 16' ' ' LEU . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.92 58.26 2.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.27 84.04 2.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.422 -0.799 . . . . 0.0 109.422 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.99 -149.53 7.29 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -78.06 -37.68 46.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.596 -0.943 . . . . 0.0 109.454 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 t -125.09 -175.43 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 p -85.31 127.19 34.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.86 66.9 5.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 79' ' ' LEU . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 55' ' ' VAL . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 83' ' ' PHE . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 69' ' ' LEU . 30.2 t -142.31 161.69 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -141.46 173.08 11.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.545 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -117.12 94.73 4.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.539 -0.726 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.49 -72.94 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -110.7 -38.71 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -176.26 113.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.705 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -57.16 -46.51 82.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.592 -0.693 . . . . 0.0 110.0 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 75' ' ' ASP . . . -147.08 -158.36 7.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -122.53 -160.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.677 -0.896 . . . . 0.0 109.373 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.08 -32.78 73.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.392 -0.817 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 74' ' ' ALA . 39.1 m -66.1 162.47 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' HD13 ' A' ' 77' ' ' ILE . . . -71.97 67.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.4 ' HB2' ' HA3' ' A' ' 70' ' ' GLY . 9.1 m-20 -83.04 -27.65 30.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 109.464 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.746 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -108.77 15.1 23.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.675 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.633 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.9 mp -116.42 -30.83 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.279 -0.888 . . . . 0.0 109.058 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 76' ' ' MET . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 61' ' ' ILE . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.566 ' OD2' HG23 ' A' ' 99' ' ' THR . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.413 HG13 ' CG ' ' A' ' 59' ' ' ASP . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 83' ' ' PHE . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 64' ' ' LYS . 14.0 tt -67.15 -27.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -56.23 -23.01 33.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.78 . . . . 0.0 110.541 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -171.83 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.39 -0.818 . . . . 0.0 109.708 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.39 -7.39 5.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.26 176.1 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -1.21 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.2 t -155.96 -79.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.653 -0.654 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.566 HG23 ' OD2' ' A' ' 84' ' ' ASP . 9.1 t -99.74 44.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -51.08 -25.82 5.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.14 68.99 0.05 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.02 154.8 18.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 109.832 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.1 mtm -142.14 -52.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.18 56.83 13.64 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 -118.26 156.84 28.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.61 -0.681 . . . . 0.0 109.234 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 27' ' ' GLY . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.721 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 15' ' ' SER . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.763 ' HB2' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.518 ' CG ' HD22 ' A' ' 66' ' ' LEU . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 33' ' ' ILE . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.721 HG11 ' HA3' ' A' ' 5' ' ' GLY . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.959 HG21 HG22 ' A' ' 20' ' ' VAL . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.54 ' HB2' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD13 ' A' ' 16' ' ' LEU . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.32 69.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 t -89.23 68.48 8.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.5 4.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.562 -0.964 . . . . 0.0 109.3 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 t -161.65 -174.25 4.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.664 -0.647 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 130.98 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.87 83.8 2.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' A' ' 83' ' ' PHE . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.511 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 90' ' ' ILE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CB ' ' A' ' 26' ' ' ALA . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t -114.15 155.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -121.06 153.53 37.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 109.296 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -98.59 77.64 2.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 19' ' ' GLN . 45.1 tp -84.1 -43.18 15.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.712 . . . . 0.0 109.28 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.05 -65.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.678 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -178.02 125.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.522 HD13 ' HG2' ' A' ' 76' ' ' MET . 5.0 mt -63.63 -63.19 1.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.97 108.69 0.49 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.35 -30.25 8.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -1.011 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.46 -71.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -132.23 -157.73 0.84 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 65.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.716 -0.615 . . . . 0.0 109.786 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -94.16 -41.95 9.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 108.873 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.522 ' HG2' HD13 ' A' ' 69' ' ' LEU . 7.3 tmm? -64.43 -30.63 71.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.42 -21.16 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.548 -0.72 . . . . 0.0 109.898 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.688 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.489 ' N ' HD22 ' A' ' 79' ' ' LEU . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.531 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CG ' ' A' ' 59' ' ' ASP . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 93' ' ' ILE . 7.4 tp -68.13 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.03 -37.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.17 -22.85 8.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 110.156 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.25 -41.18 2.19 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -155.18 -172.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.844 . . . . 0.0 109.236 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . 0.5 OUTLIER -150.41 -79.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.496 -0.752 . . . . 0.0 109.246 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' THR . 10.0 t -119.03 52.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.56 -24.25 13.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.548 -0.72 . . . . 0.0 110.172 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.19 91.57 0.09 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.38 56.7 4.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.96 . . . . 0.0 109.495 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 mtp -84.8 -50.31 7.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.66 38.87 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.763 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.47 171.55 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 36' ' ' ASP . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 15' ' ' SER . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.544 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.888 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.796 HD13 ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 19' ' ' GLN . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.919 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.653 HG11 ' HA3' ' A' ' 5' ' ' GLY . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.919 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 HD11 ' A' ' 16' ' ' LEU . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HD3' HD13 ' A' ' 16' ' ' LEU . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.62 67.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 m -93.35 44.71 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.48 -90.79 2.19 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 p -100.26 -28.48 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 109.202 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 m -171.1 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.236 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.0 -178.71 0.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.128 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -171.91 112.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.409 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 48' ' ' LEU . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 51' ' ' LEU . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.713 HD13 ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD22 ' HB1' ' A' ' 26' ' ' ALA . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.86 152.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' C ' HG21 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -99.65 -173.5 2.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.454 -0.779 . . . . 0.0 110.601 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' N ' HG21 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -124.28 100.54 6.74 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 tp -167.67 -43.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 109.162 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -150.04 118.59 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -52.3 167.01 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 110.007 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -88.0 -30.55 19.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.608 -0.683 . . . . 0.0 109.221 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.37 24.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -148.06 -58.29 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.929 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.62 -45.53 9.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.552 -0.718 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.1 m -98.37 154.87 17.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.654 -0.654 . . . . 0.0 109.331 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.76 65.13 0.69 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.731 . . . . 0.0 109.268 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -79.03 -51.37 9.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.398 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 80' ' ' ILE . 8.6 tmm? -60.07 -31.32 69.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 109.377 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 77' ' ' ILE . 5.0 mp -84.63 -23.6 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.513 -0.742 . . . . 0.0 109.854 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.514 HG21 HG21 ' A' ' 99' ' ' THR . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.713 ' CD2' HD13 ' A' ' 61' ' ' ILE . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 59' ' ' ASP . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 65' ' ' LYS . 7.8 tp -58.35 -27.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.68 -35.87 62.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.728 . . . . 0.0 109.61 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.1 -70.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.526 -0.734 . . . . 0.0 109.539 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.78 -34.86 2.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.8 mm -88.32 -65.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.772 -0.84 . . . . 0.0 109.765 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.75 -163.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.773 . . . . 0.0 109.19 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 99' ' ' THR . 5.8 t -74.09 65.55 1.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.505 -0.747 . . . . 0.0 109.281 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.52 80.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 0.0 109.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.34 70.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -155.42 29.57 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.966 . . . . 0.0 109.56 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.32 -65.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.76 2.65 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.38 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -155.87 167.21 31.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.552 -0.718 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 27' ' ' GLY . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' C ' HD21 ' A' ' 23' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 16' ' ' LEU . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 15' ' ' SER . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HG3' HD11 ' A' ' 18' ' ' ILE . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 15' ' ' SER . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.667 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HA3' ' A' ' 5' ' ' GLY . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' HE1' HD13 ' A' ' 50' ' ' LEU . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.828 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.61 -27.44 64.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -72.24 66.17 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 0.0 109.515 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.02 -127.01 2.58 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.7 p -71.18 -30.43 66.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.93 . . . . 0.0 109.245 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 t -175.89 -59.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.547 -0.721 . . . . 0.0 109.337 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -136.68 169.1 18.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.03 55.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' NE ' HD22 ' A' ' 48' ' ' LEU . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 50' ' ' LEU . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 HD22 ' NE ' ' A' ' 45' ' ' ARG . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 ' HE1' ' A' ' 34' ' ' PHE . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 55' ' ' VAL . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 88' ' ' VAL . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.749 HD13 ' CB ' ' A' ' 26' ' ' ALA . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 69' ' ' LEU . 25.1 t -133.11 128.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -78.45 149.99 33.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.612 -0.68 . . . . 0.0 109.232 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 58.51 5.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.469 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' CD ' ' A' ' 19' ' ' GLN . 2.6 mt -62.71 -163.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 109.055 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.15 -45.03 61.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.341 -0.85 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -176.46 147.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 109.939 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -57.74 -57.49 12.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.573 -0.704 . . . . 0.0 110.05 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.98 -139.82 4.05 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -106.41 -163.82 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.15 76.58 0.35 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -161.61 -171.16 2.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.482 -0.761 . . . . 0.0 109.142 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 73' ' ' THR . . . -93.61 46.97 1.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.225 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.81 -47.3 16.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.54 ' O ' HD12 ' A' ' 80' ' ' ILE . 7.4 tmm? -61.44 -40.56 94.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.1 mp -79.49 -21.57 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.588 -0.695 . . . . 0.0 109.978 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.732 ' CG2' HG21 ' A' ' 99' ' ' THR . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 55' ' ' VAL . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 61' ' ' ILE . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' HG ' ' A' ' 62' ' ' LEU . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.859 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -63.27 -29.9 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -51.21 -25.63 5.81 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.397 -0.814 . . . . 0.0 110.68 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -164.65 -63.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.71 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.32 -25.98 1.86 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 98' ' ' SER . 49.7 mt -65.72 162.81 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.99 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.3 t -62.42 -162.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.732 HG21 ' CG2' ' A' ' 80' ' ' ILE . 5.2 t -71.55 68.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.322 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.38 80.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.77 45.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 83.25 2.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.645 -0.915 . . . . 0.0 109.629 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtp -152.84 145.41 24.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.42 60.53 0.37 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.411 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 -132.4 164.87 25.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.638 -0.664 . . . . 0.0 109.346 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 51' ' ' LEU . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 18' ' ' ILE . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.648 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.787 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 15' ' ' SER . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.505 ' NE2' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 33' ' ' ILE . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 7' ' ' ALA . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.804 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD2' HD13 ' A' ' 3' ' ' LEU . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 20' ' ' VAL . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.53 -21.24 36.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 t -71.71 67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.46 -156.72 7.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.2 m -63.09 -44.49 95.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -1.04 . . . . 0.0 109.32 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.2 m -140.81 -176.53 4.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -62.87 122.57 16.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.17 70.93 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.342 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 61' ' ' ILE . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 51' ' ' LEU . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' A' ' 88' ' ' VAL . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 51' ' ' LEU . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.634 HD13 ' CB ' ' A' ' 26' ' ' ALA . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.45 112.91 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 179.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 109.879 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' N ' HG21 ' A' ' 93' ' ' ILE . 21.3 mmtt -121.59 117.88 27.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.65 -0.656 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' NE2' ' A' ' 19' ' ' GLN . 3.9 tp -177.88 -41.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -120.73 114.66 21.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.97 148.89 3.88 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.439 -0.788 . . . . 0.0 110.41 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 69' ' ' LEU . 4.0 mm? -57.87 -26.74 62.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 110.198 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.0 150.85 5.52 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -112.22 61.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.94 . . . . 0.0 109.01 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -150.05 -157.89 0.86 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.79 . . . . 0.0 108.975 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' ALA . 9.5 m -48.73 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' THR . . . -48.93 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.55 -0.719 . . . . 0.0 111.147 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' THR . 63.2 m-20 -103.65 -44.4 5.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD12 ' A' ' 80' ' ' ILE . 17.6 ttt -64.09 -39.91 95.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.534 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.2 mp -72.63 -24.18 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.672 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 99' ' ' THR . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' CD2' HD13 ' A' ' 61' ' ' ILE . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' OD1' ' A' ' 59' ' ' ASP . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.477 HG12 HD12 ' A' ' 61' ' ' ILE . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 62' ' ' LEU . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.544 HG21 ' N ' ' A' ' 65' ' ' LYS . 12.7 tt -62.37 -24.23 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -58.52 -19.99 42.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.316 -0.865 . . . . 0.0 110.605 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.84 -43.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 120.37 30.5 1.41 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 96' ' ' GLY . 25.7 pt -155.77 -174.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -1.002 . . . . 0.0 109.267 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.02 -178.74 5.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.31 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 HG21 HG21 ' A' ' 80' ' ' ILE . 3.5 t -74.67 67.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.72 85.26 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.24 106.55 0.23 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -110.46 144.96 38.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.956 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -34.28 76.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.747 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.31 -33.59 0.65 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.392 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -135.84 170.05 16.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 109.26 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 27' ' ' GLY . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.629 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.925 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' CB ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' HG3' HD11 ' A' ' 18' ' ' ILE . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 15' ' ' SER . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.68 ' OE1' HD22 ' A' ' 66' ' ' LEU . 13.7 mm100 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 16' ' ' LEU . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB1' ' CD ' ' A' ' 64' ' ' LYS . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.925 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.683 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.787 HG21 HG22 ' A' ' 20' ' ' VAL . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 8' ' ' ARG . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 16' ' ' LEU . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . -68.78 -25.98 64.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 m -59.08 -19.63 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.443 -0.786 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.46 -168.98 0.19 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -61.38 -74.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.546 -0.973 . . . . 0.0 109.702 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -83.18 -172.19 4.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.53 -0.731 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 23.1 p-10 -145.76 101.96 3.61 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 50' ' ' LEU . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.499 ' H ' HD12 ' A' ' 48' ' ' LEU . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 46' ' ' LYS . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 61' ' ' ILE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.616 HG23 HD21 ' A' ' 51' ' ' LEU . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.504 HD22 ' HB1' ' A' ' 26' ' ' ALA . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.86 138.5 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' CD ' ' HB1' ' A' ' 22' ' ' ALA . 15.5 mtpp -105.53 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.876 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -23.63 30.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.84 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD22 ' OE1' ' A' ' 19' ' ' GLN . 3.8 tt -64.47 -54.06 38.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.1 63.58 7.73 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -47.38 159.66 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.592 -0.693 . . . . 0.0 110.994 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 HD21 ' A' ' 79' ' ' LEU . 3.8 mm? -61.31 -77.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.712 -0.617 . . . . 0.0 110.26 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.35 -138.32 2.41 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.417 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.684 -0.892 . . . . 0.0 110.142 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.91 -8.05 35.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.641 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 74' ' ' ALA . 5.1 t -62.55 -157.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.014 . . . . 0.0 109.156 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 73' ' ' THR . . . -87.8 44.22 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.21 -39.06 21.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.6 ttp -63.12 -17.19 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' CG ' ' A' ' 81' ' ' LYS . 4.8 mp -107.36 -25.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD12 ' A' ' 69' ' ' LEU . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 90' ' ' ILE . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' CG ' HG22 ' A' ' 77' ' ' ILE . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' HB2' HD11 ' A' ' 90' ' ' ILE . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 61' ' ' ILE . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.85 -30.72 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -43.95 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 179.98 -39.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.93 52.83 0.88 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 97' ' ' ILE . 17.2 mt -103.01 10.96 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.712 -0.875 . . . . 0.0 110.354 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.44 -72.95 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.107 -0.996 . . . . 0.0 109.21 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 99' ' ' THR . 8.5 t -105.58 52.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.05 80.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.89 73.69 0.45 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.33 175.26 0.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.0 109.635 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.6 ttt -138.35 142.97 39.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 71.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -139.34 168.16 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.662 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.772 HG12 ' N ' ' A' ' 16' ' ' LEU . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.58 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.609 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 16.3 mm100 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 HG21 ' A' ' 33' ' ' ILE . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HB1' ' HD3' ' A' ' 64' ' ' LYS . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.633 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG11 ' HA3' ' A' ' 5' ' ' GLY . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.918 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 16' ' ' LEU . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.32 -21.08 21.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.53 -22.07 19.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.65 -172.51 0.27 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -60.54 -37.0 79.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.411 -1.053 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 m -131.48 175.5 9.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.126 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -65.65 120.71 13.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 109.399 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.8 69.87 3.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.669 . . . . 0.0 109.235 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.552 HD11 ' HG2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 55' ' ' VAL . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.96 115.49 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.657 ' HD3' ' HB1' ' A' ' 22' ' ' ALA . 12.3 tttt -122.38 66.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -60.31 155.52 17.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.46 -0.775 . . . . 0.0 110.041 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -36.88 13.49 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -130.59 -53.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.517 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -163.1 153.99 16.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.505 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.0 mm? -55.93 -58.56 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.137 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.35 -104.91 1.72 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -162.54 -46.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.926 . . . . 0.0 109.43 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.78 -45.14 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 74' ' ' ALA . 18.7 m -64.71 164.28 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.429 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 73' ' ' THR . . . -60.33 91.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 109.701 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -110.05 -24.36 10.81 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.795 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -105.8 2.21 27.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.75 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -121.47 -34.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.064 -1.023 . . . . 0.0 110.061 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.658 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.795 HD13 ' O ' ' A' ' 76' ' ' MET . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 90' ' ' ILE . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 56' ' ' GLU . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CD1' ' HA2' ' A' ' 96' ' ' GLY . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt -43.4 -32.69 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.38 -13.21 9.8 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.449 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -78.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA2' ' CD1' ' A' ' 92' ' ' PHE . . . 136.13 74.83 0.07 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.22 -19.59 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.746 -0.855 . . . . 0.0 110.258 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -53.63 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 99' ' ' THR . 9.2 t -98.5 53.21 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.742 . . . . 0.0 109.064 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.79 80.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.602 -0.686 . . . . 0.0 109.413 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.16 68.02 1.82 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -117.56 -173.5 2.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.1 mtp -152.64 -62.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.658 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.94 30.56 9.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.532 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -104.93 159.26 15.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 27' ' ' GLY . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 37' ' ' LYS . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.765 HG22 ' OG ' ' A' ' 15' ' ' SER . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.765 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 33' ' ' ILE . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.942 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 16' ' ' LEU . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.5 60.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -134.96 82.73 1.98 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.99 -136.0 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -76.81 -34.44 57.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.954 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -143.63 -67.52 0.35 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 p -160.09 159.37 31.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.6 63.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.499 -0.751 . . . . 0.0 109.447 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 48' ' ' LEU . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG11 ' CE1' ' A' ' 83' ' ' PHE . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' A' ' 88' ' ' VAL . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 88' ' ' VAL . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 26' ' ' ALA . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.647 HG21 HD22 ' A' ' 69' ' ' LEU . 8.9 p -104.28 133.96 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -152.6 119.01 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.34 173.96 10.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 109.707 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.2 mm? -64.68 -32.5 74.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.633 -0.667 . . . . 0.0 109.227 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -139.51 -45.97 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -177.41 -173.88 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.0 109.575 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -123.49 43.19 3.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.509 -0.744 . . . . 0.0 109.341 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.03 -172.84 19.17 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -164.04 -64.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.655 -0.909 . . . . 0.0 109.345 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -135.55 -60.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.37 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 74' ' ' ALA . 3.2 m -71.34 169.29 15.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.686 . . . . 0.0 109.289 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 73' ' ' THR . . . -72.59 65.23 0.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.44 -47.62 22.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.51 -0.744 . . . . 0.0 109.023 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.448 ' HG2' HD11 ' A' ' 69' ' ' LEU . 4.0 tmm? -63.13 -37.03 85.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.9 mp -81.22 -20.78 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 110.121 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.653 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' CG2' HG21 ' A' ' 99' ' ' THR . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 83' ' ' PHE . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 63' ' ' VAL . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.7 tp -64.43 78.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.8 t70 -179.12 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.02 28.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.682 -0.636 . . . . 0.0 110.252 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.83 28.17 30.68 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.6 pt -148.46 158.12 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -1.025 . . . . 0.0 109.856 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -160.48 -68.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.473 HG21 ' CG2' ' A' ' 80' ' ' ILE . 11.8 t -95.36 34.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.29 -25.88 2.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.654 . . . . 0.0 110.269 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.17 71.8 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.35 166.8 23.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.918 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.2 mtp -161.16 113.9 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.24 -86.0 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . 11.5 mmt180 -110.14 145.84 36.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.622 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 19' ' ' GLN . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 11' ' ' THR . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.664 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.831 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 14' ' ' GLN . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.783 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 10.8 mm100 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.01 HG22 HG21 ' A' ' 33' ' ' ILE . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.602 ' HB1' ' HG3' ' A' ' 64' ' ' LYS . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.743 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 62' ' ' LEU . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' CG ' HD12 ' A' ' 3' ' ' LEU . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 20' ' ' VAL . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 51' ' ' LEU . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.58 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -98.15 36.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.51 -0.744 . . . . 0.0 109.604 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.7 -44.77 5.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 p -160.24 -48.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.625 -0.927 . . . . 0.0 109.384 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -138.48 -56.78 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.743 . . . . 0.0 109.552 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -169.13 165.56 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.55 109.33 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 61' ' ' ILE . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 61' ' ' ILE . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 3' ' ' LEU . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.617 HD11 HG11 ' A' ' 55' ' ' VAL . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.41 109.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' HG3' ' HB1' ' A' ' 22' ' ' ALA . 3.7 mmtt -66.59 -168.85 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.701 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -115.77 119.61 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tp -179.79 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.21 112.5 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.4 121.67 8.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.472 -0.767 . . . . 0.0 110.013 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HB3' ' CG ' ' A' ' 76' ' ' MET . 5.1 mt -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.565 -0.71 . . . . 0.0 109.7 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.98 150.51 20.57 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 -58.78 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.577 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -131.34 -67.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -99.28 -158.39 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . . . -66.22 79.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.664 -0.648 . . . . 0.0 109.65 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -96.27 -37.08 10.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 108.914 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.795 ' O ' HD13 ' A' ' 80' ' ' ILE . 8.5 tmm? -86.65 -1.57 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 110.314 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.509 HG23 ' HA ' ' A' ' 102' ' ' GLU . 4.6 mp -112.66 -27.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 80' ' ' ILE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.795 HD13 ' O ' ' A' ' 76' ' ' MET . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 59' ' ' ASP . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 61' ' ' ILE . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 94' ' ' ASP . 6.8 tp -58.85 -43.68 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 93' ' ' ILE . 1.1 m-20 -102.79 39.48 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.722 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.2 80.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.26 44.83 3.33 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 98' ' ' SER . 9.7 mm -108.62 171.01 2.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.457 -1.025 . . . . 0.0 108.969 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.463 ' H ' HG22 ' A' ' 97' ' ' ILE . 2.1 m -62.62 -175.75 0.09 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 108.92 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.1 m -67.38 81.7 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -105.91 121.15 43.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.88 -37.9 1.54 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HA ' HG23 ' A' ' 77' ' ' ILE . 9.4 pt-20 -63.03 -28.1 69.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.942 . . . . 0.0 109.646 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.5 ttt -141.72 151.56 43.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.517 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.37 -92.85 0.12 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.8 mttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.438 179.909 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -129.65 155.94 45.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.345 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' HG23 ' A' ' 60' ' ' VAL . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 35' ' ' THR . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 38' ' ' ALA . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 15' ' ' SER . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' HG23 ' A' ' 11' ' ' THR . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.566 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.659 HE22 HD22 ' A' ' 66' ' ' LEU . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.93 HG22 HG21 ' A' ' 33' ' ' ILE . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD12 HG23 ' A' ' 33' ' ' ILE . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 5' ' ' GLY . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 HG22 ' A' ' 20' ' ' VAL . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.731 ' CB ' ' HB3' ' A' ' 7' ' ' ALA . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.676 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -75.35 59.88 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -116.68 -33.18 4.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.44 -157.94 0.11 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.9 m -61.5 -68.99 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.509 -0.995 . . . . 0.0 109.6 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -95.11 170.59 9.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.6 -0.687 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.27 156.62 25.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.85 78.98 2.0 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.704 . . . . 0.0 109.114 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD11 ' HG ' ' A' ' 79' ' ' LEU . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 61' ' ' ILE . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 90' ' ' ILE . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.36 136.51 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 22' ' ' ALA . 1.2 ptmt -93.29 -176.08 4.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.469 -0.769 . . . . 0.0 110.165 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -129.77 125.76 36.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.615 -0.678 . . . . 0.0 109.549 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.659 HD22 HE22 ' A' ' 19' ' ' GLN . 0.9 OUTLIER 178.81 -55.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -100.8 121.8 42.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -43.18 123.29 2.83 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.446 0.641 . . . . 0.0 111.341 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.708 HD13 ' HG2' ' A' ' 76' ' ' MET . 6.4 mt -54.94 -42.82 72.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.651 -0.656 . . . . 0.0 110.326 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.67 -174.25 44.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -168.51 49.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.637 -0.919 . . . . 0.0 109.336 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.31 -158.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 74' ' ' ALA . 7.2 t -53.36 -43.15 67.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB1' ' HB ' ' A' ' 77' ' ' ILE . . . 179.44 68.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.201 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.88 -31.74 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.39 -0.819 . . . . 0.0 109.046 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.708 ' HG2' HD13 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -101.43 -39.38 7.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.311 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.4 mp -56.36 -22.13 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.89 -1.131 . . . . 0.0 109.374 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.469 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.702 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 99' ' ' THR . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.704 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HE2' HD23 ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 59' ' ' ASP . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 80' ' ' ILE . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 94' ' ' ASP . 8.6 tt -48.76 -46.16 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 93' ' ' ILE . 1.2 m-20 -119.13 42.27 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.872 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -165.42 -47.48 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 0.0 110.41 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 98.57 -35.16 4.79 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 96' ' ' GLY . 1.4 pt -156.26 -175.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.56 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.453 -0.779 . . . . 0.0 109.739 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 1.004 HG23 HG21 ' A' ' 80' ' ' ILE . 6.1 t -87.21 56.63 4.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.59 68.69 0.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.82 52.45 37.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.9 114.78 3.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.91 . . . . 0.0 109.804 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.9 mtt -164.23 30.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.427 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.85 -55.4 0.02 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 60' ' ' VAL . 1.4 mpt_? -120.45 152.55 37.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.645 -0.66 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.46 HD12 ' HD2' ' A' ' 29' ' ' LYS . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' HB3' HD11 ' A' ' 51' ' ' LEU . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.011 ' HB3' HG23 ' A' ' 35' ' ' THR . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 16' ' ' LEU . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.73 HG22 ' OG ' ' A' ' 15' ' ' SER . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HG3' HD11 ' A' ' 18' ' ' ILE . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.765 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.698 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 15' ' ' SER . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.826 ' NE2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 33' ' ' ILE . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 5' ' ' GLY . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD2' HD12 ' A' ' 3' ' ' LEU . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 20' ' ' VAL . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CD2' HD12 ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.011 HG23 ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CD ' HD13 ' A' ' 16' ' ' LEU . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -50.73 -27.1 6.45 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 m -73.16 66.52 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.09 -121.34 2.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 m -94.25 -74.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.915 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -105.73 -47.4 3.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 p -174.48 163.79 3.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.641 -0.662 . . . . 0.0 109.595 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 44.17 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.986 HD12 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.78 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 2' ' ' ARG . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.41 88.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -61.44 179.31 0.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.066 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HB2' HG21 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -107.31 120.59 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.61 -0.681 . . . . 0.0 109.874 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.826 HD23 ' NE2' ' A' ' 19' ' ' GLN . 50.6 tp -178.56 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -134.64 110.77 9.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -60.74 144.28 52.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 109.747 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD13 ' CG ' ' A' ' 76' ' ' MET . 2.0 mp -61.76 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.554 -0.716 . . . . 0.0 109.222 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.88 140.23 46.88 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.11 29.54 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.536 -0.979 . . . . 0.0 109.745 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -102.78 -66.15 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.498 -0.751 . . . . 0.0 109.318 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 t -120.99 -157.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -95.14 -49.97 5.27 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' ILE . 1.7 tmt? -59.28 -21.83 60.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.757 -0.59 . . . . 0.0 109.759 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp -97.84 -20.09 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.426 -0.797 . . . . 0.0 109.909 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 HD12 ' A' ' 48' ' ' LEU . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.853 ' CG2' HG21 ' A' ' 99' ' ' THR . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.571 ' HD1' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 89' ' ' SER . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 83' ' ' PHE . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 65' ' ' LYS . 7.9 tp -61.89 -28.99 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.08 -33.7 76.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.752 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.19 -60.64 0.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 109.825 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.64 2.94 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 98' ' ' SER . 24.6 mm -85.98 167.47 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.735 -0.861 . . . . 0.0 109.603 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.9 m -55.66 -68.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.853 HG21 ' CG2' ' A' ' 80' ' ' ILE . 2.0 t 179.93 66.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.39 79.29 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.656 -0.652 . . . . 0.0 109.489 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.95 82.09 0.08 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 117.66 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.962 . . . . 0.0 109.284 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.7 ptm -168.91 -42.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.682 . . . . 0.0 109.483 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.25 -69.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.492 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 164.76 25.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.687 . . . . 0.0 109.332 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 51' ' ' LEU . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' C ' HD21 ' A' ' 23' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 16' ' ' LEU . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 35' ' ' THR . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.882 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 33' ' ' ILE . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD2' ' HB2' ' A' ' 7' ' ' ALA . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.7 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD2' HD13 ' A' ' 3' ' ' LEU . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.805 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.909 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 16' ' ' LEU . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -62.95 -16.68 60.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 t -98.53 76.6 2.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.876 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.57 -147.86 4.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -60.89 -29.03 69.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -1.004 . . . . 0.0 109.239 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.49 173.9 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.58 152.24 35.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.39 83.2 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 55' ' ' VAL . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.7 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 69' ' ' LEU . 39.0 t -125.38 108.29 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -73.56 -176.2 2.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.668 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.42 76.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.608 -0.682 . . . . 0.0 109.285 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 66' ' ' LEU . 29.9 tp -90.21 -66.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -113.02 -67.94 0.96 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.343 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -178.6 151.93 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.61 -0.681 . . . . 0.0 109.207 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 76' ' ' MET . 3.6 mm? -56.74 -65.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 110.367 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.45 -138.01 2.8 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.93 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.581 -0.952 . . . . 0.0 109.811 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.67 -24.35 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 110.48 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.1 t -61.05 -160.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.329 -0.857 . . . . 0.0 109.723 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.54 67.47 0.76 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.19 -57.05 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.823 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 69' ' ' LEU . 3.6 tpp -62.43 -41.16 98.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 77' ' ' ILE . 3.8 mp -66.5 -20.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.461 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.633 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.961 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.74 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 59' ' ' ASP . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.961 HD12 HD13 ' A' ' 80' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.598 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.28 -28.86 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.02 -23.54 38.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.518 -0.739 . . . . 0.0 110.241 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.18 -67.7 0.94 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.84 . . . . 0.0 109.762 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.9 -30.26 1.66 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.2 pt -127.64 -170.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 109.336 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.82 150.0 38.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.762 . . . . 0.0 109.582 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' THR . 2.5 t -68.89 77.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.0 72.19 3.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.654 . . . . 0.0 109.442 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.1 55.67 4.71 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -122.35 84.91 2.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.529 -0.983 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -63.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.476 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.08 -71.72 0.19 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.578 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.547 HD12 ' HD2' ' A' ' 29' ' ' LYS . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 51' ' ' LEU . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 19' ' ' GLN . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 16' ' ' LEU . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.73 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 15' ' ' SER . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.742 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 33' ' ' ILE . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HD2' HD12 ' A' ' 3' ' ' LEU . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 ' CD1' ' A' ' 16' ' ' LEU . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 4' ' ' PHE . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 61' ' ' ILE . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.704 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 28' ' ' VAL . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.409 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 79' ' ' LEU . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 HD13 ' A' ' 90' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 90' ' ' ILE . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 61' ' ' ILE . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.882 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 27' ' ' GLY . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.715 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.727 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 HG21 ' A' ' 35' ' ' THR . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 33' ' ' ILE . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 7' ' ' ALA . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 5' ' ' GLY . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.791 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.747 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 8' ' ' ARG . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.125 0.488 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 48' ' ' LEU . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD21 HG23 ' A' ' 61' ' ' ILE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 61' ' ' ILE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.698 HD13 ' CD2' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 HG23 ' A' ' 28' ' ' VAL . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.685 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.574 ' N ' HD22 ' A' ' 79' ' ' LEU . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 86' ' ' GLN . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.422 ' CB ' HD23 ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 51' ' ' LEU . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.66 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' HD12 ' A' ' 18' ' ' ILE . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 HD11 HG21 ' A' ' 35' ' ' THR . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.655 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.833 HG22 HG21 ' A' ' 33' ' ' ILE . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 7' ' ' ALA . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.874 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.874 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.749 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 48' ' ' LEU . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 61' ' ' ILE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG13 ' HG ' ' A' ' 51' ' ' LEU . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD1' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 88' ' ' VAL . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 11.2 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.745 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.745 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' ILE . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 61' ' ' ILE . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' CZ ' HG11 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 51' ' ' LEU . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.819 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' ILE . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.815 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 4.6 mm100 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.047 HG22 HG21 ' A' ' 33' ' ' ILE . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.047 HG21 HG22 ' A' ' 20' ' ' VAL . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 50' ' ' LEU . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.84 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 61' ' ' ILE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HD1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 51' ' ' LEU . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 26' ' ' ALA . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' HD11 ' A' ' 90' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 56' ' ' GLU . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.864 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.825 ' HA3' HG21 ' A' ' 28' ' ' VAL . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.793 HG22 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.509 ' O ' HD12 ' A' ' 18' ' ' ILE . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.793 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.811 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 14' ' ' GLN . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 7' ' ' ALA . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 ' HA3' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 61' ' ' ILE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.512 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.74 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.9 mp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 ' CD1' ' A' ' 90' ' ' ILE . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.74 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 90' ' ' ILE . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 ' CG ' ' A' ' 59' ' ' ASP . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CD1' HD13 ' A' ' 80' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 51' ' ' LEU . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 38' ' ' ALA . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.691 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' THR . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.753 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 33' ' ' ILE . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.893 HD11 ' HB2' ' A' ' 7' ' ' ALA . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.916 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 5' ' ' GLY . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 24' ' ' LYS . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.761 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.279 0.562 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.675 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 51' ' ' LEU . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.6 ' O ' HG22 ' A' ' 88' ' ' VAL . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 48' ' ' LEU . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 61' ' ' ILE . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 56' ' ' GLU . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 61' ' ' ILE . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.862 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 27' ' ' GLY . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.718 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 15' ' ' SER . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 18' ' ' ILE . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.736 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.718 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.859 HG22 HG21 ' A' ' 33' ' ' ILE . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 5' ' ' GLY . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.859 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 16' ' ' LEU . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.692 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 51' ' ' LEU . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.586 ' OD1' HG22 ' A' ' 88' ' ' VAL . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' ARG . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 88' ' ' VAL . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 mp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.805 ' N ' HD22 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 77' ' ' ILE . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.586 HG22 ' OD1' ' A' ' 59' ' ' ASP . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 27' ' ' GLY . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.674 ' CA ' HG21 ' A' ' 28' ' ' VAL . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.002 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 16' ' ' LEU . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.755 HG22 ' OG ' ' A' ' 15' ' ' SER . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HG3' HD11 ' A' ' 18' ' ' ILE . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.871 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.813 HD11 HG21 ' A' ' 35' ' ' THR . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 15' ' ' SER . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.713 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.869 HG22 HG21 ' A' ' 33' ' ' ILE . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.002 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.75 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 20' ' ' VAL . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.813 HG21 HD11 ' A' ' 16' ' ' LEU . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HD3' HD22 ' A' ' 16' ' ' LEU . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 79' ' ' LEU . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 55' ' ' VAL . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 83' ' ' PHE . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.633 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 61' ' ' ILE . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.413 HG13 ' CG ' ' A' ' 59' ' ' ASP . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 83' ' ' PHE . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 27' ' ' GLY . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.721 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 15' ' ' SER . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.763 ' HB2' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 33' ' ' ILE . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.721 HG11 ' HA3' ' A' ' 5' ' ' GLY . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.959 HG21 HG22 ' A' ' 20' ' ' VAL . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.54 ' HB2' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD13 ' A' ' 16' ' ' LEU . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' A' ' 83' ' ' PHE . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.511 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 90' ' ' ILE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CB ' ' A' ' 26' ' ' ALA . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.688 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.489 ' N ' HD22 ' A' ' 79' ' ' LEU . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.531 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CG ' ' A' ' 59' ' ' ASP . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 93' ' ' ILE . 7.4 tp . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 36' ' ' ASP . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 15' ' ' SER . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.544 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.888 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.796 HD13 ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 19' ' ' GLN . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.919 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.653 HG11 ' HA3' ' A' ' 5' ' ' GLY . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.919 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 HD11 ' A' ' 16' ' ' LEU . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HD3' HD13 ' A' ' 16' ' ' LEU . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 48' ' ' LEU . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 51' ' ' LEU . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.713 HD13 ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD22 ' HB1' ' A' ' 26' ' ' ALA . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.713 ' CD2' HD13 ' A' ' 61' ' ' ILE . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 59' ' ' ASP . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 27' ' ' GLY . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' C ' HD21 ' A' ' 23' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 16' ' ' LEU . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 15' ' ' SER . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HG3' HD11 ' A' ' 18' ' ' ILE . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 15' ' ' SER . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.667 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.749 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HA3' ' A' ' 5' ' ' GLY . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' HE1' HD13 ' A' ' 50' ' ' LEU . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.828 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' NE ' HD22 ' A' ' 48' ' ' LEU . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 50' ' ' LEU . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.56 HD22 ' NE ' ' A' ' 45' ' ' ARG . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 ' HE1' ' A' ' 34' ' ' PHE . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 55' ' ' VAL . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 88' ' ' VAL . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.749 HD13 ' CB ' ' A' ' 26' ' ' ALA . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 55' ' ' VAL . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 61' ' ' ILE . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' HG ' ' A' ' 62' ' ' LEU . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.859 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 51' ' ' LEU . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 18' ' ' ILE . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.648 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.787 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 15' ' ' SER . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 33' ' ' ILE . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 7' ' ' ALA . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.804 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD2' HD13 ' A' ' 3' ' ' LEU . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 20' ' ' VAL . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 61' ' ' ILE . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 51' ' ' LEU . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' A' ' 88' ' ' VAL . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 51' ' ' LEU . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.634 HD13 ' CB ' ' A' ' 26' ' ' ALA . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.672 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' CD2' HD13 ' A' ' 61' ' ' ILE . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' OD1' ' A' ' 59' ' ' ASP . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.477 HG12 HD12 ' A' ' 61' ' ' ILE . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 62' ' ' LEU . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 27' ' ' GLY . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.629 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.925 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' CB ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' HG3' HD11 ' A' ' 18' ' ' ILE . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 15' ' ' SER . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.549 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 13.7 mm100 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 16' ' ' LEU . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.925 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.683 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.787 HG21 HG22 ' A' ' 20' ' ' VAL . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 8' ' ' ARG . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 16' ' ' LEU . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 23.1 p-10 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 50' ' ' LEU . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.499 ' H ' HD12 ' A' ' 48' ' ' LEU . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 46' ' ' LYS . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 61' ' ' ILE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.616 HG23 HD21 ' A' ' 51' ' ' LEU . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD22 ' HB1' ' A' ' 26' ' ' ALA . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' CG ' ' A' ' 81' ' ' LYS . 4.8 mp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 90' ' ' ILE . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' CG ' HG22 ' A' ' 77' ' ' ILE . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' HB2' HD11 ' A' ' 90' ' ' ILE . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 61' ' ' ILE . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.772 HG12 ' N ' ' A' ' 16' ' ' LEU . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.58 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.609 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 16.3 mm100 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 HG21 ' A' ' 33' ' ' ILE . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.633 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG11 ' HA3' ' A' ' 5' ' ' GLY . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.918 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 16' ' ' LEU . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.552 HD11 ' HG2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 55' ' ' VAL . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.658 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 90' ' ' ILE . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 56' ' ' GLU . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 27' ' ' GLY . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 37' ' ' LYS . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.765 HG22 ' OG ' ' A' ' 15' ' ' SER . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.765 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 33' ' ' ILE . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.942 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 16' ' ' LEU . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 48' ' ' LEU . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG11 ' CE1' ' A' ' 83' ' ' PHE . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' A' ' 88' ' ' VAL . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 88' ' ' VAL . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 26' ' ' ALA . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 92' ' ' PHE . 8.9 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG22 ' CE ' ' A' ' 81' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.653 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 83' ' ' PHE . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 63' ' ' VAL . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . 11.5 mmt180 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.622 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 19' ' ' GLN . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 11' ' ' THR . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.664 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.831 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 14' ' ' GLN . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.783 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 19.5 mm-40 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.01 HG22 HG21 ' A' ' 33' ' ' ILE . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.743 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 62' ' ' LEU . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' CG ' HD12 ' A' ' 3' ' ' LEU . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 20' ' ' VAL . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 51' ' ' LEU . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 61' ' ' ILE . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 61' ' ' ILE . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 3' ' ' LEU . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.617 HD11 HG11 ' A' ' 55' ' ' VAL . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 80' ' ' ILE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.744 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 59' ' ' ASP . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 61' ' ' ILE . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' HG23 ' A' ' 60' ' ' VAL . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 35' ' ' THR . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 38' ' ' ALA . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 15' ' ' SER . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' HG23 ' A' ' 11' ' ' THR . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.566 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.657 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.93 HG22 HG21 ' A' ' 33' ' ' ILE . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD12 HG23 ' A' ' 33' ' ' ILE . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 5' ' ' GLY . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 HG22 ' A' ' 20' ' ' VAL . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.731 ' CB ' ' HB3' ' A' ' 7' ' ' ALA . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.676 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD11 ' HG ' ' A' ' 79' ' ' LEU . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 61' ' ' ILE . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 90' ' ' ILE . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.702 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 90' ' ' ILE . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.704 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HE2' HD23 ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 59' ' ' ASP . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 80' ' ' ILE . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 60' ' ' VAL . 1.4 mpt_? . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.46 HD12 ' HD2' ' A' ' 29' ' ' LYS . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.591 ' HB3' HD11 ' A' ' 51' ' ' LEU . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.011 ' HB3' HG23 ' A' ' 35' ' ' THR . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 16' ' ' LEU . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.73 HG22 ' OG ' ' A' ' 15' ' ' SER . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HG3' HD11 ' A' ' 18' ' ' ILE . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.765 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.698 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 15' ' ' SER . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.675 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 33' ' ' ILE . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 5' ' ' GLY . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD2' HD12 ' A' ' 3' ' ' LEU . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 20' ' ' VAL . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CD2' HD12 ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.011 HG23 ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CD ' HD13 ' A' ' 16' ' ' LEU . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.296 0.569 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.986 HD12 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.78 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 2' ' ' ARG . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 HD12 ' A' ' 48' ' ' LEU . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.571 ' HD1' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 89' ' ' SER . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 83' ' ' PHE . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 51' ' ' LEU . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.446 ' C ' HD21 ' A' ' 23' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 16' ' ' LEU . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 35' ' ' THR . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.882 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 33' ' ' ILE . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD2' ' HB2' ' A' ' 7' ' ' ALA . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.7 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD2' HD13 ' A' ' 3' ' ' LEU . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.805 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.909 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 16' ' ' LEU . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 55' ' ' VAL . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.7 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.762 0.315 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.633 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.961 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.74 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 59' ' ' ASP . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.961 HD12 HD13 ' A' ' 80' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.598 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -133.02 170.27 15.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.592 -0.693 . . . . 0.0 109.5 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.547 HD12 ' HD2' ' A' ' 29' ' ' LYS . 13.0 mt -107.23 86.29 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.692 -0.63 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 51' ' ' LEU . 12.1 m-85 -97.39 145.94 25.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.67 . . . . 0.0 109.572 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.81 148.55 19.58 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 31.9 t80 -110.67 137.48 48.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.893 . . . . 0.0 109.009 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HB1' ' CB ' ' A' ' 19' ' ' GLN . . . -143.34 166.7 24.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.462 -0.774 . . . . 0.0 110.342 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -162.48 120.3 2.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 16' ' ' LEU . 32.3 m -60.88 129.07 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.746 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 t -114.69 -26.93 7.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -108.42 151.4 26.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.566 -0.709 . . . . 0.0 109.67 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -65.1 -28.79 69.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.611 -0.68 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -62.46 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.338 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -72.68 63.58 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.328 -0.858 . . . . 0.0 109.887 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.8 t -65.24 -52.39 54.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.73 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.4 tt -48.57 -41.65 31.22 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.531 -0.731 . . . . 0.0 109.985 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -29.68 68.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 15' ' ' SER . 41.8 mt -73.51 -29.11 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.579 -0.7 . . . . 0.0 109.505 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.742 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 37.0 mm-40 -81.48 -50.31 9.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -0.845 . . . . 0.0 109.239 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 54.6 t -51.61 -51.64 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.15 68.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.607 ' HB1' ' HD3' ' A' ' 64' ' ' LYS . . . -70.48 -36.19 73.71 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 33' ' ' ILE . 60.3 mt -73.66 -46.84 44.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -60.26 -42.08 94.6 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.94 -34.66 76.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.39 -33.31 67.09 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.48 44.88 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.474 -1.851 . . . . 0.0 108.474 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 94.3 t -117.2 144.25 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.749 -0.854 . . . . 0.0 109.232 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HD2' HD12 ' A' ' 3' ' ' LEU . 9.3 mttt -77.96 138.61 38.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.712 . . . . 0.0 109.369 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -61.47 -35.64 78.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.462 -0.774 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.02 66.84 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.656 -0.653 . . . . 0.0 109.41 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -111.01 58.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.415 -0.803 . . . . 0.0 109.182 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 48.0 mm -115.06 88.05 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.469 -0.769 . . . . 0.0 109.155 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.3 m-85 -83.55 82.02 8.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.74 . . . . 0.0 109.477 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 ' CD1' ' A' ' 16' ' ' LEU . 6.9 t -88.34 -175.72 5.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.642 -0.661 . . . . 0.0 109.528 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.5 m-20 -132.51 114.2 13.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.14 64.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.533 -0.729 . . . . 0.0 109.585 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -51.03 -24.04 3.48 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.562 -0.711 . . . . 0.0 110.886 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.05 70.44 7.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -158.73 7.75 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -60.82 -30.39 70.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.424 -1.045 . . . . 0.0 109.265 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -153.45 -173.93 4.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.26 151.17 37.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.38 92.35 3.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.688 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -105.68 56.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.62 -0.675 . . . . 0.0 109.27 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -105.64 -14.47 15.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.435 -0.791 . . . . 0.0 110.238 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.37 -30.46 64.75 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -92.73 -31.64 15.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.397 -1.061 . . . . 0.0 108.423 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.6 t70 -63.32 -35.84 81.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 4.7 mt -85.33 -36.96 20.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 4' ' ' PHE . 8.1 tp -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 17.4 mtp180 -63.39 -26.64 68.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.0 ptm -105.16 8.92 34.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.546 -0.721 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 16.6 mmtt -116.31 -25.15 7.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.275 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 61' ' ' ILE . 16.9 m -61.24 137.12 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.19 179.39 5.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.28 114.97 7.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.576 -0.703 . . . . 0.0 109.375 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.92 26.88 47.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.91 153.21 30.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.569 -0.959 . . . . 0.0 109.357 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.68 121.09 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.32 -0.863 . . . . 0.0 109.042 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.704 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -101.3 99.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.556 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 28' ' ' VAL . 5.2 mt -78.92 130.03 35.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.33 102.64 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.598 -0.689 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.607 ' HD3' ' HB1' ' A' ' 22' ' ' ALA . 58.4 tttt -100.52 59.27 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 125.15 22.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.418 -0.801 . . . . 0.0 109.702 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.588 HD21 HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -112.99 44.47 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.595 -0.691 . . . . 0.0 109.647 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -176.02 -60.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.779 . . . . 0.0 109.929 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 179.95 131.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.567 HD13 ' HG3' ' A' ' 76' ' ' MET . 3.7 mt -81.56 -31.34 32.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.153 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.92 131.81 2.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.23 109.48 6.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.6 -73.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 m -113.78 -54.65 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -177.8 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -59.6 -38.29 80.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.567 ' HG3' HD13 ' A' ' 69' ' ' LEU . 6.8 tmm? -97.56 4.78 50.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 110.194 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.409 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -119.05 -23.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 110.147 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -68.19 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.163 -0.961 . . . . 0.0 109.372 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 79' ' ' LEU . 2.1 pt? -57.05 -30.86 64.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.686 -0.634 . . . . 0.0 109.814 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 HD13 ' A' ' 90' ' ' ILE . 30.2 mm -63.85 -37.13 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -77.6 -36.58 51.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.85 -31.86 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 90' ' ' ILE . 24.1 m-85 -80.55 -40.61 25.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.306 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.14 -33.0 70.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.57 -25.82 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.785 -0.572 . . . . 0.0 109.782 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.58 4.25 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.0 110.504 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.78 66.19 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.2 t -110.83 148.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.883 . . . . 0.0 109.409 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -99.35 164.34 12.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 109.316 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 61' ' ' ILE . 37.6 mt -140.89 101.4 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.639 -0.663 . . . . 0.0 109.312 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -78.68 133.51 37.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.718 -0.614 . . . . 0.0 109.573 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -110.1 134.03 52.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.584 -0.698 . . . . 0.0 109.406 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.882 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -59.83 -27.18 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.602 -0.686 . . . . 0.0 109.524 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -49.86 -38.48 35.55 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.376 -0.828 . . . . 0.0 111.111 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.17 28.47 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -50.74 3.58 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.8 pt -130.82 175.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.619 -0.93 . . . . 0.0 109.589 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 -69.98 0.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.378 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 99' ' ' THR . 8.3 t -132.11 51.55 2.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.556 -0.715 . . . . 0.0 109.246 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -61.31 88.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.504 -0.747 . . . . 0.0 109.598 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.06 96.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -111.0 29.86 7.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.606 -0.937 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -63.33 1.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.614 -0.679 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -175.37 65.02 0.1 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.454 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -132.0 168.91 17.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 109.527 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 27' ' ' GLY . 8.1 mp -104.88 85.18 2.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.581 -0.699 . . . . 0.0 109.821 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 m-85 -85.54 155.99 20.95 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -143.55 121.85 1.75 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 48' ' ' LEU . 38.9 t80 -92.85 138.48 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.921 . . . . 0.0 109.011 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.985 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.88 113.55 6.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -0.835 . . . . 0.0 110.547 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -107.7 103.62 12.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 16' ' ' LEU . 26.7 m -52.62 164.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.16 -44.77 0.63 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.715 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.0 t -85.66 164.13 17.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.5 m -109.77 89.62 3.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.493 -0.754 . . . . 0.0 109.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -176.99 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.643 -0.661 . . . . 0.0 109.462 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -167.73 33.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.589 -0.695 . . . . 0.0 109.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.727 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.19 -46.82 88.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.605 -0.684 . . . . 0.0 109.843 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.747 HD11 HG21 ' A' ' 35' ' ' THR . 2.5 tt -51.95 -43.29 63.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.501 -0.75 . . . . 0.0 109.601 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -65.47 -43.47 90.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.415 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.4 mt -66.22 -35.37 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 110.024 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.01 -49.02 31.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.33 -0.857 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 33' ' ' ILE . 75.2 t -52.12 -42.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.235 -0.916 . . . . 0.0 109.009 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -34.28 77.76 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.31 72.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 7' ' ' ALA . 88.8 mt -74.03 -48.52 29.54 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -58.91 -44.55 91.29 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.9 -32.94 72.4 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.11 -31.31 64.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.5 44.84 0.28 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 5' ' ' GLY . 69.1 t -117.58 145.54 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.717 -0.872 . . . . 0.0 109.025 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -85.13 141.61 30.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.66 -32.29 73.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 109.311 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -23.59 63.46 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.661 -0.649 . . . . 0.0 109.396 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 58.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.391 -0.818 . . . . 0.0 108.928 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.791 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -112.93 92.22 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.743 . . . . 0.0 109.315 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m-85 -82.13 75.9 9.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.747 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -85.24 143.37 28.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.682 -0.636 . . . . 0.0 109.778 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 8' ' ' ARG . 1.6 m-20 -117.92 109.24 16.27 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -66.02 81.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 66.3 4.17 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.7 m -45.68 -27.41 0.79 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.691 -0.631 . . . . 0.0 111.528 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.27 -97.04 0.21 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -57.71 -51.81 68.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.641 -0.917 . . . . 0.0 109.821 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -95.6 82.81 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.571 -0.706 . . . . 0.0 109.296 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -59.72 149.07 31.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.66 62.16 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.561 -0.712 . . . . 0.0 109.889 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -71.37 65.37 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.476 -0.765 . . . . 0.0 109.547 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.9 mmpt? -108.2 -47.56 3.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.416 -0.803 . . . . 0.0 109.375 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.22 -40.61 84.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 48' ' ' LEU . 9.1 tt -70.59 -46.66 63.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.927 . . . . 0.0 108.972 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -29.65 69.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.57 -0.706 . . . . 0.0 109.37 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.8 mt -89.98 -25.41 20.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.657 -0.652 . . . . 0.0 109.32 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD21 HG23 ' A' ' 61' ' ' ILE . 14.1 tp -64.71 -33.03 74.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 108.674 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 15.8 mtp85 -65.64 -29.63 70.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.74 17.85 20.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.52 -0.737 . . . . 0.0 110.308 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -121.45 -35.82 3.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.389 -0.82 . . . . 0.0 109.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 61' ' ' ILE . 29.8 m -56.95 142.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 0.0 110.136 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.67 174.83 6.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.56 116.36 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.23 26.53 39.88 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.1 t0 -82.37 153.89 25.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.467 -1.019 . . . . 0.0 109.617 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.09 115.34 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.698 HD13 ' CD2' ' A' ' 83' ' ' PHE . 14.4 mt -94.37 102.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 109.407 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 HG23 ' A' ' 28' ' ' VAL . 5.8 mt -78.72 122.3 25.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 69' ' ' LEU . 26.3 t -109.29 136.08 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 109.601 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 169.78 10.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.701 -0.625 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -134.33 99.5 4.4 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.8 tp -114.92 -27.09 7.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.717 . . . . 0.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.42 -50.91 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 110.094 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.24 133.56 0.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.279 -0.888 . . . . 0.0 109.66 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG11 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -68.51 -63.4 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.232 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.06 -162.27 30.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -129.56 -44.2 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.666 -0.902 . . . . 0.0 109.7 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.7 39.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.84 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 74' ' ' ALA . 4.9 t -166.32 -157.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.35 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 73' ' ' THR . . . -90.21 47.79 1.49 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.576 -0.702 . . . . 0.0 109.794 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 73' ' ' THR . 78.1 m-20 -78.04 -43.87 28.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.783 ' HG2' HD13 ' A' ' 69' ' ' LEU . 1.2 tmt? -60.87 -32.16 71.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.0 mp -92.67 -18.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.656 . . . . 0.0 109.939 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.06 -70.65 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.685 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -55.91 -20.72 16.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.438 -0.789 . . . . 0.0 110.672 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.574 ' N ' HD22 ' A' ' 79' ' ' LEU . 67.4 mt -73.34 -43.16 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -67.9 -34.42 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -64.62 -48.36 75.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' A' ' 61' ' ' ILE . 30.1 m-85 -70.02 -30.01 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -62.96 -34.35 77.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 109.305 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.64 35.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.806 -0.558 . . . . 0.0 110.195 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -83.24 4.0 28.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.484 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.87 30.22 70.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 86' ' ' GLN . 57.7 t -108.29 150.12 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.702 -0.881 . . . . 0.0 109.327 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m -99.08 167.19 10.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.9 mt -141.82 133.05 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' CB ' HD23 ' A' ' 62' ' ' LEU . 84.2 mtt180 -107.96 149.73 27.99 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -124.72 131.21 53.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.537 -0.727 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.1 tt -63.86 -26.51 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.545 -0.722 . . . . 0.0 109.723 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -58.5 -27.99 64.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 0.0 110.105 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.81 -52.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.95 46.13 0.21 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.05 159.15 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.669 -0.901 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HG ' ' H ' ' A' ' 90' ' ' ILE . 3.2 m -66.05 -71.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.631 -0.668 . . . . 0.0 109.634 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 80' ' ' ILE . 2.2 t -177.4 68.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -58.82 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.72 -34.04 0.19 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 77' ' ' ILE . 52.0 mt-10 -76.75 -29.69 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.933 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -161.93 -173.12 3.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.472 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.66 -98.77 0.13 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.2 pttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.474 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.9 mtt-85 -146.17 160.2 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.601 -0.687 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.6 mp -101.51 84.11 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 51' ' ' LEU . 40.9 m-85 -83.21 139.88 32.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.688 . . . . 0.0 109.497 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.13 131.07 6.11 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 35.0 t80 -93.63 150.82 20.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.679 -0.895 . . . . 0.0 108.651 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -153.47 94.25 1.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.806 . . . . 0.0 110.528 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.66 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 2.8 tmm_? -93.15 112.67 24.68 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 31.5 m -58.59 -174.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.703 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -164.72 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -88.25 161.34 17.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.839 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -81.96 -27.79 33.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -62.45 -158.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.607 -0.683 . . . . 0.0 109.345 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -71.0 64.45 0.33 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.12 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' HD12 ' A' ' 18' ' ' ILE . 11.1 t -63.12 -60.88 2.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.435 -0.79 . . . . 0.0 109.731 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 HD11 HG21 ' A' ' 35' ' ' THR . 2.3 tt -46.19 -39.66 10.05 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.901 -0.499 . . . . 0.0 111.13 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.16 -43.74 90.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.457 -0.777 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.4 mt -65.84 -28.84 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 109.836 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.655 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mt-30 -74.66 -55.34 5.99 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.434 -0.791 . . . . 0.0 109.445 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.833 HG22 HG21 ' A' ' 33' ' ' ILE . 57.8 t -48.57 -61.28 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.751 -0.593 . . . . 0.0 110.359 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.86 14.72 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.842 . . . . 0.0 109.763 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -73.94 -34.3 64.26 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 7' ' ' ALA . 71.6 mt -75.58 -42.11 52.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.874 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.85 95.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.3 -33.99 76.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -73.73 -32.98 64.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.0 44.73 0.36 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.9 t -114.29 149.49 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.85 -0.794 . . . . 0.0 109.165 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.666 . . . . 0.0 109.522 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -64.44 -33.98 77.12 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.44 -23.94 64.67 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 109.219 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 6.4 mtt-85 -109.72 58.66 0.61 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.874 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 36.6 mm -112.48 89.22 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.656 -0.652 . . . . 0.0 109.244 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -78.47 75.48 4.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.749 HG21 HD11 ' A' ' 16' ' ' LEU . 6.6 t -78.53 -173.95 3.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.786 -0.571 . . . . 0.0 110.015 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 t70 -149.62 130.7 14.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.78 50.57 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . . . -55.9 -22.04 23.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 0.0 110.284 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -72.93 68.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.876 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 -166.64 11.67 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -58.88 -31.37 68.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.423 -1.046 . . . . 0.0 109.228 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -142.1 163.29 33.26 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.5 t -60.85 174.31 0.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -156.26 43.86 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 48' ' ' LEU . 33.2 mtm105 -60.71 84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 44' ' ' ASP . 17.9 mtmt -117.37 -20.63 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.651 -0.655 . . . . 0.0 109.97 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.18 -58.86 12.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -57.42 -30.26 64.81 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.391 -1.064 . . . . 0.0 109.176 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -67.01 -61.54 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.09 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mt -62.87 -29.25 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 61' ' ' ILE . 12.1 tp -65.35 -38.88 91.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 18.3 mtp180 -60.02 -21.58 61.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 109.802 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 ptt? -111.1 1.87 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 110.825 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -109.69 -28.06 9.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.984 . . . . 0.0 109.795 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG13 ' HG ' ' A' ' 51' ' ' LEU . 23.5 m -59.73 144.87 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.464 -0.773 . . . . 0.0 110.204 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.22 138.04 44.15 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.08 101.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.25 17.32 5.78 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD1' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -98.21 -163.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.103 -1.233 . . . . 0.0 109.639 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -140.65 121.17 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 88' ' ' VAL . 29.4 mt -99.39 96.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.721 . . . . 0.0 109.597 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.74 106.63 10.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 64' ' ' LYS . 11.2 p -105.58 161.39 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.961 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 93' ' ' ILE . 20.0 tttt -138.67 161.79 36.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -126.29 89.76 3.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -49.35 57.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 109.318 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.06 -43.66 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.645 -0.66 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 130.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.63 -0.669 . . . . 0.0 109.314 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.6 100.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.703 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.07 21.79 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.07 -170.38 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.621 -0.929 . . . . 0.0 109.508 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.21 -27.76 55.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 74' ' ' ALA . 14.2 m -60.88 167.55 2.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.485 -0.759 . . . . 0.0 109.171 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 73' ' ' THR . . . -67.45 77.25 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' HD21 ' A' ' 79' ' ' LEU . 3.2 m-20 -95.17 -25.5 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.665 -0.647 . . . . 0.0 109.48 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.689 ' C ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -102.47 4.04 38.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.427 -0.795 . . . . 0.0 109.859 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.745 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -119.03 -23.07 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.071 . . . . 0.0 110.211 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -70.55 0.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -61.74 -25.83 67.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.716 HD12 ' HG ' ' A' ' 79' ' ' LEU . 1.7 mp -66.17 -37.33 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.745 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -78.84 -33.0 46.36 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.03 -34.06 72.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.605 -0.684 . . . . 0.0 109.169 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' ILE . 19.5 m-85 -79.81 -35.8 37.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -61.55 -35.36 77.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.29 37.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -81.54 2.23 30.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.509 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.59 34.12 54.54 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 61' ' ' ILE . 61.3 t -113.85 150.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.691 -0.888 . . . . 0.0 109.434 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.31 109.14 19.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.69 -0.631 . . . . 0.0 109.343 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 38.3 mt -82.54 106.23 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -78.47 123.18 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' CZ ' HG11 ' A' ' 63' ' ' VAL . 8.2 m-85 -100.83 114.69 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.558 -0.713 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 64' ' ' LYS . 6.1 tp -59.15 -24.51 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.0 109.644 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -28.81 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -120.31 -68.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.38 -0.825 . . . . 0.0 109.644 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.1 -29.02 0.64 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.43 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.565 -0.962 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 p -61.35 157.11 17.34 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 99' ' ' THR . 3.6 t -71.6 71.41 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.61 -0.681 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.16 75.39 1.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.491 -0.756 . . . . 0.0 109.388 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.4 72.88 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.5 -173.26 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.525 -0.985 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.3 mtt -99.59 85.6 3.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.57 -28.37 69.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.537 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 2.0 mtt180 -124.2 153.91 40.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.481 -0.762 . . . . 0.0 109.566 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.2 mt -105.87 79.64 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.713 -0.617 . . . . 0.0 109.374 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 51' ' ' LEU . 60.0 m-85 -80.91 137.67 36.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.221 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.77 125.84 4.26 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 23.8 t80 -87.4 148.14 25.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.638 -0.919 . . . . 0.0 109.055 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -150.84 91.56 1.73 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 110.546 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -90.12 109.22 20.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 28.5 m -55.63 -176.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -160.83 -43.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.819 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.1 t -83.93 -159.29 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.567 -0.708 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -123.86 -40.75 2.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.398 -0.814 . . . . 0.0 110.473 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -48.39 -76.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.739 -0.6 . . . . 0.0 111.357 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' ILE . 5.4 pt20 -152.79 59.34 0.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.197 -0.939 . . . . 0.0 109.889 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.05 -41.01 87.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.492 -0.755 . . . . 0.0 109.493 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.3 tt -60.06 -40.99 91.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.72 -49.59 61.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.699 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -62.93 -38.62 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.602 -0.686 . . . . 0.0 109.2 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.815 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 4.6 mm100 -63.89 -55.62 21.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.734 -0.604 . . . . 0.0 109.713 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.047 HG22 HG21 ' A' ' 33' ' ' ILE . 74.4 t -51.97 -45.99 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.215 -0.928 . . . . 0.0 109.234 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.76 -28.85 67.75 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 64' ' ' LYS . . . -76.23 -36.92 58.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.9 mt -74.13 -40.76 62.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -44.15 90.33 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -60.09 -35.16 74.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -68.56 -32.03 71.67 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 122.18 43.43 0.4 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 5' ' ' GLY . 91.0 t -113.92 139.9 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.812 -0.816 . . . . 0.0 109.085 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 139.47 46.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.634 . . . . 0.0 109.403 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -62.34 -34.71 77.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.717 . . . . 0.0 109.356 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -24.43 66.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.611 -0.681 . . . . 0.0 109.387 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.95 58.53 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.372 -0.83 . . . . 0.0 109.249 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.047 HG21 HG22 ' A' ' 20' ' ' VAL . 44.3 mm -112.41 87.62 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -78.85 81.45 5.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.65 -0.656 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.8 t -102.65 153.05 20.49 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 m-20 -112.99 146.78 38.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.576 -0.702 . . . . 0.0 109.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.01 57.45 1.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' A' ' 9' ' ' VAL . . . -49.4 -26.47 3.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.517 -0.739 . . . . 0.0 110.816 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 m -72.21 66.4 0.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.535 -0.728 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.52 -81.82 0.09 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -114.76 -73.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.946 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -127.55 -46.91 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.571 -0.706 . . . . 0.0 109.449 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 p -171.18 136.26 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.531 -0.73 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.55 50.55 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.402 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -64.97 81.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 109.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 50' ' ' LEU . 15.3 mmtm -113.8 -27.47 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.694 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.51 -49.67 76.0 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -72.37 -28.6 63.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -1.036 . . . . 0.0 109.397 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.84 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 t70 -69.08 -34.3 74.9 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 46' ' ' LYS . 4.6 mt -89.24 -29.24 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 61' ' ' ILE . 14.0 tp -60.08 -35.91 76.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 19.2 mtp180 -61.88 -28.61 69.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.626 . . . . 0.0 109.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -108.51 12.05 26.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.595 -0.691 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -119.41 -30.96 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 110.19 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' HD1' ' A' ' 83' ' ' PHE . 29.5 m -60.63 154.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 tt0 -112.52 157.49 21.07 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -60.64 111.69 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 0.0 109.844 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.83 23.02 11.18 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -100.22 166.12 11.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -1.078 . . . . 0.0 109.488 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.35 134.33 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.543 -0.723 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 51' ' ' LEU . 67.4 mt -112.96 98.88 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 26' ' ' ALA . 5.2 mt -78.95 129.29 34.33 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.17 138.62 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.57 -0.706 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HD2' ' HB1' ' A' ' 22' ' ' ALA . 2.0 ttpp -103.42 152.54 21.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.633 -0.667 . . . . 0.0 109.578 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -99.93 59.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.73 -43.85 78.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -72.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.411 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -177.12 138.02 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.707 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 2.2 mm? -56.3 -45.61 80.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.715 . . . . 0.0 110.111 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.18 -122.48 2.39 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.01 -44.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.999 . . . . 0.0 109.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -155.79 -46.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.462 -0.774 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 74' ' ' ALA . 4.4 m -61.16 169.56 2.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.501 -0.749 . . . . 0.0 109.488 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 73' ' ' THR . . . -72.03 64.15 0.51 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.0 109.41 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.47 -44.67 20.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.958 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 80' ' ' ILE . 4.6 ttt -62.56 -38.67 90.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.2 mp -77.58 -30.23 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.636 -0.665 . . . . 0.0 109.682 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -70.36 0.11 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.365 -0.835 . . . . 0.0 110.26 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.6 pt? -55.44 -30.85 61.26 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.229 -0.92 . . . . 0.0 109.741 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 76' ' ' MET . 47.8 mt -64.25 -47.84 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -63.19 -32.77 74.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.323 -0.861 . . . . 0.0 108.957 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.84 -50.51 66.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' HD11 ' A' ' 90' ' ' ILE . 53.9 m-85 -69.44 -32.51 71.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.55 -0.718 . . . . 0.0 109.145 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -61.34 -32.89 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.638 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.19 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.728 -0.607 . . . . 0.0 110.096 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -85.27 3.06 41.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.568 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.32 31.0 61.77 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 56' ' ' GLU . 63.3 t -111.85 153.42 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.603 -0.939 . . . . 0.0 109.372 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -104.21 160.46 14.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.78 -0.575 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -134.54 105.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.217 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 8.7 mtt180 -78.69 148.61 33.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.85 122.31 40.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.544 -0.723 . . . . 0.0 109.206 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.864 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.62 -29.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 109.512 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -54.43 -30.08 51.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.358 -0.839 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -139.81 -44.09 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.04 -37.45 2.99 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 98' ' ' SER . 47.3 mt -77.23 162.97 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.71 -0.876 . . . . 0.0 109.19 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.7 m -73.52 -162.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 99' ' ' THR . 3.4 t -72.64 66.6 0.73 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 108.975 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.92 87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.571 -0.706 . . . . 0.0 109.76 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.26 108.33 0.51 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -101.87 -31.8 10.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.629 -0.924 . . . . 0.0 109.364 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.6 mtp -147.41 119.77 8.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.583 -0.698 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.42 -63.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mttt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.395 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 5.0 mmm180 -132.48 157.17 45.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.591 -0.693 . . . . 0.0 109.18 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.2 mp -105.02 85.9 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.6 -0.688 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 61.9 m-85 -82.48 141.93 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.825 ' HA3' HG21 ' A' ' 28' ' ' VAL . . . -129.01 113.97 1.66 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 47.3 t80 -86.49 138.71 31.53 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.49 108.97 3.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.458 -0.776 . . . . 0.0 110.456 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 2.1 ttm180 -96.25 144.52 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.1 m -100.57 144.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.458 -0.776 . . . . 0.0 110.508 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -116.87 -36.63 3.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.793 HG22 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -87.26 176.46 7.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -108.57 -17.72 13.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.624 -0.672 . . . . 0.0 110.235 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.25 -64.17 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.171 -0.955 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.509 ' O ' HD12 ' A' ' 18' ' ' ILE . 7.6 pt20 -176.66 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.546 -0.721 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.793 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -64.38 -35.29 80.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.482 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.811 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.8 tt -57.4 -42.55 82.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.471 -0.768 . . . . 0.0 109.004 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.85 -59.73 3.28 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 14' ' ' GLN . 4.9 mt -53.09 -41.72 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.62 -0.675 . . . . 0.0 110.198 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.792 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.8 mm-40 -62.75 -49.49 74.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.79 . . . . 0.0 109.011 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.9 t -51.08 -49.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -58.17 -34.29 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.221 -0.924 . . . . 0.0 108.556 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.5 -46.12 73.84 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB2' ' A' ' 7' ' ' ALA . 8.2 mt -67.17 -45.33 77.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' NZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.3 mmtt -62.73 -37.6 87.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.46 -45.33 80.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.336 -0.853 . . . . 0.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.11 71.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.47 42.11 0.44 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.825 HG21 ' HA3' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -98.0 168.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -1.041 . . . . 0.0 109.136 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -96.1 131.97 41.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 109.425 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.95 -33.15 74.75 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.0 -24.57 63.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.8 mtt180 -110.93 58.49 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 108.987 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -108.61 90.58 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 8.0 m-85 -83.93 81.86 8.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -107.06 144.85 33.13 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -94.96 -173.93 3.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.558 -0.714 . . . . 0.0 109.587 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.31 66.8 1.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . -74.02 60.28 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.564 -0.71 . . . . 0.0 109.772 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 29.8 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.408 -0.808 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.77 -52.54 1.19 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.41 -48.6 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.947 . . . . 0.0 109.353 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.0 p -133.51 -54.36 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.597 -0.689 . . . . 0.0 109.314 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.89 153.54 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 109.357 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.64 54.88 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.744 . . . . 0.0 109.308 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -64.33 84.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -114.18 -20.89 10.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.626 -0.671 . . . . 0.0 109.952 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.34 -67.6 2.12 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -52.97 -29.07 26.76 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 121.354 -1.086 . . . . 0.0 109.627 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.8 t70 -67.53 -57.15 7.0 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.41 -29.58 68.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 61' ' ' ILE . 7.9 tp -62.76 -41.45 99.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 30.0 mtp180 -57.47 -24.0 53.18 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.578 -0.701 . . . . 0.0 110.014 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.82 3.72 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.453 -0.78 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.3 -25.49 7.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.083 -1.011 . . . . 0.0 110.295 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -61.18 148.84 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.329 -0.857 . . . . 0.0 110.077 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.62 135.62 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.49 102.49 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.55 16.81 5.84 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.9 p30 -100.84 -178.17 3.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.245 . . . . 0.0 109.885 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.43 130.49 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 90' ' ' ILE . 58.5 mt -108.88 100.97 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.584 -0.697 . . . . 0.0 109.516 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.79 127.78 32.52 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -124.86 136.8 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 0.0 109.814 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -91.04 -171.52 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -147.54 61.68 1.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.484 -0.76 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.97 -31.6 72.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -151.6 -64.02 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.321 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -178.81 142.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.684 . . . . 0.0 109.49 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.8 mm? -54.14 -72.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.39 -139.44 10.51 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -136.63 -65.54 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.381 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -135.65 -45.93 0.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 74' ' ' ALA . 40.3 m -64.5 162.28 15.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.423 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 73' ' ' THR . . . -71.32 70.35 0.59 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.493 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -94.09 -39.39 10.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.47 -0.769 . . . . 0.0 108.933 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.41 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 5.9 tmm? -74.59 -49.27 22.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.74 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.9 mp -64.51 -17.38 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.687 . . . . 0.0 110.147 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -70.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.6 pt? -59.01 -30.02 67.68 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.407 -0.808 . . . . 0.0 109.649 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 ' CD1' ' A' ' 90' ' ' ILE . 18.0 mm -63.39 -32.81 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.74 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -83.92 -37.43 22.36 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.24 -34.4 77.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.655 . . . . 0.0 109.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 90' ' ' ILE . 30.8 m-85 -79.66 -37.49 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.6 -33.66 75.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.5 -22.63 37.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.725 -0.609 . . . . 0.0 109.867 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -82.35 3.77 26.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.568 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.23 29.58 64.16 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 ' CG ' ' A' ' 59' ' ' ASP . 85.9 t -115.76 151.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.572 -0.957 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.28 160.65 14.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 109.541 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CD1' HD13 ' A' ' 80' ' ' ILE . 50.1 mt -133.64 102.11 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -78.62 142.85 36.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.618 -0.676 . . . . 0.0 109.649 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -111.21 143.55 41.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -65.6 -28.27 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.53 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -97.81 29.7 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.836 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -174.31 -65.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 109.489 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 110.62 22.9 6.16 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 96' ' ' GLY . 13.6 pt -155.92 -176.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.421 -1.046 . . . . 0.0 109.313 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -63.01 161.79 12.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.307 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' THR . 5.2 t -71.16 71.02 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.556 -0.715 . . . . 0.0 109.355 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -71.19 70.53 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.529 -0.732 . . . . 0.0 109.324 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.71 40.93 0.04 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 77' ' ' ILE . 9.2 pt-20 -121.92 144.46 48.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.969 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.9 mtt -69.52 -69.05 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.412 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.63 49.21 3.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.454 -1.027 . . . . 0.0 109.73 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ttp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 -138.63 147.81 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 109.412 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mt -103.11 82.4 2.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 109.388 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 51' ' ' LEU . 34.8 m-85 -80.89 137.82 36.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.62 -0.675 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -129.68 132.02 6.9 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 37.8 t80 -96.33 131.99 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.616 -0.932 . . . . 0.0 108.89 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -130.24 158.78 38.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.171 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -155.02 124.9 6.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 38' ' ' ALA . 24.5 m -69.84 -170.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 110.514 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -170.41 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.7 t -90.72 151.96 21.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.705 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -71.59 -23.5 61.74 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.577 -0.702 . . . . 0.0 110.31 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.36 -162.16 0.59 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.535 -0.728 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.691 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.86 110.98 0.58 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.171 -0.956 . . . . 0.0 109.695 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' THR . 2.8 p -122.23 -56.18 1.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -51.07 -36.9 42.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 0.0 109.956 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.07 -41.8 97.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 109.262 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.9 mt -69.34 -33.26 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.687 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.753 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.1 mp0 -70.46 -52.7 20.23 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.452 -0.78 . . . . 0.0 109.305 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 33' ' ' ILE . 58.2 t -51.8 -62.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.63 6.76 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.927 ' HB1' ' CD ' ' A' ' 64' ' ' LYS . . . -71.5 -38.31 71.18 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.893 HD11 ' HB2' ' A' ' 7' ' ' ALA . 2.5 mt -74.82 -38.52 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.916 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.75 -40.91 96.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.19 -34.91 77.35 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 62' ' ' LEU . . . -71.4 -32.5 68.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.34 45.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 5' ' ' GLY . 87.9 t -114.7 149.78 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.857 -0.79 . . . . 0.0 109.241 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.95 131.44 34.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.635 -0.665 . . . . 0.0 109.281 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 24' ' ' LYS . . . -57.65 -33.9 68.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.349 -0.844 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -25.16 65.95 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 2.3 mtt180 -107.36 58.55 0.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 38.4 mm -113.5 117.36 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 20.1 m-85 -112.08 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.761 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -78.66 166.6 22.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.678 -0.639 . . . . 0.0 109.837 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -124.84 111.7 15.79 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -72.56 66.38 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -54.73 -24.03 20.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.562 -0.711 . . . . 0.0 110.426 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -72.11 66.67 0.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.513 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.83 -155.64 6.51 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -63.57 -31.23 72.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.952 . . . . 0.0 109.433 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.4 m -156.89 -174.82 5.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 109.395 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p -62.1 129.82 42.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.553 -0.717 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -101.34 66.97 1.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.568 -0.707 . . . . 0.0 109.608 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -72.89 65.36 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.409 -0.807 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -107.58 -25.54 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.658 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.79 98.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -84.09 -26.91 28.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.978 . . . . 0.0 109.402 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.675 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 t70 -64.72 -36.2 83.52 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 mt -85.92 -28.39 24.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.5 tp -60.0 -33.8 72.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.376 -0.828 . . . . 0.0 109.457 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -67.09 -33.99 76.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.644 -0.66 . . . . 0.0 109.345 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.1 ptp -99.8 12.87 35.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.598 -0.689 . . . . 0.0 110.124 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -36.1 3.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 51' ' ' LEU . 27.7 m -58.73 149.4 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.399 -0.813 . . . . 0.0 110.069 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.6 ' O ' HG22 ' A' ' 88' ' ' VAL . 6.9 tp10 -116.98 156.63 27.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.54 110.01 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.741 . . . . 0.0 109.741 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.19 23.06 8.72 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 16.7 m-20 -102.3 165.41 11.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -1.024 . . . . 0.0 109.554 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 136.84 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 83' ' ' PHE . 26.2 mt -115.47 95.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.594 -0.691 . . . . 0.0 109.356 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.68 125.83 29.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.9 105.9 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 109.914 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.927 ' CD ' ' HB1' ' A' ' 22' ' ' ALA . 4.3 tttm -102.02 66.1 1.01 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.531 ' HD3' HD23 ' A' ' 69' ' ' LEU . 12.1 pttt -58.49 146.27 35.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.551 -0.718 . . . . 0.0 110.295 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD11 HE21 ' A' ' 19' ' ' GLN . 0.7 OUTLIER -79.89 -33.22 40.13 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.47 -45.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.605 -0.684 . . . . 0.0 109.437 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -174.76 139.4 0.53 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.677 -0.639 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.571 HD11 ' HG3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -103.96 33.54 3.4 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.34 139.37 2.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -150.37 -65.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.613 -0.933 . . . . 0.0 109.678 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -63.42 -66.39 0.55 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.7 m -92.67 155.34 17.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.574 -0.704 . . . . 0.0 109.581 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 77' ' ' ILE . . . -71.68 68.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.593 -0.692 . . . . 0.0 109.276 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.39 -47.52 15.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.09 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.571 ' HG3' HD11 ' A' ' 69' ' ' LEU . 37.3 ttp -62.82 -40.61 97.94 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' HB1' ' A' ' 74' ' ' ALA . 3.6 mp -75.5 -14.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.624 -0.672 . . . . 0.0 110.445 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -70.38 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.213 -0.929 . . . . 0.0 109.337 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 48' ' ' LEU . 2.6 pt? -56.61 -26.56 56.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.525 -0.734 . . . . 0.0 110.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 76' ' ' MET . 32.3 mt -68.43 -43.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -31.9 68.45 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -71.17 -30.39 66.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.713 -0.617 . . . . 0.0 109.492 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 61' ' ' ILE . 11.9 m-30 -89.17 -30.09 18.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.535 -0.728 . . . . 0.0 109.545 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.39 -32.61 73.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.35 -19.65 27.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.707 -0.621 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.53 4.08 29.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 110.471 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 30.43 62.51 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 56' ' ' GLU . 59.3 t -112.59 150.13 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.592 -0.946 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 m -104.61 153.3 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.646 -0.659 . . . . 0.0 109.544 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 61' ' ' ILE . 53.5 mt -127.46 120.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.636 -0.665 . . . . 0.0 109.527 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -93.42 126.56 38.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 3.0 m-85 -105.37 131.33 52.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.472 -0.767 . . . . 0.0 109.542 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.862 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -55.18 -24.28 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.64 -0.662 . . . . 0.0 110.047 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.79 -47.23 59.83 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -158.23 23.51 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.0 110.386 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.47 -17.22 53.48 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.892 HD12 ' HB2' ' A' ' 100' ' ' ASP . 27.4 pt -153.09 -175.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -1.192 . . . . 0.0 109.565 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -148.11 -77.25 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.562 -0.711 . . . . 0.0 109.317 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 99' ' ' THR . 8.8 t -90.38 52.29 2.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.725 . . . . 0.0 109.128 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 97' ' ' ILE . 15.4 t70 -62.91 86.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.645 -0.659 . . . . 0.0 109.396 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.61 -52.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -61.87 -26.59 68.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.927 . . . . 0.0 109.75 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.14 64.7 1.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.53 -0.731 . . . . 0.0 109.382 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.36 54.14 0.5 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.704 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' CE ' HG11 ' A' ' 60' ' ' VAL . 22.5 ttp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -134.5 158.27 44.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.547 -0.721 . . . . 0.0 109.345 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 27' ' ' GLY . 5.3 mp -101.69 86.6 2.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.6 -0.687 . . . . 0.0 109.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.23 153.74 20.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -142.28 145.38 15.54 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.394 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.9 t80 -108.13 148.4 29.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.4 168.65 20.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.784 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -169.43 109.25 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.718 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.2 m -57.88 143.33 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.572 -0.705 . . . . 0.0 110.728 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.81 -33.39 3.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 15' ' ' SER . 8.7 t -97.22 172.26 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.79 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -85.88 -28.71 24.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.164 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.5 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.596 -0.69 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 18' ' ' ILE . 4.1 pt20 -70.93 66.97 0.39 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.736 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -69.78 -52.94 20.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 109.538 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.718 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 tt -51.34 -36.49 43.14 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.43 -43.7 76.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.515 -0.741 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 14' ' ' GLN . 8.1 mt -70.0 -35.5 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.63 -0.668 . . . . 0.0 109.676 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -65.71 -48.79 70.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.27 -0.894 . . . . 0.0 108.678 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.859 HG22 HG21 ' A' ' 33' ' ' ILE . 93.4 t -53.35 -47.7 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.391 -0.818 . . . . 0.0 109.185 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -58.85 -33.41 70.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -67.7 -36.13 80.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 48.4 mt -74.19 -46.65 40.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.24 -41.58 97.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.21 -34.8 77.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.38 -32.46 66.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 122.81 44.31 0.34 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 5' ' ' GLY . 84.5 t -115.68 146.16 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.892 -0.769 . . . . 0.0 109.132 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.86 141.19 33.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 24' ' ' LYS . . . -62.34 -31.98 72.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.461 -0.774 . . . . 0.0 109.363 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -24.23 64.72 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.664 -0.647 . . . . 0.0 109.325 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -110.18 58.56 0.61 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.462 -0.774 . . . . 0.0 109.098 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.859 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -113.21 80.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -78.88 78.29 5.32 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.5 t -83.77 173.17 11.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.747 -0.595 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -126.92 108.28 10.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 16' ' ' LEU . 12.7 mmmm -68.28 78.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -77.86 59.09 2.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.614 -0.679 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 29.8 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.376 -0.828 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.39 -123.96 4.5 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -83.51 -30.46 27.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.989 . . . . 0.0 109.466 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -149.82 -49.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -176.87 155.49 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 109.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -119.96 84.22 2.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 109.589 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -78.7 70.12 4.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.673 . . . . 0.0 109.363 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -111.49 -19.88 12.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.539 -0.726 . . . . 0.0 110.085 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.29 -61.22 7.65 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -73.13 -28.3 62.17 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.637 -0.919 . . . . 0.0 108.903 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.0 t0 -58.04 -29.41 65.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.427 -0.796 . . . . 0.0 109.273 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 26.2 mt -107.12 -27.07 10.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.692 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.06 -32.83 73.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 108.762 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -25.55 65.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.551 -0.718 . . . . 0.0 109.811 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.1 ptp -107.86 -19.79 13.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 109.959 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -83.93 -28.9 27.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 51' ' ' LEU . 19.5 m -57.32 134.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.5 155.67 19.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.3 103.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.582 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.22 23.32 9.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.586 ' OD1' HG22 ' A' ' 88' ' ' VAL . 25.4 p-10 -92.58 175.44 6.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -1.08 . . . . 0.0 109.404 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG11 ' CE ' ' A' ' 1' ' ' MET . 1.6 m -116.84 135.35 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.59 -0.694 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 88' ' ' VAL . 75.8 mt -108.99 97.79 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.653 -0.654 . . . . 0.0 109.312 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.3 mt -78.68 143.25 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' CG1' HD21 ' A' ' 69' ' ' LEU . 26.2 t -139.41 162.25 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.501 -0.749 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -131.66 172.92 11.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -129.31 75.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.666 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 66' ' ' LEU . 41.4 tp -70.58 -39.14 74.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.569 -0.707 . . . . 0.0 109.317 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.02 -51.12 0.49 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.638 -0.664 . . . . 0.0 109.303 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -178.01 122.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.614 -0.679 . . . . 0.0 109.445 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' HG3' ' A' ' 76' ' ' MET . 9.5 mt -62.99 -52.01 64.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.619 -0.676 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.56 52.11 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -147.09 -53.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 109.561 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -113.68 -75.71 0.59 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 109.636 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -111.0 -158.78 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.477 -0.764 . . . . 0.0 109.411 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.47 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 109.565 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.26 -30.41 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.711 . . . . 0.0 109.615 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.731 ' HG3' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -99.22 -37.67 9.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.541 -0.725 . . . . 0.0 109.518 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.1 mp -64.95 -26.36 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -71.45 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -56.07 -22.42 27.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.223 -0.923 . . . . 0.0 110.05 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.805 ' N ' HD22 ' A' ' 79' ' ' LEU . 27.7 mt -65.98 -46.25 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 77' ' ' ILE . 6.2 mmtt -66.45 -37.77 85.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -63.87 -45.1 90.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 55' ' ' VAL . 26.9 m-85 -71.39 -31.75 67.65 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.3 -38.24 88.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 109.59 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.09 -19.82 26.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.58 -0.7 . . . . 0.0 110.204 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 2.73 25.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 110.75 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 33.18 53.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.586 HG22 ' OD1' ' A' ' 59' ' ' ASP . 77.3 t -121.16 153.76 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.643 -0.916 . . . . 0.0 109.165 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.2 m -109.17 166.54 10.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 0.0 109.517 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 33.9 mt -140.17 103.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -85.14 139.53 31.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 0.0 109.445 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -117.44 131.42 56.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.562 -0.711 . . . . 0.0 109.479 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 64' ' ' LYS . 7.5 tp -61.14 -23.41 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.733 . . . . 0.0 109.943 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.79 -26.31 61.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.333 -0.854 . . . . 0.0 110.17 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -157.1 -47.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.475 -0.766 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.76 27.11 9.22 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 98' ' ' SER . 23.0 mt -97.76 164.9 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.563 -0.963 . . . . 0.0 109.322 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 97' ' ' ILE . 16.8 m -63.2 -166.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -0.769 . . . . 0.0 109.354 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -67.88 82.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.616 -0.678 . . . . 0.0 109.363 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.85 36.34 2.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.642 . . . . 0.0 109.544 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -129.09 33.18 3.11 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -114.83 148.36 38.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.666 -0.902 . . . . 0.0 109.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -99.68 -56.88 2.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.92 41.93 53.94 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.8 mttt . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.693 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.7 177.37 7.68 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.597 -0.689 . . . . 0.0 109.163 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 27' ' ' GLY . 4.0 mp -121.58 104.23 9.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.583 -0.698 . . . . 0.0 109.786 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' NH1' ' A' ' 32' ' ' ARG . 70.4 m-85 -81.64 150.83 27.89 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.674 ' CA ' HG21 ' A' ' 28' ' ' VAL . . . -125.3 102.94 0.69 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 34.9 t80 -87.27 131.31 34.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 108.771 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.002 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -146.64 120.76 9.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.364 -0.835 . . . . 0.0 110.569 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -111.71 103.45 11.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 16' ' ' LEU . 27.5 m -58.02 148.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 110.714 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -120.11 -40.03 2.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.755 HG22 ' OG ' ' A' ' 15' ' ' SER . 6.1 t -89.4 161.16 16.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.515 -0.741 . . . . 0.0 109.466 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -107.85 85.57 2.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.547 -0.721 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -169.6 -61.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.635 -0.665 . . . . 0.0 109.404 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HG3' HD11 ' A' ' 18' ' ' ILE . 5.9 pt20 -161.75 32.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.871 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -59.03 -46.73 87.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.547 -0.72 . . . . 0.0 109.975 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.813 HD11 HG21 ' A' ' 35' ' ' THR . 52.6 tp -49.76 -42.96 47.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.518 -0.739 . . . . 0.0 109.858 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -40.6 90.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 15' ' ' SER . 15.8 mt -67.85 -37.05 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.882 -0.512 . . . . 0.0 109.738 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.713 ' CB ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -68.33 -52.2 36.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.869 HG22 HG21 ' A' ' 33' ' ' ILE . 75.6 t -52.96 -45.8 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.424 -0.797 . . . . 0.0 109.398 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -59.86 -42.84 94.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.425 -0.797 . . . . 0.0 109.082 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.91 99.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.002 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.9 mt -70.14 -49.53 49.67 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -61.11 -36.89 80.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.319 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.48 -45.3 84.99 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.86 70.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.75 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 120.21 44.22 0.45 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -97.31 161.55 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -1.006 . . . . 0.0 109.205 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -86.37 124.9 33.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -61.07 -28.98 69.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.339 -0.85 . . . . 0.0 108.983 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.82 -23.87 60.83 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' NH1' ' CZ ' ' A' ' 4' ' ' PHE . 2.4 mtt-85 -112.26 58.02 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 109.031 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 20' ' ' VAL . 44.7 mm -104.94 85.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -81.72 88.25 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.626 -0.671 . . . . 0.0 109.306 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.813 HG21 HD11 ' A' ' 16' ' ' LEU . 6.3 t -98.54 152.89 19.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.652 -0.655 . . . . 0.0 109.818 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -117.68 98.13 6.21 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HD3' HD22 ' A' ' 16' ' ' LEU . 2.1 mmmp? -60.89 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.579 -0.701 . . . . 0.0 109.823 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.92 58.26 2.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.654 -0.654 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.27 84.04 2.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.422 -0.799 . . . . 0.0 109.422 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.99 -149.53 7.29 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -78.06 -37.68 46.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.596 -0.943 . . . . 0.0 109.454 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 t -125.09 -175.43 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 p -85.31 127.19 34.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.86 66.9 5.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.9 ttm-85 -72.03 65.27 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.443 -0.786 . . . . 0.0 109.222 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -104.23 -48.2 3.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -54.53 -38.76 63.97 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 79' ' ' LEU . 8.2 tt -73.46 -45.05 56.47 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -31.25 70.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -88.86 -27.09 21.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.621 -0.674 . . . . 0.0 109.303 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 55' ' ' VAL . 12.9 tp -60.29 -32.72 71.46 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -63.87 -24.28 67.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 mmt -110.31 10.84 23.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 0.0 110.392 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -119.94 -30.14 4.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.0 110.36 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG13 ' HG ' ' A' ' 51' ' ' LEU . 24.2 m -58.28 154.71 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.866 . . . . 0.0 110.159 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -111.09 137.93 48.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.07 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.173 -0.955 . . . . 0.0 110.472 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.25 19.87 5.73 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.1 p-10 -100.49 -175.68 2.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.289 -1.124 . . . . 0.0 109.907 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.79 124.76 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 83' ' ' PHE . 15.3 mt -99.19 103.11 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.683 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mt -78.92 138.06 37.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.442 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 69' ' ' LEU . 30.2 t -142.31 161.69 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.661 -0.649 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -141.46 173.08 11.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.545 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -117.12 94.73 4.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.539 -0.726 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -87.49 -72.94 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -110.7 -38.71 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -176.26 113.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.705 . . . . 0.0 109.444 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -57.16 -46.51 82.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.592 -0.693 . . . . 0.0 110.0 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 75' ' ' ASP . . . -147.08 -158.36 7.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -122.53 -160.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.677 -0.896 . . . . 0.0 109.373 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.08 -32.78 73.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.392 -0.817 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 74' ' ' ALA . 39.1 m -66.1 162.47 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' HD13 ' A' ' 77' ' ' ILE . . . -71.97 67.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.4 ' HB2' ' HA3' ' A' ' 70' ' ' GLY . 9.1 m-20 -83.04 -27.65 30.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 109.464 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.746 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -108.77 15.1 23.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.675 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.633 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.9 mp -116.42 -30.83 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.279 -0.888 . . . . 0.0 109.058 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -72.88 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.516 -0.74 . . . . 0.0 109.277 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.18 -15.14 21.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.434 -0.791 . . . . 0.0 110.672 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 76' ' ' MET . 1.0 OUTLIER -77.87 -34.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -87.01 -32.18 20.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -63.72 -47.41 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 61' ' ' ILE . 19.6 m-85 -69.19 -37.28 78.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.566 ' OD2' HG23 ' A' ' 99' ' ' THR . 6.6 t0 -63.14 -36.73 84.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.48 -15.7 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.684 -0.635 . . . . 0.0 110.222 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -90.21 16.48 8.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.06 70.18 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.413 HG13 ' CG ' ' A' ' 59' ' ' ASP . 46.8 t -124.85 148.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.657 -0.908 . . . . 0.0 109.388 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -108.52 164.92 11.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 83' ' ' PHE . 42.0 mt -133.28 106.46 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.629 -0.67 . . . . 0.0 109.275 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -79.49 138.92 37.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 109.682 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.34 146.88 44.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 64' ' ' LYS . 14.0 tt -67.15 -27.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.549 -0.719 . . . . 0.0 109.649 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -56.23 -23.01 33.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.453 -0.78 . . . . 0.0 110.541 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -171.83 -40.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.39 -0.818 . . . . 0.0 109.708 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.39 -7.39 5.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.26 176.1 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -1.21 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.2 t -155.96 -79.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.653 -0.654 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.566 HG23 ' OD2' ' A' ' 84' ' ' ASP . 9.1 t -99.74 44.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -51.08 -25.82 5.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 173.14 68.99 0.05 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.02 154.8 18.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.486 -1.008 . . . . 0.0 109.832 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.1 mtm -142.14 -52.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.18 56.83 13.64 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.3 mmt180 -118.26 156.84 28.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.61 -0.681 . . . . 0.0 109.234 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 27' ' ' GLY . 8.3 mt -92.64 86.27 5.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.502 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 2' ' ' ARG . 22.6 m-85 -89.58 136.67 32.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.703 . . . . 0.0 109.484 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.721 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -130.45 131.47 6.55 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -95.33 141.31 29.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.687 -0.89 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.53 161.06 38.01 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.489 0.661 . . . . 0.0 109.873 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -161.48 110.0 1.52 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 16' ' ' LEU . 35.0 m -64.19 162.16 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.619 -0.676 . . . . 0.0 110.412 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 27.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 15' ' ' SER . 15.3 t -145.63 161.97 38.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.475 -0.766 . . . . 0.0 109.958 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -67.83 -37.34 81.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.488 -0.758 . . . . 0.0 109.349 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 109.365 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.36 71.03 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.722 . . . . 0.0 109.737 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.763 ' HB2' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -60.14 -25.37 65.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.474 -0.767 . . . . 0.0 109.989 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.0 tt -60.4 -45.44 93.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -67.17 -43.12 83.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 15' ' ' SER . 8.9 mt -65.99 -35.99 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.518 ' CG ' HD22 ' A' ' 66' ' ' LEU . 4.6 mm-40 -69.39 -51.61 34.98 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 33' ' ' ILE . 58.7 t -50.82 -48.54 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.03 -31.94 69.28 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -70.01 -38.08 75.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 7' ' ' ALA . 6.6 mt -72.95 -43.67 62.03 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.77 -42.7 99.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.72 -34.96 75.18 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -70.77 -31.56 68.39 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 121.96 44.16 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.721 HG11 ' HA3' ' A' ' 5' ' ' GLY . 66.2 t -116.45 144.15 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.79 -0.83 . . . . 0.0 109.414 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.77 138.28 42.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.31 75.38 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -25.28 65.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -106.16 58.35 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.959 HG21 HG22 ' A' ' 20' ' ' VAL . 47.1 mm -116.48 90.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.756 . . . . 0.0 108.965 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.54 ' HB2' HD13 ' A' ' 51' ' ' LEU . 9.1 m-85 -87.97 74.27 8.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.224 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.6 t -78.75 174.65 11.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.603 -0.685 . . . . 0.0 109.633 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.7 m-20 -129.52 112.48 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.617 -0.677 . . . . 0.0 109.215 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD13 ' A' ' 16' ' ' LEU . 11.5 mmmm -71.84 68.94 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 109.301 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.48 -28.32 69.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.69 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 t -89.23 68.48 8.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.99 -144.5 4.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.562 -0.964 . . . . 0.0 109.3 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 t -161.65 -174.25 4.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.664 -0.647 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 130.98 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.87 83.8 2.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.513 -0.742 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.552 -0.718 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -88.0 9.24 23.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.555 -0.716 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.09 -51.94 40.8 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.57 -33.76 64.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.652 -0.911 . . . . 0.0 108.55 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.34 -30.31 66.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.507 -0.745 . . . . 0.0 109.598 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.17 -34.57 8.79 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 34' ' ' PHE . 11.8 tp -67.02 -41.67 86.23 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -57.4 -25.98 60.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -105.19 -0.25 26.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.459 -0.776 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 1.6 tmtt? -109.74 -25.57 10.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.129 -0.982 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' A' ' 83' ' ' PHE . 17.3 m -59.57 160.2 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.802 . . . . 0.0 110.134 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -52.83 102.69 0.06 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.67 22.52 5.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.511 ' CG ' HG13 ' A' ' 88' ' ' VAL . 2.5 p30 -100.62 -162.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -1.115 . . . . 0.0 109.92 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.57 124.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.429 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 90' ' ' ILE . 61.3 mt -107.71 96.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.766 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CB ' ' A' ' 26' ' ' ALA . 1.5 tt -82.68 125.08 30.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.555 -0.716 . . . . 0.0 109.145 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 t -114.15 155.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.509 -0.745 . . . . 0.0 109.783 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HA ' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -121.06 153.53 37.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 109.296 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -98.59 77.64 2.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 19' ' ' GLN . 45.1 tp -84.1 -43.18 15.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.712 . . . . 0.0 109.28 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.05 -65.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.678 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -178.02 125.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.522 HD13 ' HG2' ' A' ' 76' ' ' MET . 5.0 mt -63.63 -63.19 1.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.97 108.69 0.49 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -107.35 -30.25 8.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.481 -1.011 . . . . 0.0 109.547 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.46 -71.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -132.23 -157.73 0.84 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 65.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.716 -0.615 . . . . 0.0 109.786 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -94.16 -41.95 9.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 108.873 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.522 ' HG2' HD13 ' A' ' 69' ' ' LEU . 7.3 tmm? -64.43 -30.63 71.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.42 -21.16 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.548 -0.72 . . . . 0.0 109.898 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -69.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.688 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.08 -18.34 24.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.356 -0.84 . . . . 0.0 110.642 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.489 ' N ' HD22 ' A' ' 79' ' ' LEU . 59.4 mt -75.72 -43.04 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -67.69 -33.79 75.61 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.91 -48.87 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.531 ' CE1' HG11 ' A' ' 55' ' ' VAL . 30.2 m-85 -70.88 -28.54 64.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.59 -0.694 . . . . 0.0 109.359 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.02 -36.23 80.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.744 . . . . 0.0 109.54 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.9 -23.64 36.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.722 -0.611 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -81.97 2.18 32.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.529 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.17 66.12 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CG ' ' A' ' 59' ' ' ASP . 89.5 t -109.89 151.88 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.717 -0.872 . . . . 0.0 109.362 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.36 164.1 11.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 83' ' ' PHE . 21.8 mt -144.09 114.52 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.496 -0.753 . . . . 0.0 109.371 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -94.77 153.45 17.75 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 22.6 m-85 -128.58 117.23 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 93' ' ' ILE . 7.4 tp -68.13 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.625 0.726 . . . . 0.0 109.382 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 179.03 -37.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.17 -22.85 8.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 110.156 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.25 -41.18 2.19 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -155.18 -172.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.844 . . . . 0.0 109.236 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . 0.5 OUTLIER -150.41 -79.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.496 -0.752 . . . . 0.0 109.246 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' THR . 10.0 t -119.03 52.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.56 -24.25 13.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.548 -0.72 . . . . 0.0 110.172 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.19 91.57 0.09 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.38 56.7 4.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.569 -0.96 . . . . 0.0 109.495 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 mtp -84.8 -50.31 7.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.66 38.87 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.763 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.47 171.55 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 4.0 mp -101.03 84.95 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 32' ' ' ARG . 42.7 m-85 -82.51 146.12 29.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -131.41 141.19 12.47 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 77.5 t80 -110.07 132.78 53.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.64 97.02 3.35 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.117 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -99.11 109.4 22.12 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 36' ' ' ASP . 35.5 m -59.24 158.81 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.75 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 22.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 15' ' ' SER . 13.8 t -143.96 151.85 40.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -66.12 -33.63 76.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.709 . . . . 0.0 109.364 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -172.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.616 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.544 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.72 77.36 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.679 . . . . 0.0 109.914 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.888 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -73.09 -38.66 66.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.77 . . . . 0.0 109.48 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.796 HD13 ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -60.27 -38.13 82.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.496 -0.753 . . . . 0.0 109.213 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.5 -51.93 45.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.604 -0.685 . . . . 0.0 109.272 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.5 mt -62.27 -36.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.657 . . . . 0.0 109.359 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.9 mt-30 -62.03 -53.81 50.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.675 -0.641 . . . . 0.0 109.706 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 16' ' ' LEU . 79.7 t -52.37 -47.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 0.0 109.158 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -36.83 79.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.09 -40.65 78.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 19' ' ' GLN . 10.0 mp -68.54 -45.81 71.18 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.919 ' NZ ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -62.6 -43.76 98.01 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.64 -33.38 70.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -72.18 -31.04 65.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.31 43.32 0.51 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.653 HG11 ' HA3' ' A' ' 5' ' ' GLY . 92.2 t -109.2 147.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -85.75 136.46 33.33 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' CG1' ' A' ' 33' ' ' ILE . . . -59.37 -37.55 78.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.559 -0.713 . . . . 0.0 109.648 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -25.34 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -109.4 58.8 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.919 HD11 ' NZ ' ' A' ' 24' ' ' LYS . 31.0 mm -110.81 86.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 108.992 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 51' ' ' LEU . 70.9 m-85 -80.0 78.41 6.63 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.672 HG21 HD11 ' A' ' 16' ' ' LEU . 5.3 t -80.44 -178.76 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.573 0.702 . . . . 0.0 110.009 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.1 m-20 -149.69 102.18 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HD3' HD13 ' A' ' 16' ' ' LEU . 6.4 mmmt -70.3 70.48 0.41 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.47 0.653 . . . . 0.0 109.599 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.62 67.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.591 -0.693 . . . . 0.0 109.861 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 m -93.35 44.71 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.48 -90.79 2.19 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 p -100.26 -28.48 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 109.202 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 m -171.1 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.236 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.0 -178.71 0.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.128 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -171.91 112.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.409 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 48' ' ' LEU . 46.6 mtp180 -116.96 29.09 8.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -68.89 -18.03 64.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 110.112 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.57 -57.12 21.51 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -68.65 -37.42 79.66 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.454 -1.027 . . . . 0.0 109.211 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.66 63.53 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.405 -0.81 . . . . 0.0 109.515 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.56 -30.3 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.4 tp -67.48 -38.19 84.01 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -62.98 -28.79 70.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.64 -0.663 . . . . 0.0 109.699 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.97 -14.42 15.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 39.5 mmtt -94.46 -30.25 14.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.248 -0.907 . . . . 0.0 110.1 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 51' ' ' LEU . 23.8 m -61.24 135.75 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 172.52 7.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -67.32 110.73 3.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.56 21.69 21.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -86.96 172.95 9.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.356 -1.085 . . . . 0.0 109.104 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -127.3 126.66 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.713 HD13 ' CD2' ' A' ' 83' ' ' PHE . 2.7 mp -96.71 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD22 ' HB1' ' A' ' 26' ' ' ALA . 1.4 mt -81.76 126.57 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.86 152.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' C ' HG21 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -99.65 -173.5 2.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.454 -0.779 . . . . 0.0 110.601 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' N ' HG21 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -124.28 100.54 6.74 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 tp -167.67 -43.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.733 . . . . 0.0 109.162 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -150.04 118.59 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -52.3 167.01 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 110.007 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -88.0 -30.55 19.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.608 -0.683 . . . . 0.0 109.221 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.37 24.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -148.06 -58.29 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.929 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.62 -45.53 9.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.552 -0.718 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.1 m -98.37 154.87 17.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.654 -0.654 . . . . 0.0 109.331 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.76 65.13 0.69 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.731 . . . . 0.0 109.268 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -79.03 -51.37 9.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.398 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 80' ' ' ILE . 8.6 tmm? -60.07 -31.32 69.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 109.377 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 77' ' ' ILE . 5.0 mp -84.63 -23.6 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.513 -0.742 . . . . 0.0 109.854 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -59.45 -68.98 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.8 -16.29 16.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.0 110.53 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.514 HG21 HG21 ' A' ' 99' ' ' THR . 32.7 mt -77.57 -44.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -65.28 -32.73 74.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -66.67 -48.61 68.81 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.713 ' CD2' HD13 ' A' ' 61' ' ' ILE . 8.8 m-30 -73.55 -27.8 61.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.678 -0.639 . . . . 0.0 109.387 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 -45.1 93.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.63 -16.31 48.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.655 . . . . 0.0 110.395 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -84.25 6.47 22.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.558 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.76 30.81 65.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 59' ' ' ASP . 44.6 t -119.62 149.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.736 -0.861 . . . . 0.0 109.251 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -105.36 164.37 11.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.611 -0.68 . . . . 0.0 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 80' ' ' ILE . 57.0 mt -134.42 119.49 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -93.15 134.28 35.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.631 -0.668 . . . . 0.0 109.78 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -110.91 121.39 45.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.559 -0.713 . . . . 0.0 109.122 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 65' ' ' LYS . 7.8 tp -58.35 -27.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.68 -35.87 62.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.728 . . . . 0.0 109.61 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.1 -70.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.526 -0.734 . . . . 0.0 109.539 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.78 -34.86 2.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.8 mm -88.32 -65.5 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.772 -0.84 . . . . 0.0 109.765 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.75 -163.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.773 . . . . 0.0 109.19 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 99' ' ' THR . 5.8 t -74.09 65.55 1.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.505 -0.747 . . . . 0.0 109.281 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.52 80.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 0.0 109.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.34 70.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -155.42 29.57 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.966 . . . . 0.0 109.56 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.32 -65.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.76 2.65 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.38 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -155.87 167.21 31.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.552 -0.718 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 27' ' ' GLY . 6.9 mt -98.54 77.85 2.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 32' ' ' ARG . 29.7 m-85 -81.83 153.12 26.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 137.8 9.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' C ' HD21 ' A' ' 23' ' ' LEU . 39.4 t80 -108.29 138.87 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.697 -0.884 . . . . 0.0 108.888 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -137.77 150.69 47.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.597 -0.689 . . . . 0.0 109.719 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 100.24 3.31 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 16' ' ' LEU . 31.3 m -60.06 134.86 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.588 0.709 . . . . 0.0 110.541 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -113.0 -30.74 6.91 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 15' ' ' SER . 4.9 t -96.55 -177.35 3.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -128.31 89.09 2.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -176.43 -56.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.535 -0.728 . . . . 0.0 109.312 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HG3' HD11 ' A' ' 18' ' ' ILE . 6.6 pt20 -162.43 30.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.237 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -60.07 -39.58 86.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 110.012 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -58.58 -40.46 83.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.0 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -48.82 64.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 15' ' ' SER . 12.8 mt -59.78 -41.32 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.702 -0.624 . . . . 0.0 109.32 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.667 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 9.5 mm-40 -63.63 -51.03 67.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.705 -0.622 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.966 HG22 HG21 ' A' ' 33' ' ' ILE . 97.4 t -56.03 -47.37 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.354 -0.841 . . . . 0.0 108.881 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.91 -38.38 88.17 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.01 92.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.0 mp -68.93 -48.14 63.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.41 -42.35 98.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.72 . . . . 0.0 109.174 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.83 -34.65 69.93 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -71.39 -33.75 69.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 125.49 41.71 0.34 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HA3' ' A' ' 5' ' ' GLY . 55.0 t -106.87 153.0 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.729 -0.866 . . . . 0.0 108.73 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.05 139.71 30.37 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -65.58 -25.01 67.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.573 -0.705 . . . . 0.0 109.706 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.37 -27.43 67.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -121.04 67.72 0.87 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 20' ' ' VAL . 41.0 mm -108.78 85.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' HE1' HD13 ' A' ' 50' ' ' LEU . 2.8 m-85 -78.34 78.39 4.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.828 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -83.67 163.14 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.698 -0.626 . . . . 0.0 109.841 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.91 101.08 6.66 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -68.69 74.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.874 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.61 -27.44 64.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.501 -0.75 . . . . 0.0 109.904 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -72.24 66.17 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 0.0 109.515 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.02 -127.01 2.58 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.7 p -71.18 -30.43 66.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.62 -0.93 . . . . 0.0 109.245 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 t -175.89 -59.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.547 -0.721 . . . . 0.0 109.337 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 p -136.68 169.1 18.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.724 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.03 55.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' NE ' HD22 ' A' ' 48' ' ' LEU . 35.2 ttt85 -72.07 64.5 0.53 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.521 -0.737 . . . . 0.0 109.459 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 50' ' ' LEU . 13.5 mtmt -105.95 -47.0 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.388 -0.82 . . . . 0.0 109.27 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.3 69.51 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 HD22 ' NE ' ' A' ' 45' ' ' ARG . 10.3 tt -79.75 -44.72 20.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.702 -0.881 . . . . 0.0 109.075 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -36.0 78.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 109.008 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 ' HE1' ' A' ' 34' ' ' PHE . 6.0 mt -76.64 -29.32 56.38 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 55' ' ' VAL . 6.1 tp -65.37 -35.17 80.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -65.76 -29.2 69.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -103.54 -13.73 16.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.378 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -34.06 11.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 88' ' ' VAL . 13.5 p -55.49 135.95 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.752 -0.592 . . . . 0.0 110.533 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.7 tt0 -106.01 163.75 12.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.32 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.82 111.68 2.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.584 -0.697 . . . . 0.0 109.606 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.47 23.27 16.78 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -90.28 156.19 18.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.362 -1.081 . . . . 0.0 109.487 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.14 127.89 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 83' ' ' PHE . 23.7 mt -114.17 104.28 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.749 HD13 ' CB ' ' A' ' 26' ' ' ALA . 4.3 mt -81.12 136.42 35.91 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 69' ' ' LEU . 25.1 t -133.11 128.17 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.509 -0.744 . . . . 0.0 109.704 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -78.45 149.99 33.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.612 -0.68 . . . . 0.0 109.232 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 58.51 5.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.469 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' CD ' ' A' ' 19' ' ' GLN . 2.6 mt -62.71 -163.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 109.055 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.15 -45.03 61.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.341 -0.85 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -176.46 147.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.459 -0.776 . . . . 0.0 109.939 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -57.74 -57.49 12.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.573 -0.704 . . . . 0.0 110.05 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.98 -139.82 4.05 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -106.41 -163.82 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.972 . . . . 0.0 109.467 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.15 76.58 0.35 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -161.61 -171.16 2.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.482 -0.761 . . . . 0.0 109.142 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' H ' HG22 ' A' ' 73' ' ' THR . . . -93.61 46.97 1.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.225 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.81 -47.3 16.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.54 ' O ' HD12 ' A' ' 80' ' ' ILE . 7.4 tmm? -61.44 -40.56 94.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.1 mp -79.49 -21.57 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.588 -0.695 . . . . 0.0 109.978 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -75.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.016 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.17 -14.29 35.94 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.781 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.732 ' CG2' HG21 ' A' ' 99' ' ' THR . 35.8 mt -84.15 -29.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.965 -1.084 . . . . 0.0 108.198 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -33.98 14.86 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.86 -45.46 89.4 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 61' ' ' ILE . 12.6 m-30 -74.83 -24.8 58.67 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.96 -51.85 67.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.478 -0.764 . . . . 0.0 109.267 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.1 -19.33 61.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.814 -0.554 . . . . 0.0 110.23 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.17 2.03 29.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -0.95 . . . . 0.0 110.702 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.37 31.88 65.54 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 55' ' ' VAL . 93.0 t -111.92 152.62 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.611 -0.935 . . . . 0.0 109.154 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.3 142.82 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.622 -0.674 . . . . 0.0 109.822 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 61' ' ' ILE . 59.0 mt -122.19 103.11 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' HG ' ' A' ' 62' ' ' LEU . 10.1 mtt180 -78.29 151.88 32.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.844 -0.535 . . . . 0.0 109.589 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.83 141.51 51.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.72 -0.613 . . . . 0.0 109.479 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.859 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -63.27 -29.9 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -51.21 -25.63 5.81 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.397 -0.814 . . . . 0.0 110.68 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -164.65 -63.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.732 . . . . 0.0 109.71 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.32 -25.98 1.86 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 98' ' ' SER . 49.7 mt -65.72 162.81 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.517 -0.99 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.3 t -62.42 -162.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.732 HG21 ' CG2' ' A' ' 80' ' ' ILE . 5.2 t -71.55 68.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.608 -0.682 . . . . 0.0 109.322 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.38 80.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.77 45.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 83.25 2.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.645 -0.915 . . . . 0.0 109.629 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtp -152.84 145.41 24.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.731 . . . . 0.0 109.516 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.42 60.53 0.37 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.411 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 1.2 mmm180 -132.4 164.87 25.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.638 -0.664 . . . . 0.0 109.346 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.3 mp -112.37 80.91 1.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.605 -0.685 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 51' ' ' LEU . 57.7 m-85 -81.74 144.77 30.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.692 -0.63 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.18 135.93 8.38 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 69.4 t80 -99.53 145.72 27.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.667 -0.902 . . . . 0.0 109.046 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -148.66 164.98 32.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.948 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -162.51 108.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 16' ' ' LEU . 29.7 m -57.66 137.54 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.588 -0.695 . . . . 0.0 110.854 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -114.75 -34.79 5.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.8 t -95.16 -174.71 3.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.309 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -128.86 87.88 2.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.49 -0.756 . . . . 0.0 109.768 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -176.82 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 0.0 109.297 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HD11 ' A' ' 18' ' ' ILE . 8.2 pt20 -163.35 33.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.648 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.23 -51.91 67.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 0.0 110.023 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.787 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 tt -50.76 -35.77 33.39 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.933 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.37 -38.58 65.62 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 15' ' ' SER . 11.4 mt -72.49 -36.53 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.604 -0.685 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.505 ' NE2' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -67.84 -48.45 66.13 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 33' ' ' ILE . 84.1 t -53.02 -47.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.398 -0.814 . . . . 0.0 109.264 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -33.22 71.87 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -36.11 76.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 7' ' ' ALA . 29.3 mt -73.03 -46.47 51.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.804 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.3 -43.0 99.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.504 -0.747 . . . . 0.0 109.055 179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.92 -33.7 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.2 -31.67 66.09 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.18 45.15 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -119.26 150.44 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.862 -0.787 . . . . 0.0 108.96 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD2' HD13 ' A' ' 3' ' ' LEU . 4.8 mttt -86.74 142.37 28.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.662 -0.649 . . . . 0.0 109.259 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.65 -31.65 72.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.522 -0.737 . . . . 0.0 109.272 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -23.97 65.46 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.583 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 28.2 mtt-85 -113.52 58.96 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.476 -0.765 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 20' ' ' VAL . 48.3 mm -112.1 85.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 109.033 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 31.2 m-85 -84.28 88.82 7.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.683 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 t -96.95 -178.08 4.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.632 -0.668 . . . . 0.0 109.714 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.78 107.58 9.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 72.36 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.53 -21.24 36.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.341 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 t -71.71 67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.46 -156.72 7.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.2 m -63.09 -44.49 95.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -1.04 . . . . 0.0 109.32 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.2 m -140.81 -176.53 4.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p -62.87 122.57 16.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.17 70.93 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.342 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -72.61 65.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -116.66 -16.26 10.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.294 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.64 -43.35 98.05 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -88.74 -29.67 19.64 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.362 -1.081 . . . . 0.0 109.07 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -58.17 -32.68 68.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.285 -0.884 . . . . 0.0 108.697 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 22.4 mt -89.88 -33.68 16.37 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 61' ' ' ILE . 6.0 tp -61.8 -35.31 77.83 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 33.4 mtp180 -63.48 -28.73 70.16 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.3 ptm -113.79 15.3 18.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -121.08 -32.49 3.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 51' ' ' LEU . 28.5 m -56.45 137.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -0.875 . . . . 0.0 110.193 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.69 148.61 22.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.24 100.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.07 19.31 6.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' A' ' 88' ' ' VAL . 28.8 p-10 -99.53 -174.86 2.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.31 149.2 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.484 -0.76 . . . . 0.0 109.231 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 51' ' ' LEU . 22.0 mt -121.56 96.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.634 HD13 ' CB ' ' A' ' 26' ' ' ALA . 1.6 mt -78.84 131.32 36.42 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.45 112.91 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.513 -0.742 . . . . 0.0 109.518 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 179.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.652 -0.655 . . . . 0.0 109.879 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' N ' HG21 ' A' ' 93' ' ' ILE . 21.3 mmtt -121.59 117.88 27.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.65 -0.656 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' NE2' ' A' ' 19' ' ' GLN . 3.9 tp -177.88 -41.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -120.73 114.66 21.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.97 148.89 3.88 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.439 -0.788 . . . . 0.0 110.41 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 69' ' ' LEU . 4.0 mm? -57.87 -26.74 62.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.617 -0.677 . . . . 0.0 110.198 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.0 150.85 5.52 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -112.22 61.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.94 . . . . 0.0 109.01 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -150.05 -157.89 0.86 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.79 . . . . 0.0 108.975 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' ALA . 9.5 m -48.73 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' THR . . . -48.93 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.55 -0.719 . . . . 0.0 111.147 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' THR . 63.2 m-20 -103.65 -44.4 5.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD12 ' A' ' 80' ' ' ILE . 17.6 ttt -64.09 -39.91 95.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.534 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.2 mp -72.63 -24.18 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -73.89 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.619 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.672 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.75 -14.59 33.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.411 -0.806 . . . . 0.0 110.775 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 99' ' ' THR . 44.1 mt -83.58 -32.19 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.812 -1.18 . . . . 0.0 107.981 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -31.46 20.06 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -63.79 -55.21 24.8 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' CD2' HD13 ' A' ' 61' ' ' ILE . 24.4 m-85 -64.17 -27.46 69.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.6 -52.62 64.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.709 . . . . 0.0 109.411 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.29 62.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.733 -0.604 . . . . 0.0 110.025 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 1.4 28.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.627 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.78 31.79 59.91 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' OD1' ' A' ' 59' ' ' ASP . 78.5 t -117.9 153.76 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.601 -0.941 . . . . 0.0 109.197 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 m -109.76 151.81 26.48 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.477 HG12 HD12 ' A' ' 61' ' ' ILE . 53.8 mt -124.69 121.56 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 62' ' ' LEU . 13.4 mtt85 -95.53 153.93 17.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.837 -0.54 . . . . 0.0 109.67 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.18 131.15 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.544 HG21 ' N ' ' A' ' 65' ' ' LYS . 12.7 tt -62.37 -24.23 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.966 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -58.52 -19.99 42.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.316 -0.865 . . . . 0.0 110.605 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -154.84 -43.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 120.37 30.5 1.41 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 96' ' ' GLY . 25.7 pt -155.77 -174.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -1.002 . . . . 0.0 109.267 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.02 -178.74 5.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.635 -0.666 . . . . 0.0 109.31 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 HG21 HG21 ' A' ' 80' ' ' ILE . 3.5 t -74.67 67.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.72 85.26 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.24 106.55 0.23 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -110.46 144.96 38.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.956 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -34.28 76.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.747 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.31 -33.59 0.65 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.392 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -135.84 170.05 16.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 109.26 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 27' ' ' GLY . 3.9 mp -112.51 86.5 2.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.675 -0.641 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -87.38 149.38 24.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 109.343 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.629 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.38 119.82 1.86 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -85.95 144.7 27.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.666 -0.902 . . . . 0.0 108.869 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.925 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -151.17 155.09 38.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' CB ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -146.87 135.51 22.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' LEU . 33.8 m -92.76 136.13 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 0.0 110.671 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -115.43 -31.71 5.83 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 15' ' ' SER . 6.5 t -95.2 161.89 13.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 m -107.23 91.39 3.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 109.515 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -176.43 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.742 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' HG3' HD11 ' A' ' 18' ' ' ILE . 2.3 pt20 -171.24 36.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -38.68 87.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 109.637 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 tt -61.19 -40.68 94.83 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -43.88 78.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 15' ' ' SER . 19.8 mt -64.13 -44.17 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.68 ' OE1' HD22 ' A' ' 66' ' ' LEU . 13.7 mm100 -62.98 -50.43 70.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.474 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 16' ' ' LEU . 68.6 t -51.36 -48.35 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -30.53 69.31 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB1' ' CD ' ' A' ' 64' ' ' LYS . . . -72.42 -44.27 62.66 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.925 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.8 mt -69.31 -38.94 78.48 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.683 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -64.93 -45.24 86.65 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.38 -33.87 70.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.9 -31.6 69.48 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.44 43.92 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA3' ' A' ' 5' ' ' GLY . 98.7 t -117.65 144.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.804 -0.821 . . . . 0.0 109.035 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -81.88 144.2 31.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.664 -0.648 . . . . 0.0 109.706 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.69 73.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -23.5 64.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.591 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -112.39 59.31 0.64 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.372 -0.83 . . . . 0.0 108.976 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.787 HG21 HG22 ' A' ' 20' ' ' VAL . 48.1 mm -112.48 92.49 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.513 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -80.41 92.16 5.8 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.714 HG21 HD11 ' A' ' 16' ' ' LEU . 7.4 t -100.66 165.73 11.25 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.678 0.751 . . . . 0.0 110.648 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 8' ' ' ARG . 2.0 m-20 -127.75 125.61 40.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 16' ' ' LEU . 1.8 mmmp? -95.17 95.45 8.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . . . -68.78 -25.98 64.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.489 -0.757 . . . . 0.0 109.813 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 m -59.08 -19.63 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.443 -0.786 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.46 -168.98 0.19 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -61.38 -74.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.546 -0.973 . . . . 0.0 109.702 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -83.18 -172.19 4.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.53 -0.731 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 23.1 p-10 -145.76 101.96 3.61 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.435 0.636 . . . . 0.0 110.44 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -141.54 36.0 1.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.551 -0.718 . . . . 0.0 109.449 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 50' ' ' LEU . 28.5 mtmt -79.05 -18.57 53.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 0.0 109.79 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.38 -82.15 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -49.48 -27.58 4.43 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.508 -0.995 . . . . 0.0 110.017 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.499 ' H ' HD12 ' A' ' 48' ' ' LEU . 2.0 t70 -63.37 -59.9 4.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 46' ' ' LYS . 2.3 mt -72.16 -29.37 63.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 61' ' ' ILE . 7.6 tp -58.94 -33.89 71.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 21.7 mtp180 -64.62 -18.19 64.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.663 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -120.76 3.82 10.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 -25.79 9.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.357 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.4 m -60.21 141.85 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.307 -0.871 . . . . 0.0 109.908 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -94.73 170.42 9.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.664 -0.647 . . . . 0.0 109.453 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -64.8 112.38 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.717 . . . . 0.0 109.432 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.5 25.96 29.03 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.6 t0 -86.82 157.96 19.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.45 -1.03 . . . . 0.0 109.436 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -108.7 131.23 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.42 -0.8 . . . . 0.0 109.281 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.616 HG23 HD21 ' A' ' 51' ' ' LEU . 9.6 mt -110.91 101.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.504 HD22 ' HB1' ' A' ' 26' ' ' ALA . 2.5 mt -81.12 127.5 32.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 109.746 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.86 138.5 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' CD ' ' HB1' ' A' ' 22' ' ' ALA . 15.5 mtpp -105.53 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.876 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -23.63 30.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.583 -0.698 . . . . 0.0 109.84 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD22 ' OE1' ' A' ' 19' ' ' GLN . 3.8 tt -64.47 -54.06 38.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.1 63.58 7.73 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -47.38 159.66 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.592 -0.693 . . . . 0.0 110.994 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD12 HD21 ' A' ' 79' ' ' LEU . 3.8 mm? -61.31 -77.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.712 -0.617 . . . . 0.0 110.26 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.35 -138.32 2.41 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.417 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.684 -0.892 . . . . 0.0 110.142 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.91 -8.05 35.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.641 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.53 HG23 ' N ' ' A' ' 74' ' ' ALA . 5.1 t -62.55 -157.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.014 . . . . 0.0 109.156 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 73' ' ' THR . . . -87.8 44.22 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.21 -39.06 21.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.6 ttp -63.12 -17.19 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' CG ' ' A' ' 81' ' ' LYS . 4.8 mp -107.36 -25.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -69.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.399 -0.813 . . . . 0.0 110.497 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD12 ' A' ' 69' ' ' LEU . 2.6 pt? -57.41 -28.71 63.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.31 -0.869 . . . . 0.0 109.621 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 90' ' ' ILE . 31.9 mm -65.53 -47.45 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' CG ' HG22 ' A' ' 77' ' ' ILE . 6.1 mtmt -64.77 -35.73 82.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -63.74 -44.9 92.16 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' HB2' HD11 ' A' ' 90' ' ' ILE . 36.4 m-85 -72.21 -32.48 66.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.682 -0.636 . . . . 0.0 109.305 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.17 -34.44 76.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.627 -0.67 . . . . 0.0 109.524 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.61 33.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.44 3.79 30.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 110.431 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.8 69.63 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 61' ' ' ILE . 56.8 t -114.58 149.29 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.639 -0.918 . . . . 0.0 109.377 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -102.73 153.82 19.77 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' PHE . 52.4 mt -131.46 108.28 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.773 . . . . 0.0 109.238 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.66 133.99 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.708 -0.62 . . . . 0.0 109.798 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.2 139.21 41.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.85 -30.72 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.482 -0.761 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -43.95 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 179.98 -39.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.5 -0.75 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.93 52.83 0.88 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 97' ' ' ILE . 17.2 mt -103.01 10.96 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.712 -0.875 . . . . 0.0 110.354 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.44 -72.95 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.107 -0.996 . . . . 0.0 109.21 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 99' ' ' THR . 8.5 t -105.58 52.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.05 80.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.89 73.69 0.45 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.33 175.26 0.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.0 109.635 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.6 ttt -138.35 142.97 39.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.517 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 71.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -139.34 168.16 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.64 -0.662 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.08 89.81 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.561 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 12.1 m-85 -91.13 145.3 24.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.665 -0.647 . . . . 0.0 109.47 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -137.33 125.49 3.36 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -91.12 144.79 25.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.94 . . . . 0.0 108.715 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -145.49 166.04 26.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.474 -0.766 . . . . 0.0 110.031 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -163.14 116.2 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.772 HG12 ' N ' ' A' ' 16' ' ' LEU . 20.2 m -62.58 145.33 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 t -121.12 -39.47 2.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 15' ' ' SER . 5.1 t -95.0 142.41 27.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.27 -41.9 89.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.765 . . . . 0.0 109.944 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.4 -159.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.163 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.58 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.3 tp-100 -56.71 107.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.296 -0.877 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -122.82 -48.02 2.04 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.664 -0.648 . . . . 0.0 109.558 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -58.2 -38.21 76.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.686 -0.634 . . . . 0.0 109.616 -179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.78 -48.44 80.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.501 -0.749 . . . . 0.0 109.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.5 mt -60.68 -38.14 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.595 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.609 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 16.3 mm100 -65.26 -56.41 12.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.591 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 HG21 ' A' ' 33' ' ' ILE . 60.2 t -50.99 -51.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.381 -0.825 . . . . 0.0 109.577 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -28.29 55.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.489 -0.757 . . . . 0.0 109.178 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.657 ' HB1' ' HD3' ' A' ' 64' ' ' LYS . . . -76.89 -40.16 48.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 7' ' ' ALA . 3.4 mt -73.15 -37.23 66.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.633 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -67.62 -43.75 79.65 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -58.74 -35.79 73.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -67.68 -32.05 72.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.87 44.37 0.37 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG11 ' HA3' ' A' ' 5' ' ' GLY . 96.6 t -113.45 146.95 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.814 -0.815 . . . . 0.0 109.067 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -79.14 138.24 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.723 -0.611 . . . . 0.0 109.372 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.02 73.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.0 108.864 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.99 -24.08 64.18 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -108.69 58.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.098 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.918 HG21 HG22 ' A' ' 20' ' ' VAL . 46.6 mm -115.4 90.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.235 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 50' ' ' LEU . 4.8 m-85 -87.77 89.9 8.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.195 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 16' ' ' LEU . 6.8 t -100.42 164.43 11.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.674 -0.641 . . . . 0.0 109.699 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 110.56 18.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 109.333 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -71.24 70.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.673 . . . . 0.0 109.58 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.32 -21.08 21.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 0.0 110.498 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.53 -22.07 19.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.65 -172.51 0.27 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -60.54 -37.0 79.79 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.411 -1.053 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 m -131.48 175.5 9.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.126 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -65.65 120.71 13.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 109.399 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.8 69.87 3.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.629 -0.669 . . . . 0.0 109.235 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -72.08 65.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.558 0.694 . . . . 0.0 109.371 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -113.0 -19.77 11.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 109.949 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.81 -75.64 0.26 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.552 HD11 ' HG2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -54.21 -26.88 30.81 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.33 -1.1 . . . . 0.0 109.492 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -61.66 -54.86 37.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.34 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 20.9 mt -78.39 -30.29 47.75 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.7 tp -59.66 -36.31 76.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 55.6 mtp180 -63.28 -26.77 68.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.67 -0.644 . . . . 0.0 109.633 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -111.0 3.1 18.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -109.4 -27.83 9.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.08 -1.013 . . . . 0.0 110.123 -179.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 51' ' ' LEU . 29.0 m -61.0 163.71 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.386 -0.821 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -122.56 161.05 24.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 109.312 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.49 113.87 3.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.561 -0.712 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.47 25.05 16.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.3 m-20 -96.36 158.17 15.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -1.07 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.14 118.55 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 55' ' ' VAL . 31.7 mt -97.08 105.13 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.0 mt -78.71 123.68 27.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.59 -0.694 . . . . 0.0 109.168 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.96 115.49 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 109.672 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.657 ' HD3' ' HB1' ' A' ' 22' ' ' ALA . 12.3 tttt -122.38 66.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -60.31 155.52 17.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.46 -0.775 . . . . 0.0 110.041 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -36.88 13.49 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -130.59 -53.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.517 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -163.1 153.99 16.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.62 -0.675 . . . . 0.0 109.505 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.0 mm? -55.93 -58.56 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.137 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.35 -104.91 1.72 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -162.54 -46.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.926 . . . . 0.0 109.43 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.78 -45.14 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 74' ' ' ALA . 18.7 m -64.71 164.28 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.501 -0.749 . . . . 0.0 109.429 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 73' ' ' THR . . . -60.33 91.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 109.701 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -110.05 -24.36 10.81 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.795 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -105.8 2.21 27.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.75 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG22 ' HE2' ' A' ' 81' ' ' LYS . 4.7 mp -121.47 -34.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.064 -1.023 . . . . 0.0 110.061 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -62.12 -72.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.658 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -61.79 -14.34 31.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.795 HD13 ' O ' ' A' ' 76' ' ' MET . 1.0 OUTLIER -78.24 -32.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.39 -34.77 36.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.74 79.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.699 -0.626 . . . . 0.0 109.376 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 90' ' ' ILE . 29.3 m-85 -69.39 -31.23 69.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -63.64 -39.12 93.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.4 41.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 110.257 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.95 6.88 20.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.14 64.69 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 56' ' ' GLU . 45.7 t -120.6 147.27 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.66 -0.906 . . . . 0.0 109.386 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 83' ' ' PHE . 40.4 mt -133.7 105.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -79.87 129.59 34.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.68 -0.637 . . . . 0.0 109.477 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CD1' ' HA2' ' A' ' 96' ' ' GLY . 4.2 m-85 -86.27 165.72 16.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 109.756 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.8 tt -43.4 -32.69 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 122.077 -0.389 . . . . 0.0 111.944 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.38 -13.21 9.8 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.449 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -78.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' HA2' ' CD1' ' A' ' 92' ' ' PHE . . . 136.13 74.83 0.07 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.22 -19.59 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.746 -0.855 . . . . 0.0 110.258 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -53.63 -77.73 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 99' ' ' THR . 9.2 t -98.5 53.21 1.03 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.742 . . . . 0.0 109.064 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.79 80.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.602 -0.686 . . . . 0.0 109.413 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.16 68.02 1.82 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -117.56 -173.5 2.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 46.1 mtp -152.64 -62.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.658 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.94 30.56 9.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.532 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -104.93 159.26 15.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 0.0 109.633 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 27' ' ' GLY . 3.5 mt -104.74 87.61 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.616 -0.678 . . . . 0.0 109.72 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.19 150.54 20.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.334 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -141.58 150.82 22.24 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 25.2 t80 -113.47 140.28 48.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.717 -0.873 . . . . 0.0 108.996 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.48 150.4 46.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.543 -0.723 . . . . 0.0 110.14 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -151.34 99.12 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 37' ' ' LYS . 35.2 m -55.73 163.0 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.533 0.682 . . . . 0.0 111.145 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.77 25.93 0.33 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.765 HG22 ' OG ' ' A' ' 15' ' ' SER . 13.2 t -144.77 157.14 44.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.366 -0.833 . . . . 0.0 109.606 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -31.47 71.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 109.189 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.28 -162.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.74 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -90.95 68.54 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.575 -0.703 . . . . 0.0 109.913 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.765 ' OG ' HG22 ' A' ' 11' ' ' THR . 0.4 OUTLIER -62.3 -30.7 71.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.504 -0.748 . . . . 0.0 109.749 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.6 tt -58.22 -45.02 88.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.32 -0.862 . . . . 0.0 108.924 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 2.7 t0 -64.87 -46.73 80.6 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mt -58.92 -55.28 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -53.83 -47.74 70.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 109.897 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 33' ' ' ILE . 96.8 t -52.32 -46.38 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.451 -0.78 . . . . 0.0 109.236 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 4.1 mtt85 -62.12 -34.71 76.86 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' GLN . . . -65.82 -39.51 90.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 7' ' ' ALA . 5.5 mt -72.87 -44.08 61.77 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.77 -42.57 99.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -60.64 -34.08 73.75 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -72.76 -31.41 64.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' HD22 ' A' ' 3' ' ' LEU . . . 123.18 44.75 0.31 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.7 t -118.65 138.02 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.805 -0.821 . . . . 0.0 109.233 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.17 142.57 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.71 -31.37 72.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.07 -24.53 65.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.583 -0.698 . . . . 0.0 109.222 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.47 58.37 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.459 -0.776 . . . . 0.0 109.143 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.942 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -113.7 86.94 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -78.91 70.11 5.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.686 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 16' ' ' LEU . 8.3 t -79.23 156.77 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.613 -0.68 . . . . 0.0 109.283 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 1.2 m-20 -126.57 108.22 10.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 109.448 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -64.09 86.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.5 60.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.743 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -134.96 82.73 1.98 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.99 -136.0 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -76.81 -34.44 57.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.954 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -143.63 -67.52 0.35 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.577 -0.702 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 p -160.09 159.37 31.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.55 -0.719 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.6 63.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.499 -0.751 . . . . 0.0 109.447 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -70.58 66.01 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.472 -0.767 . . . . 0.0 109.865 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.7 mmmt -98.35 -44.94 6.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.102 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.71 59.98 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 48' ' ' LEU . 8.3 tt -75.87 -35.34 59.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.98 73.16 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 46' ' ' LYS . 1.3 mt -88.35 -29.58 20.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.492 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -63.85 -38.86 92.66 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.2 mtp180 -60.15 -22.78 63.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.664 -0.648 . . . . 0.0 109.903 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.4 ptp -110.94 -4.08 15.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.386 -0.821 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -107.19 -19.15 13.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.0 -1.063 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG11 ' CE1' ' A' ' 83' ' ' PHE . 4.7 m -57.21 161.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.083 -1.01 . . . . 0.0 110.147 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 tp10 -108.64 168.28 9.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 109.359 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.29 104.31 4.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.38 19.66 32.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' A' ' 88' ' ' VAL . 5.6 p-10 -78.98 170.42 16.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.188 -1.183 . . . . 0.0 109.584 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.74 117.76 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 88' ' ' VAL . 69.1 mt -95.51 97.81 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 109.564 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 26' ' ' ALA . 2.7 mt -79.65 117.02 20.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.647 HG21 HD22 ' A' ' 69' ' ' LEU . 8.9 p -104.28 133.96 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -0.782 . . . . 0.0 109.581 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -152.6 119.01 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.34 173.96 10.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 109.707 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.2 mm? -64.68 -32.5 74.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.633 -0.667 . . . . 0.0 109.227 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -139.51 -45.97 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -177.41 -173.88 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.0 109.575 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 63' ' ' VAL . 0.4 OUTLIER -123.49 43.19 3.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.509 -0.744 . . . . 0.0 109.341 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.03 -172.84 19.17 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -164.04 -64.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.655 -0.909 . . . . 0.0 109.345 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -135.55 -60.24 0.75 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.37 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 74' ' ' ALA . 3.2 m -71.34 169.29 15.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.686 . . . . 0.0 109.289 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 73' ' ' THR . . . -72.59 65.23 0.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.44 -47.62 22.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.51 -0.744 . . . . 0.0 109.023 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.448 ' HG2' HD11 ' A' ' 69' ' ' LEU . 4.0 tmm? -63.13 -37.03 85.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.9 mp -81.22 -20.78 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.644 -0.66 . . . . 0.0 110.121 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -68.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 0.0 109.664 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.653 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -14.34 21.84 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.735 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' CG2' HG21 ' A' ' 99' ' ' THR . 52.5 mt -79.33 -38.39 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.8 -28.89 61.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.66 -40.18 66.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.582 -0.699 . . . . 0.0 109.758 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.654 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 26.3 m-85 -79.39 -29.42 42.03 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.755 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.8 -38.8 89.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.516 -0.74 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.12 -23.32 41.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.75 -0.594 . . . . 0.0 110.123 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.65 0.9 36.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.489 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.46 32.78 61.78 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 77.0 t -112.64 154.35 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.926 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -103.61 162.62 12.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 83' ' ' PHE . 36.1 mt -139.32 100.37 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.462 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.6 mtt180 -80.71 120.41 24.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 63' ' ' VAL . 4.3 m-85 -92.65 140.68 29.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.498 -0.751 . . . . 0.0 109.626 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.7 tp -64.43 78.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.497 0.665 . . . . 0.0 109.643 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' PHE . 3.8 t70 -179.12 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.02 28.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.682 -0.636 . . . . 0.0 110.252 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.83 28.17 30.68 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.6 pt -148.46 158.12 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -1.025 . . . . 0.0 109.856 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -160.48 -68.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.473 HG21 ' CG2' ' A' ' 80' ' ' ILE . 11.8 t -95.36 34.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.29 -25.88 2.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.654 . . . . 0.0 110.269 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.17 71.8 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.35 166.8 23.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.918 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.2 mtp -161.16 113.9 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.562 -0.711 . . . . 0.0 109.429 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.24 -86.0 0.07 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . 11.5 mmt180 -110.14 145.84 36.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HA ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -96.96 79.62 2.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.557 -0.714 . . . . 0.0 109.126 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 29.2 m-85 -78.77 140.94 38.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.486 -0.759 . . . . 0.0 109.377 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.622 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -133.68 134.55 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 8' ' ' ARG . 31.0 t80 -90.69 143.04 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -141.33 77.92 1.62 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 1.2 tpp85 -81.03 89.44 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 19' ' ' GLN . 26.8 m -58.57 170.07 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.065 0.935 . . . . 0.0 111.209 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 32.85 0.17 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -104.16 -158.57 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.671 -0.643 . . . . 0.0 109.385 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 11' ' ' THR . 67.6 p -122.89 -78.41 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -76.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.664 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.38 111.44 24.08 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 9' ' ' VAL . 5.0 p -123.13 -48.63 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.613 -0.679 . . . . 0.0 109.842 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.831 HD12 HG21 ' A' ' 35' ' ' THR . 0.8 OUTLIER -59.61 -37.24 78.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.774 -0.579 . . . . 0.0 109.81 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.43 -52.7 60.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.781 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 14' ' ' GLN . 15.0 mt -59.33 -32.48 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.783 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 19.5 mm-40 -75.18 -54.14 7.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.01 HG22 HG21 ' A' ' 33' ' ' ILE . 62.6 t -51.52 -48.61 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.441 -0.787 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -32.4 66.65 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.602 ' HB1' ' HG3' ' A' ' 64' ' ' LYS . . . -69.93 -33.74 72.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.944 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mt -76.22 -45.32 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.743 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -61.94 -41.98 98.58 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.36 -34.92 77.62 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 62' ' ' LEU . . . -73.46 -33.47 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.94 45.42 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.8 t -114.61 137.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.847 -0.796 . . . . 0.0 109.213 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' CG ' HD12 ' A' ' 3' ' ' LEU . 16.3 mmmt -64.16 130.36 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.743 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.39 -30.07 71.26 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -23.12 60.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 31.5 mtt-85 -110.75 58.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 20' ' ' VAL . 44.1 mm -111.08 93.74 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 51' ' ' LEU . 5.1 m-85 -87.01 76.1 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.58 -0.7 . . . . 0.0 109.132 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 16' ' ' LEU . 4.3 t -84.31 158.06 21.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.812 -0.555 . . . . 0.0 109.717 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -116.17 114.1 23.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 70.25 0.69 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 0.0 109.128 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.58 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -98.15 36.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.51 -0.744 . . . . 0.0 109.604 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.7 -44.77 5.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 p -160.24 -48.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.625 -0.927 . . . . 0.0 109.384 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -138.48 -56.78 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.743 . . . . 0.0 109.552 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -169.13 165.56 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -160.55 109.33 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -123.62 41.22 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -88.97 -20.85 23.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.661 -0.649 . . . . 0.0 109.893 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.56 -77.14 0.16 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -52.85 -29.34 27.4 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 121.256 -1.143 . . . . 0.0 109.543 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -63.73 -55.08 25.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -72.07 -30.04 64.72 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 61' ' ' ILE . 10.1 tp -60.87 -33.76 73.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.508 -0.745 . . . . 0.0 108.993 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 25.4 mtp180 -66.43 -28.8 68.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 ptm -107.73 16.73 23.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.596 -0.69 . . . . 0.0 109.897 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 -34.64 3.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 61' ' ' ILE . 21.8 m -57.22 145.39 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.308 -0.87 . . . . 0.0 109.896 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.88 166.83 10.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.0 109.465 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -64.72 112.66 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.589 -0.694 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.32 24.01 25.34 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' O ' HG13 ' A' ' 88' ' ' VAL . 3.4 m-20 -94.9 171.5 8.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -1.083 . . . . 0.0 109.332 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 3' ' ' LEU . 1.6 m -118.98 148.79 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.456 -0.777 . . . . 0.0 109.95 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.617 HD11 HG11 ' A' ' 55' ' ' VAL . 56.2 mt -124.74 95.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -78.56 141.28 38.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.589 -0.694 . . . . 0.0 109.7 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.41 109.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' HG3' ' HB1' ' A' ' 22' ' ' ALA . 3.7 mmtt -66.59 -168.85 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.513 -0.742 . . . . 0.0 109.701 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -115.77 119.61 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.494 HD22 ' NE2' ' A' ' 19' ' ' GLN . 4.0 tp -179.79 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.21 112.5 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.4 121.67 8.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.472 -0.767 . . . . 0.0 110.013 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HB3' ' CG ' ' A' ' 76' ' ' MET . 5.1 mt -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.565 -0.71 . . . . 0.0 109.7 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.98 150.51 20.57 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 -58.78 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.577 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -131.34 -67.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -99.28 -158.39 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . . . -66.22 79.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.664 -0.648 . . . . 0.0 109.65 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -96.27 -37.08 10.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.439 -0.788 . . . . 0.0 108.914 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.795 ' O ' HD13 ' A' ' 80' ' ' ILE . 8.5 tmm? -86.65 -1.57 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.681 -0.637 . . . . 0.0 110.314 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.509 HG23 ' HA ' ' A' ' 102' ' ' GLU . 4.6 mp -112.66 -27.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 2.2 tp60 -59.91 -74.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.439 -0.788 . . . . 0.0 110.441 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 80' ' ' ILE . 2.3 pt? -58.84 -32.6 69.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 110.081 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.795 HD13 ' O ' ' A' ' 76' ' ' MET . 1.6 mp -68.15 -28.82 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -32.06 19.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.36 -46.45 80.1 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 61' ' ' ILE . 31.9 m-85 -65.88 -34.61 78.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.63 -38.0 86.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.99 -21.64 37.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.82 -0.55 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -84.23 5.83 25.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.521 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.99 66.17 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 59' ' ' ASP . 46.8 t -115.24 148.42 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.959 . . . . 0.0 109.414 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -103.35 163.15 12.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.696 -0.627 . . . . 0.0 109.564 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 61' ' ' ILE . 41.2 mt -134.56 122.14 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -97.58 140.21 32.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.743 -0.598 . . . . 0.0 109.845 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.7 135.71 55.05 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 94' ' ' ASP . 6.8 tp -58.85 -43.68 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 93' ' ' ILE . 1.1 m-20 -102.79 39.48 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.546 -0.722 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.2 80.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.26 44.83 3.33 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 98' ' ' SER . 9.7 mm -108.62 171.01 2.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.457 -1.025 . . . . 0.0 108.969 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.463 ' H ' HG22 ' A' ' 97' ' ' ILE . 2.1 m -62.62 -175.75 0.09 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 108.92 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.1 m -67.38 81.7 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 109.375 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -105.91 121.15 43.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.612 -0.68 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.88 -37.9 1.54 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HA ' HG23 ' A' ' 77' ' ' ILE . 9.4 pt-20 -63.03 -28.1 69.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.942 . . . . 0.0 109.646 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.5 ttt -141.72 151.56 43.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.517 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.37 -92.85 0.12 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.8 mttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.438 179.909 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -129.65 155.94 45.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.345 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' HG23 ' A' ' 60' ' ' VAL . 5.0 mp -104.79 90.68 3.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -86.64 154.88 20.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.521 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -138.7 120.88 2.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 48' ' ' LEU . 33.2 t80 -86.0 132.95 33.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.925 . . . . 0.0 109.049 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 35' ' ' THR . . . -133.97 177.46 7.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.561 -0.712 . . . . 0.0 110.005 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -175.83 116.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 38' ' ' ALA . 29.6 m -61.69 156.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 109.929 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.5 24.1 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 15' ' ' SER . 1.8 t -151.55 176.41 11.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.808 . . . . 0.0 109.321 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 m -87.87 -53.61 4.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.451 -0.78 . . . . 0.0 110.296 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.19 -159.04 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.821 -0.549 . . . . 0.0 109.988 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.27 116.06 2.04 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' HG23 ' A' ' 11' ' ' THR . 54.5 p -122.15 -62.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.383 0.611 . . . . 0.0 109.521 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.566 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -50.16 -37.34 34.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 110.145 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -61.65 -47.64 84.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.397 -0.814 . . . . 0.0 109.577 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 14' ' ' GLN . 10.6 mt -59.6 -31.31 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.714 -0.616 . . . . 0.0 110.042 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.659 HE22 HD22 ' A' ' 66' ' ' LEU . 35.1 mm-40 -75.19 -54.39 7.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.283 -0.886 . . . . 0.0 109.134 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.93 HG22 HG21 ' A' ' 33' ' ' ILE . 58.3 t -51.44 -48.4 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -60.53 -34.3 73.92 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . . . -65.87 -41.78 91.18 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD12 HG23 ' A' ' 33' ' ' ILE . 43.2 mt -70.16 -43.82 70.08 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.49 -38.05 89.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -60.18 -37.23 79.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -71.58 -31.04 66.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.1 -1.55 5.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 ' HA3' ' A' ' 5' ' ' GLY . 63.6 t -65.18 148.99 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.31 -1.112 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -85.4 141.78 29.74 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.76 71.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.503 -0.748 . . . . 0.0 109.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.59 -24.11 64.56 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.66 -0.65 . . . . 0.0 109.369 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.85 58.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.428 -0.795 . . . . 0.0 109.35 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 HG22 ' A' ' 20' ' ' VAL . 49.2 mm -112.13 108.12 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.13 75.96 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.617 -0.677 . . . . 0.0 109.314 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.731 ' CB ' ' HB3' ' A' ' 7' ' ' ALA . 4.4 t -82.72 169.79 15.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.95 112.88 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.94 73.22 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.911 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.676 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -75.35 59.88 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -116.68 -33.18 4.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.44 -157.94 0.11 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.9 m -61.5 -68.99 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.509 -0.995 . . . . 0.0 109.6 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -95.11 170.59 9.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.6 -0.687 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.27 156.62 25.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.495 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.85 78.98 2.0 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.704 . . . . 0.0 109.114 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -71.6 66.77 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -109.86 -43.52 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 0.0 109.206 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.99 -33.37 78.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD11 ' HG ' ' A' ' 79' ' ' LEU . 10.6 tt -83.12 -45.84 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.903 -0.763 . . . . 0.0 108.977 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -31.52 68.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.605 -0.685 . . . . 0.0 109.321 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.26 -29.52 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 61' ' ' ILE . 5.6 tp -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -21.82 66.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.692 -0.63 . . . . 0.0 109.844 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 ptp -113.66 -24.63 9.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.353 -0.842 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -85.35 -28.34 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 110.467 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.06 145.6 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.964 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -113.16 164.42 13.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.595 -0.691 . . . . 0.0 109.779 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.0 118.3 8.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.462 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.52 24.63 38.67 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 88' ' ' VAL . 1.5 m-20 -89.4 167.06 13.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -1.027 . . . . 0.0 109.44 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -121.47 118.11 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 90' ' ' ILE . 18.0 mt -94.65 99.89 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -83.51 114.68 21.66 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.36 136.51 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 22' ' ' ALA . 1.2 ptmt -93.29 -176.08 4.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.469 -0.769 . . . . 0.0 110.165 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -129.77 125.76 36.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.615 -0.678 . . . . 0.0 109.549 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.659 HD22 HE22 ' A' ' 19' ' ' GLN . 0.9 OUTLIER 178.81 -55.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -100.8 121.8 42.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -43.18 123.29 2.83 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.446 0.641 . . . . 0.0 111.341 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.708 HD13 ' HG2' ' A' ' 76' ' ' MET . 6.4 mt -54.94 -42.82 72.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.651 -0.656 . . . . 0.0 110.326 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.67 -174.25 44.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -168.51 49.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.637 -0.919 . . . . 0.0 109.336 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.31 -158.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 74' ' ' ALA . 7.2 t -53.36 -43.15 67.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB1' ' HB ' ' A' ' 77' ' ' ILE . . . 179.44 68.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.582 -0.699 . . . . 0.0 109.201 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.88 -31.74 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.39 -0.819 . . . . 0.0 109.046 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.708 ' HG2' HD13 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -101.43 -39.38 7.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.311 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.704 HG22 ' HE2' ' A' ' 81' ' ' LYS . 3.4 mp -56.36 -22.13 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.89 -1.131 . . . . 0.0 109.374 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.469 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -70.22 -81.1 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 109.768 179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.702 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -54.63 -23.28 16.42 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 99' ' ' THR . 14.9 mm -66.29 -36.86 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.704 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -81.49 -31.99 32.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.84 -58.6 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.523 -0.736 . . . . 0.0 109.842 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HE2' HD23 ' A' ' 79' ' ' LEU . 54.5 m-85 -61.43 -32.54 72.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.49 -0.756 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.11 51.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.771 -0.581 . . . . 0.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 13.92 10.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.486 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 30.65 65.93 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 59' ' ' ASP . 41.1 t -105.35 149.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.675 -0.897 . . . . 0.0 109.364 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 m -113.25 101.91 9.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.674 -0.641 . . . . 0.0 110.039 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.707 HD13 HD13 ' A' ' 80' ' ' ILE . 54.8 mt -78.98 104.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -89.49 136.12 33.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.753 -0.592 . . . . 0.0 109.819 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -95.98 135.17 38.1 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 94' ' ' ASP . 8.6 tt -48.76 -46.16 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 112.035 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 93' ' ' ILE . 1.2 m-20 -119.13 42.27 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.872 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -165.42 -47.48 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 0.0 110.41 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 98.57 -35.16 4.79 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 96' ' ' GLY . 1.4 pt -156.26 -175.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.56 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.453 -0.779 . . . . 0.0 109.739 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 1.004 HG23 HG21 ' A' ' 80' ' ' ILE . 6.1 t -87.21 56.63 4.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.59 68.69 0.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.82 52.45 37.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.9 114.78 3.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.653 -0.91 . . . . 0.0 109.804 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.9 mtt -164.23 30.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.427 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.85 -55.4 0.02 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' HG12 ' A' ' 60' ' ' VAL . 1.4 mpt_? -120.45 152.55 37.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.645 -0.66 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.46 HD12 ' HD2' ' A' ' 29' ' ' LYS . 18.9 mt -96.38 82.87 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 109.551 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' HB3' HD11 ' A' ' 51' ' ' LEU . 45.3 m-85 -87.44 140.55 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.645 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -128.62 150.2 18.57 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 48' ' ' LEU . 32.4 t80 -122.75 125.3 45.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.976 . . . . 0.0 109.11 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.011 ' HB3' HG23 ' A' ' 35' ' ' THR . . . -133.19 135.92 45.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.41 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 103.43 8.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.814 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 16' ' ' LEU . 34.3 m -51.04 155.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.777 . . . . 0.0 111.03 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 t -132.91 -43.8 0.88 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.73 HG22 ' OG ' ' A' ' 15' ' ' SER . 3.7 t -88.81 164.39 15.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -108.31 90.55 3.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.659 -0.651 . . . . 0.0 109.59 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -176.47 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HG3' HD11 ' A' ' 18' ' ' ILE . 3.5 pt20 -167.31 32.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.678 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.765 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -57.8 -47.07 83.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.411 -0.805 . . . . 0.0 109.927 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.698 ' N ' HG12 ' A' ' 9' ' ' VAL . 2.2 tt -51.71 -43.19 62.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.52 -0.737 . . . . 0.0 109.577 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.49 -44.58 86.63 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 15' ' ' SER . 10.9 mt -63.94 -34.78 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.742 -0.599 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.826 ' NE2' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -74.64 -49.32 21.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.92 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 33' ' ' ILE . 66.9 t -53.36 -44.82 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.211 -0.931 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.04 -42.28 89.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.36 87.57 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 19' ' ' GLN . 9.7 mp -65.62 -44.25 87.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CE ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -68.06 -45.0 75.07 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -58.87 -35.11 72.44 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.78 42.08 0.29 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 5' ' ' GLY . 88.5 t -117.45 142.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.741 -0.858 . . . . 0.0 109.096 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD2' HD12 ' A' ' 3' ' ' LEU . 1.1 mttt -81.79 142.01 32.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 24' ' ' LYS . . . -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.536 -0.727 . . . . 0.0 109.542 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.25 -24.74 68.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.615 -0.678 . . . . 0.0 109.326 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 1.1 mtt-85 -108.79 58.73 0.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 20' ' ' VAL . 41.7 mm -116.04 110.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CD2' HD12 ' A' ' 51' ' ' LEU . 29.2 m-85 -103.52 96.84 7.0 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.011 HG23 ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -110.08 126.81 54.41 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.342 0.592 . . . . 0.0 109.993 -178.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.53 105.35 17.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CD ' HD13 ' A' ' 16' ' ' LEU . 5.1 tptm -70.47 70.43 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.471 -0.768 . . . . 0.0 109.736 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -50.73 -27.1 6.45 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.364 -0.835 . . . . 0.0 110.382 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 m -73.16 66.52 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.633 -0.667 . . . . 0.0 109.285 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.09 -121.34 2.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 m -94.25 -74.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.915 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -105.73 -47.4 3.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 p -174.48 163.79 3.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.641 -0.662 . . . . 0.0 109.595 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 44.17 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -69.04 78.53 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -38.05 0.47 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.71 -54.87 28.25 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.986 HD12 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.466 -1.02 . . . . 0.0 109.16 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.78 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.43 -44.53 87.04 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.59 -27.3 61.23 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.596 -0.69 . . . . 0.0 109.174 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -61.03 -23.24 65.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.658 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mmt -100.32 -28.2 13.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -28.54 28.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.52 -0.738 . . . . 0.0 110.049 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.4 m -60.21 150.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.407 -0.808 . . . . 0.0 109.805 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.92 160.84 23.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -63.21 112.18 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.87 24.89 14.1 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.96 -175.18 3.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.522 -0.987 . . . . 0.0 109.618 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 2' ' ' ARG . 5.3 p -134.56 138.01 50.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.407 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 83' ' ' PHE . 11.7 mt -120.18 114.01 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -93.36 132.98 37.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.643 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.41 88.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -61.44 179.31 0.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.553 -0.717 . . . . 0.0 110.066 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HB2' HG21 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -107.31 120.59 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.61 -0.681 . . . . 0.0 109.874 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.826 HD23 ' NE2' ' A' ' 19' ' ' GLN . 50.6 tp -178.56 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -134.64 110.77 9.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -60.74 144.28 52.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 109.747 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD13 ' CG ' ' A' ' 76' ' ' MET . 2.0 mp -61.76 -163.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.554 -0.716 . . . . 0.0 109.222 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.88 140.23 46.88 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.11 29.54 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.536 -0.979 . . . . 0.0 109.745 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -102.78 -66.15 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.498 -0.751 . . . . 0.0 109.318 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 t -120.99 -157.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -95.14 -49.97 5.27 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.702 ' O ' HD13 ' A' ' 80' ' ' ILE . 1.7 tmt? -59.28 -21.83 60.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.757 -0.59 . . . . 0.0 109.759 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 77' ' ' ILE . 5.0 mp -97.84 -20.09 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.426 -0.797 . . . . 0.0 109.909 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -69.64 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 HD12 ' A' ' 48' ' ' LEU . 2.7 pt? -54.57 -37.42 65.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.853 ' CG2' HG21 ' A' ' 99' ' ' THR . 1.6 mp -59.84 -44.95 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -26.78 64.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.489 -0.757 . . . . 0.0 109.224 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -55.51 20.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.686 . . . . 0.0 110.049 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.571 ' HD1' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -75.67 -27.22 58.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.326 -0.859 . . . . 0.0 109.61 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.27 -48.52 77.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.329 -0.857 . . . . 0.0 109.057 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -23.11 64.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.842 -0.536 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -84.29 6.83 21.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 110.534 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.21 31.67 61.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 89' ' ' SER . 40.3 t -105.2 159.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.637 -0.919 . . . . 0.0 109.492 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -107.65 151.76 25.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.61 -0.681 . . . . 0.0 109.559 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 83' ' ' PHE . 52.7 mt -134.84 105.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -78.38 107.94 11.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.456 -0.777 . . . . 0.0 109.409 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 76' ' ' MET . 0.2 OUTLIER -92.32 129.79 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 65' ' ' LYS . 7.9 tp -61.89 -28.99 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.08 -33.7 76.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.752 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.19 -60.64 0.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 109.825 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.64 2.94 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 98' ' ' SER . 24.6 mm -85.98 167.47 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.735 -0.861 . . . . 0.0 109.603 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' HG22 ' A' ' 97' ' ' ILE . 1.9 m -55.66 -68.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.853 HG21 ' CG2' ' A' ' 80' ' ' ILE . 2.0 t 179.93 66.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.39 79.29 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.656 -0.652 . . . . 0.0 109.489 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.95 82.09 0.08 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 117.66 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.962 . . . . 0.0 109.284 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.7 ptm -168.91 -42.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.682 . . . . 0.0 109.483 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.25 -69.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.492 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 164.76 25.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.687 . . . . 0.0 109.332 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 27' ' ' GLY . 4.8 mp -106.64 83.99 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.63 -0.669 . . . . 0.0 109.369 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 51' ' ' LEU . 14.1 m-85 -83.2 143.73 30.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.526 -0.734 . . . . 0.0 109.474 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -134.37 147.91 19.28 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' C ' HD21 ' A' ' 23' ' ' LEU . 60.6 t80 -114.32 133.82 55.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 19' ' ' GLN . . . -142.36 106.93 4.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.859 . . . . 0.0 111.36 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -103.13 126.73 50.44 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 16' ' ' LEU . 19.9 m -67.94 -176.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.744 . . . . 0.0 110.413 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -159.79 -43.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -82.98 151.55 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.65 -0.656 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 m -69.6 -44.0 71.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -63.23 -163.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.738 -0.601 . . . . 0.0 109.602 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.5 pt20 -57.15 113.76 1.86 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 8.2 t -123.16 -45.4 2.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.611 0.719 . . . . 0.0 109.24 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.82 HD11 HG21 ' A' ' 35' ' ' THR . 2.1 tt -56.15 -40.31 73.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.825 -0.547 . . . . 0.0 109.804 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.1 -49.36 77.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 14' ' ' GLN . 6.0 mt -63.67 -31.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.698 -0.626 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.882 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 6.0 mm-40 -71.35 -50.2 34.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.549 -0.719 . . . . 0.0 109.412 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 33' ' ' ILE . 98.4 t -54.79 -47.57 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.31 -0.869 . . . . 0.0 109.118 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -34.92 72.48 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.56 70.89 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD2' ' HB2' ' A' ' 7' ' ' ALA . 9.0 mp -73.61 -44.92 55.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HE2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -64.7 -43.4 93.59 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -59.34 -34.76 72.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.7 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -69.54 -31.46 69.69 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' HD23 ' A' ' 3' ' ' LEU . . . 124.1 44.1 0.31 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG11 ' HA3' ' A' ' 5' ' ' GLY . 95.6 t -117.29 150.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.782 -0.834 . . . . 0.0 109.051 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD2' HD13 ' A' ' 3' ' ' LEU . 3.2 mttt -86.03 141.69 29.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.805 ' HB2' ' HE2' ' A' ' 24' ' ' LYS . . . -63.18 -34.3 77.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.517 -0.74 . . . . 0.0 109.112 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.36 -24.23 64.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.69 58.19 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.181 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.909 HG21 HG22 ' A' ' 20' ' ' VAL . 47.9 mm -113.22 85.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.54 -0.725 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -78.42 85.66 4.51 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.82 HG21 HD11 ' A' ' 16' ' ' LEU . 5.2 t -86.09 170.79 11.89 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.533 0.682 . . . . 0.0 110.5 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.91 103.54 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -70.23 69.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.404 0.621 . . . . 0.0 109.816 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 9' ' ' VAL . . . -62.95 -16.68 60.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.602 -0.686 . . . . 0.0 110.187 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 t -98.53 76.6 2.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.876 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.57 -147.86 4.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -60.89 -29.03 69.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -1.004 . . . . 0.0 109.239 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.49 173.9 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.58 152.24 35.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.39 83.2 2.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.668 -0.645 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -94.47 44.52 1.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -89.96 -14.87 33.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.388 -0.82 . . . . 0.0 110.276 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.4 -42.2 88.99 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -78.84 -36.59 42.21 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.449 -1.03 . . . . 0.0 109.082 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -28.92 69.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.559 -0.713 . . . . 0.0 109.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 34' ' ' PHE . 17.3 mt -100.73 -40.21 7.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.707 . . . . 0.0 109.387 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 6.5 tp -62.08 -31.63 72.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 67.6 mtp180 -66.34 -18.83 65.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.663 -0.648 . . . . 0.0 109.667 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.3 ptp -116.43 -7.48 11.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.837 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -99.65 -23.55 15.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 51' ' ' LEU . 15.6 m -57.74 159.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.0 110.223 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.97 137.02 52.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -52.29 101.74 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.168 -0.957 . . . . 0.0 110.375 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.69 20.97 5.91 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CG ' HG13 ' A' ' 88' ' ' VAL . 4.3 p-10 -101.37 -175.78 2.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -1.091 . . . . 0.0 109.828 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.25 136.32 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 55' ' ' VAL . 45.8 mt -113.49 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.7 HD22 ' HB1' ' A' ' 26' ' ' ALA . 3.3 mt -78.83 132.76 36.97 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 69' ' ' LEU . 39.0 t -125.38 108.29 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -73.56 -176.2 2.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.632 -0.668 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.42 76.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.608 -0.682 . . . . 0.0 109.285 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 66' ' ' LEU . 29.9 tp -90.21 -66.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -113.02 -67.94 0.96 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.343 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -178.6 151.93 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.61 -0.681 . . . . 0.0 109.207 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 76' ' ' MET . 3.6 mm? -56.74 -65.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 110.367 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.45 -138.01 2.8 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.93 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.581 -0.952 . . . . 0.0 109.811 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.67 -24.35 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 110.48 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.1 t -61.05 -160.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.329 -0.857 . . . . 0.0 109.723 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.54 67.47 0.76 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.19 -57.05 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.823 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 69' ' ' LEU . 3.6 tpp -62.43 -41.16 98.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 77' ' ' ILE . 3.8 mp -66.5 -20.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 110.461 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.34 -72.49 0.23 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.251 -0.905 . . . . 0.0 109.83 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.633 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.93 -15.12 27.57 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.348 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.961 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm -71.89 -42.03 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -73.37 -30.69 63.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -64.61 -57.4 9.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.599 -0.688 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.74 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 49.4 m-85 -61.84 -30.35 70.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.469 -0.77 . . . . 0.0 109.502 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.44 -33.66 76.05 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.83 -24.54 52.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.799 -0.563 . . . . 0.0 109.94 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.72 4.1 26.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 110.534 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.04 63.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG13 ' CG ' ' A' ' 59' ' ' ASP . 63.7 t -116.78 150.07 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.932 . . . . 0.0 109.221 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.73 154.69 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.961 HD12 HD13 ' A' ' 80' ' ' ILE . 45.4 mt -126.22 111.53 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -82.84 117.66 22.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.593 . . . . 0.0 109.938 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.598 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.6 m-85 -87.62 129.54 35.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.249 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.28 -28.86 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.02 -23.54 38.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.518 -0.739 . . . . 0.0 110.241 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.18 -67.7 0.94 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.84 . . . . 0.0 109.762 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.9 -30.26 1.66 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.2 pt -127.64 -170.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.653 -0.91 . . . . 0.0 109.336 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.82 150.0 38.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.762 . . . . 0.0 109.582 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' THR . 2.5 t -68.89 77.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.0 72.19 3.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.654 . . . . 0.0 109.442 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.1 55.67 4.71 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -122.35 84.91 2.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.529 -0.983 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -63.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.476 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.08 -71.72 0.19 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.578 179.901 . . . . . . . . 0 0 . 1 stop_ save_